HENGJR的个人主页 - 老虎社区

HENGJR

HENGJR

暂无个人介绍

IP属地：未知

2关注

19粉丝

0主题

0勋章

2021-11-20

help like pls

抱歉，原内容已删除

2021-11-19

help like pls

UWM Holdings jumped over 25% in premarket trading as it announced intent to accelerate buyback in Lieu<blockquote>UWM Holdings宣布有意加速回购，盘前交易中股价上涨超过25%</blockquote>

2021-11-18

help like pls

Economic Data Scheduled For Thursday<blockquote>经济数据定于周四公布</blockquote>

2021-11-17

help liek

Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>

2021-11-13

help like

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>

2021-11-11

help like pls

Lordstown Motors shares rose nearly 12% in premarket trading<blockquote>Lordstown Motors股价在盘前交易中上涨近12%</blockquote>

2021-11-09

help like

抱歉，原内容已删除

2021-11-08

help like

抱歉，原内容已删除

2021-11-07

help like

抱歉，原内容已删除

2021-11-05

help like pls

S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>

2021-11-03

help like pls

抱歉，原内容已删除

2021-11-02

help like pls

抱歉，原内容已删除

2021-11-01

help like pls

Federal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote>

2021-10-29

help like pls

抱歉，原内容已删除

2021-10-28

help like

Tesla Lands A Massive Deal And Breaks $1 Trillion: Are Shares A Buy?<blockquote>特斯拉达成巨额交易并突破1万亿美元：股票值得买入吗？</blockquote>

2021-10-27

help me like

GM Earnings Are Coming. Fasten Your Seat Belts.<blockquote>通用汽车财报即将公布。系好安全带。</blockquote>

2021-10-26

help like

AMD earnings look to again succeed where Intel disappointed<blockquote>AMD盈利有望在英特尔失望的地方再次取得成功</blockquote>

2021-10-23

help like pls

抱歉，原内容已删除

2021-10-22

help like pls

抱歉，原内容已删除

2021-10-19

help like pls

Tesla and 15 Other EV Stocks Are Worth Almost as Much as 50 Traditional Car Makers. How That Makes Sense.<blockquote>特斯拉和其他15只电动汽车股票的价值几乎相当于50家传统汽车制造商的价值。这怎么说得通。</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3578460931764306","uuid":"3578460931764306","gmtCreate":1615374437118,"gmtModify":1619574399943,"name":"HENGJR","pinyin":"hengjr","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":2,"tweetSize":197,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":872318530,"gmtCreate":1637421469911,"gmtModify":1637421470059,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872318530","repostId":"2184842262","repostType":4,"isVote":1,"tweetType":1,"viewCount":2079,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876209637,"gmtCreate":1637313614316,"gmtModify":1637314149260,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876209637","repostId":"1119354167","repostType":4,"repost":{"id":"1119354167","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637313184,"share":"https://www.laohu8.com/m/news/1119354167?lang=zh_CN&edition=full","pubTime":"2021-11-19 17:13","market":"us","language":"en","title":"UWM Holdings jumped over 25% in premarket trading as it announced intent to accelerate buyback in Lieu<blockquote>UWM Holdings宣布有意加速回购，盘前交易中股价上涨超过25%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119354167","media":"Tiger Newspress","summary":"UWM Holdings jumped over 25% in premarket trading as it announcedintent toacceleratebuyback in Lieu.","content":"<p>UWM Holdings jumped over 25% in premarket trading as it announcedintent toacceleratebuyback in Lieu.<img src=\"https://static.tigerbbs.com/f0d671a811afdf36d2d0ec3172fc0153\" tg-width=\"774\" tg-height=\"570\" width=\"100%\" height=\"auto\">The company&nbsp;announced that SFS Holding Corp, (“SFS”), its principal shareholder, has terminated the previously announced secondary offering of Class A Common Stock and concurrent stock repurchase effective immediately (the “Offering”). The Offering was intended to increase UWMC’s public float by approximately 50%, thereby making it a more liquid, tradable stock for larger indexes and institutional investors, while at the same time utilizing the Company’s buyback authorization to reduce the number of fully diluted shares outstanding. However, the market’s reaction to the Offering resulted in a share price level at which SFS is not willing to sell. With the termination of the Offering, no shares of common stock will be sold by SFS at this time. Instead, the Company intends to accelerate its previously announced buyback program and defer its plans to increase public float to a later date.</p><p><blockquote>UWM Holdings宣布打算加速回购，盘前交易中股价上涨超过25%。公司宣布，其主要股东SFS Holding Corp（“SFS”）已终止之前宣布的A类普通股二次发行和同步股票回购，立即生效（“发行”）。此次发行旨在将UWMC的公众持股量增加约50%，从而使其成为大型指数和机构投资者更具流动性、可交易的股票，同时利用公司的回购授权减少已发行股票的数量。然而，市场对此次发行的反应导致SFS不愿意出售的股价水平。随着发行的终止，SFS目前不会出售任何普通股。相反，该公司打算加快此前宣布的回购计划，并将增加公众持股量的计划推迟到稍后日期。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UWM Holdings jumped over 25% in premarket trading as it announced intent to accelerate buyback in Lieu<blockquote>UWM Holdings宣布有意加速回购，盘前交易中股价上涨超过25%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUWM Holdings jumped over 25% in premarket trading as it announced intent to accelerate buyback in Lieu<blockquote>UWM Holdings宣布有意加速回购，盘前交易中股价上涨超过25%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 17:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>UWM Holdings jumped over 25% in premarket trading as it announcedintent toacceleratebuyback in Lieu.<img src=\"https://static.tigerbbs.com/f0d671a811afdf36d2d0ec3172fc0153\" tg-width=\"774\" tg-height=\"570\" width=\"100%\" height=\"auto\">The company&nbsp;announced that SFS Holding Corp, (“SFS”), its principal shareholder, has terminated the previously announced secondary offering of Class A Common Stock and concurrent stock repurchase effective immediately (the “Offering”). The Offering was intended to increase UWMC’s public float by approximately 50%, thereby making it a more liquid, tradable stock for larger indexes and institutional investors, while at the same time utilizing the Company’s buyback authorization to reduce the number of fully diluted shares outstanding. However, the market’s reaction to the Offering resulted in a share price level at which SFS is not willing to sell. With the termination of the Offering, no shares of common stock will be sold by SFS at this time. Instead, the Company intends to accelerate its previously announced buyback program and defer its plans to increase public float to a later date.</p><p><blockquote>UWM Holdings宣布打算加速回购，盘前交易中股价上涨超过25%。公司宣布，其主要股东SFS Holding Corp（“SFS”）已终止之前宣布的A类普通股二次发行和同步股票回购，立即生效（“发行”）。此次发行旨在将UWMC的公众持股量增加约50%，从而使其成为大型指数和机构投资者更具流动性、可交易的股票，同时利用公司的回购授权减少已发行股票的数量。然而，市场对此次发行的反应导致SFS不愿意出售的股价水平。随着发行的终止，SFS目前不会出售任何普通股。相反，该公司打算加快此前宣布的回购计划，并将增加公众持股量的计划推迟到稍后日期。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UWMC":"UWM Holdings Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119354167","content_text":"UWM Holdings jumped over 25% in premarket trading as it announcedintent toacceleratebuyback in Lieu.The company announced that SFS Holding Corp, (“SFS”), its principal shareholder, has terminated the previously announced secondary offering of Class A Common Stock and concurrent stock repurchase effective immediately (the “Offering”). The Offering was intended to increase UWMC’s public float by approximately 50%, thereby making it a more liquid, tradable stock for larger indexes and institutional investors, while at the same time utilizing the Company’s buyback authorization to reduce the number of fully diluted shares outstanding. However, the market’s reaction to the Offering resulted in a share price level at which SFS is not willing to sell. With the termination of the Offering, no shares of common stock will be sold by SFS at this time. Instead, the Company intends to accelerate its previously announced buyback program and defer its plans to increase public float to a later date.","news_type":1,"symbols_score_info":{"UWMC":0.9}},"isVote":1,"tweetType":1,"viewCount":3041,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878424026,"gmtCreate":1637224425629,"gmtModify":1637224425738,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878424026","repostId":"1114948837","repostType":4,"repost":{"id":"1114948837","kind":"news","pubTimestamp":1637224199,"share":"https://www.laohu8.com/m/news/1114948837?lang=zh_CN&edition=full","pubTime":"2021-11-18 16:29","market":"us","language":"en","title":"Economic Data Scheduled For Thursday<blockquote>经济数据定于周四公布</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1114948837","media":"Benzinga","summary":"Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 7:30 a.m. ET.\nData on in","content":"<p><div> Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 7:30 a.m. ET. Data on initial jobless claims for the latest week will be released ay 8:30 a.m. ET. Analysts expect jobless ...</p><p><blockquote><div>亚特兰大联邦储备银行行长拉斐尔·博斯蒂克定于美国东部时间上午7:30发表讲话。最近一周首次申请失业救济人数数据将于美国东部时间上午8:30公布。分析师预计失业...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24163360/economic-data-scheduled-for-thursday\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24163360/economic-data-scheduled-for-thursday\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Economic Data Scheduled For Thursday<blockquote>经济数据定于周四公布</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEconomic Data Scheduled For Thursday<blockquote>经济数据定于周四公布</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-18 16:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 7:30 a.m. ET. Data on initial jobless claims for the latest week will be released ay 8:30 a.m. ET. Analysts expect jobless ...</p><p><blockquote><div>亚特兰大联邦储备银行行长拉斐尔·博斯蒂克定于美国东部时间上午7:30发表讲话。最近一周首次申请失业救济人数数据将于美国东部时间上午8:30公布。分析师预计失业...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24163360/economic-data-scheduled-for-thursday\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24163360/economic-data-scheduled-for-thursday\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/24163360/economic-data-scheduled-for-thursday\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/news/21/11/24163360/economic-data-scheduled-for-thursday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114948837","content_text":"Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 7:30 a.m. ET.\nData on initial jobless claims for the latest week will be released ay 8:30 a.m. ET. Analysts expect jobless claims declining to 261,000 for the November 13 week from 267,000 in the previous week.\nThe Philadelphia Fed manufacturing index for November is scheduled for release at 8:30 a.m. ET. The index is expected to decline to 21.4 in November from previous reading of 23.8.\nFederal Reserve Bank of New York President John Williams will speak at 9:30 a.m. ET.\nData on e-commerce retail sales for the third quarter will be released at 10:00 a.m. ET.\nThe index of leading economic indicators for October is scheduled for release at 10:00 a.m. ET. The LEI slowed to an increase of 0.2% in September that fell short of market estimates. Analysts, however, expect October's index rebounding 0.8%.\nThe Energy Information Administration’s weekly report on natural gas stocks in underground storage is scheduled for release at 10:30 a.m. ET.\nThe Kansas City Fed manufacturing index for November will be released at 11:00 a.m. ET.\nThe Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.\nFederal Reserve Bank of Chicago President Charles Evans is set to speak at 2:00 p.m. ET.\nSan Francisco Federal Reserve Bank President Mary Daly will speak at 3:30 p.m. ET.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878134865,"gmtCreate":1637158688164,"gmtModify":1637158688263,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help liek","listText":"help liek","text":"help liek","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/878134865","repostId":"1102706296","repostType":4,"repost":{"id":"1102706296","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637154279,"share":"https://www.laohu8.com/m/news/1102706296?lang=zh_CN&edition=full","pubTime":"2021-11-17 21:04","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102706296","media":"Tiger Newspress","summary":"U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.At 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.Tesla – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million","content":"<p>U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.</p><p><blockquote>美国股指期货周三持平，因强劲的零售盈利和数据显示经济复苏步入正轨后，投资者对美联储提前加息感到担忧。</blockquote></p><p> At 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&amp;P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.</p><p><blockquote>美国东部时间上午08:00，道琼斯电子迷你指数下跌25点，跌幅0.07%。标普500 e-mini上涨0.25点，涨幅0.01%，纳斯达克100 e-mini上涨24.25点，涨幅0.15%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3313a552f1f185ff01396db4679b33e7\" tg-width=\"1080\" tg-height=\"411\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Tesla(TSLA)</b> – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million shares. Tesla rose 1.2% in premarket action.</p><p><blockquote><b>特斯拉(TSLA)</b>——特斯拉CEO Elon Musk又出售了9.73亿美元的特斯拉股票，以支付因行使涵盖210万股股票的期权而产生的税单。特斯拉在盘前上涨1.2%。</blockquote></p><p> <b>Rivian(RIVN)</b> – Rivian turned red from green in the premarket and has yet to experience a losing session since the electric vehicle maker went public last Wednesday. Rivian has been up about 15% in each of the past two trading days and closed Tuesday at $172.01 compared with its IPO price of $78.</p><p><blockquote><b>Rivian(RIVN)</b>-Rivian在盘前由绿转红，自这家电动汽车制造商上周三上市以来尚未经历过亏损。Rivian在过去两个交易日中每个交易日均上涨约15%，周二收盘价为172.01美元，而其IPO价格为78美元。</blockquote></p><p> <b>Lucid Group(LCID)</b> – The electric vehicle maker rose another 5.5% in the premarket following a nearly 24% surge Tuesday. Yesterday’s rally came amid Lucid’s statement that it was seeing “significant demand” for its Lucid Air model.</p><p><blockquote><b>Lucid集团(LCID)</b>–这家电动汽车制造商继周二飙升近24%后，盘前又上涨5.5%。昨天的上涨是在Lucid声明看到对其Lucid Air型号的“巨大需求”之际发生的。</blockquote></p><p> <b>Pfizer(PFE),BioNTech(BNTX)</b> – The FDA has promised a quick review of the application to approve the Pfizer/BioNTech Covid-19 booster dose for all adults. The New York Times reports that a decision could come as soon as Thursday. BioNTech rose 1.6% in the premarket, while Pfizer gained 0.7%.</p><p><blockquote><b>辉瑞(PFE)、BioNTech(BNTX)</b>-FDA承诺快速审查批准辉瑞/BioNTech新冠加强剂量用于所有成年人的申请。《纽约时报》报道称，最早可能于周四做出决定。BioNTech盘前上涨1.6%，辉瑞上涨0.7%。</blockquote></p><p> <b>Roku(ROKU) </b>– The stock was downgraded to “sell” from “neutral” at Moffett Nathanson, which said signs of slowing revenue growth for the video streaming device maker have become more obvious and forced the firm to rethink its long-term assumptions. Roku shares fell 2.8% in premarket trading.</p><p><blockquote><b>Roku(Roku)</b>-Moffett Nathanson将该股评级从“中性”下调至“卖出”，该公司表示，这家视频流媒体设备制造商收入增长放缓的迹象变得更加明显，迫使该公司重新考虑其长期假设。Roku股价在盘前交易中下跌2.8%。</blockquote></p><p> <b>Baidu(BIDU)</b> – Baidu beat estimates on the top and bottom lines for its latest quarter, with the China-based e-commerce company benefiting from stronger ad sales as well as strength in cloud and artificial intelligence products. Baidu added 0.5% in the premarket.</p><p><blockquote><b>百度(BIDU)</b>-百度最近一个季度的营收和利润均超出预期，这家总部位于中国的电子商务公司受益于强劲的广告销售以及云和人工智能产品的实力。百度盘前上涨0.5%。</blockquote></p><p> <b>Visa(V)</b>&nbsp;–&nbsp;Visa&nbsp;fell 3.4% after Amazon.com&nbsp;said it would stop accepting credit cards issued by the world's largest payment processor in the United Kingdom from next year due to the high fees charged for transactions.</p><p><blockquote><b>签证(V)</b>-Visa跌3.4%，此前亚马逊表示，由于交易收取高额费用，将从明年起停止接受全球最大支付处理商英国发行的信用卡。</blockquote></p><p> <b>Boeing(BA)</b>&nbsp;–&nbsp;Wells Fargo&nbsp;upgraded shares of Boeing to overweight from equal weight, saying in a note to clients Wednesday that the company was set up for a stretch of good news following several years of underperformance.Boeing&nbsp;shares&nbsp;rose&nbsp;1.6%&nbsp;in premarket trading.</p><p><blockquote><b>波音(BA)</b>-富国银行周三在给客户的一份报告中表示，该公司在经历了几年的表现不佳后，已经准备好迎接一系列利好消息。波音股价在盘前交易中上涨1.</blockquote></p><p> <b>PayPal(PYPL)</b>&nbsp;–&nbsp;PayPal Holdings&nbsp;shares&nbsp;slip 2.3%&nbsp;in premarket trading after Bernstein analyst Harshita Rawat downgrades the stock to Market Perform from Outperform as change in the payments space accelerates putting PayPal at risk of being disrupted.</p><p><blockquote><b>PayPal(PYPL)</b>-PayPal控股公司股价在盘前交易中下跌2.3%，此前Bernstein分析师Harshita Rawat将该股评级从跑赢大盘下调至大盘表现，因为支付领域的变化加速，PayPal面临被扰乱的风险。</blockquote></p><p> <b>Lowe’s(LOW)</b> – Lowe’s rose 3.4% in the premarket after beating estimates on the top and bottom lines and raising its annual revenue forecast. The home improvement retailer earned an adjusted $2.73 per share for the third quarter, 37 cents above estimates, with comparable store sales up 2.2%. Analysts had expected comp sales to decline by 1.5%.</p><p><blockquote><b>劳氏（低）</b>-劳氏(Lowe's)在营收和利润超出预期并上调年收入预期后，盘前上涨3.4%。这家家居装修零售商第三季度调整后每股收益为2.73美元，比预期高出37美分，同店销售额增长2.2%。分析师此前预计公司销售额将下降1.5%。</blockquote></p><p> <b>Target(TGT)</b> – Target reported an adjusted quarterly profit of $3.03 per share, beating consensus estimates by 20 cents, with revenue also above Street projections. Comparable store sales rose 12.7% compared with forecasts of an 8.2% increase. Despite the beats, the retailer’s shares slid 3.7% in premarket action.</p><p><blockquote><b>目标（TGT）</b>-Target公布调整后季度利润为每股3.03美元，比市场普遍预期高出20美分，收入也高于华尔街预测。同店销售额增长12.7%，预期增长8.2%。尽管表现出色，该零售商的股价在盘前下跌了3.7%。</blockquote></p><p> <b>GlaxoSmithKline(GSK),Vir Biotechnology(VIR)</b> – The drug makers signed contracts to sell about $1 billion worth of their Covid-19 treatment to the U.S. government. The government also has an option to buy additional doses that last through March 2022. Glaxo was down 0.4% in premarket trading, but Vir’s stock soared 13.4%.</p><p><blockquote><b>葛兰素史克(GSK)、维尔生物技术(VIR)</b>-制药商签署了向美国政府出售价值约10亿美元的Covid-19治疗药物的合同。政府还可以选择购买持续到2022年3月的额外剂量。葛兰素史克在盘前交易中下跌0.4%，但Vir股价飙升13.4%。</blockquote></p><p> <b>Arrival(ARVL)</b>&nbsp;–&nbsp;Arrival&nbsp;stock&nbsp;tumbled&nbsp;13.4%&nbsp;in premarket trading.Arrival&nbsp;announced today the commencement of an underwritten public offering of 25,000,000 ordinary shares (the “Follow-on Offering”) pursuant to a registration statement on Form F-1 filed with&nbsp;SEC. In connection with the Follow-on Offering, Arrival intends to grant the underwriters the option to purchase up to 3,750,000 additional ordinary shares. All shares are being offered by Arrival.</p><p><blockquote><b>到达(ARVL)</b>Arrival股票在盘前交易中暴跌13.4%。Arrival今天宣布，根据向美国证券交易委员会提交的F-1表格登记声明，开始承销公开发行25,000,000股普通股（“后续发行”）。就后续发行而言，Arrival打算授予承销商购买最多3,750,000股额外普通股的选择权。所有股票均由Arrival发行。</blockquote></p><p> <b>La-Z-Boy(LZB)</b> – La-Z-Boy jumped 7.6% in premarket trading after the furniture maker beat estimates by 8 cents with a quarterly profit of 85 cents per share. Revenue also beat forecasts, and the company said it continues to see strong consumer demand although it has been impacted by supply chain disruptions.</p><p><blockquote><b>La-Z-Boy(LZB)</b>-La-Z-Boy在盘前交易中上涨7.6%，此前这家家具制造商超出预期8美分，季度利润为每股85美分。收入也超出了预期，该公司表示，尽管受到供应链中断的影响，但消费者需求仍然强劲。</blockquote></p><p></p><p> <b>Deere(DE) </b>– Deere workers will vote on a tentative contract offer today, after rejecting two previous tentative pacts. Those workers have been on strike since October 14.</p><p><blockquote><b>Deere（DE）</b>-在拒绝了之前的两项暂定协议后，Deere工人将于今天就暂定合同进行投票。这些工人自10月14日以来一直在罢工。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-17 21:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.</p><p><blockquote>美国股指期货周三持平，因强劲的零售盈利和数据显示经济复苏步入正轨后，投资者对美联储提前加息感到担忧。</blockquote></p><p> At 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&amp;P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.</p><p><blockquote>美国东部时间上午08:00，道琼斯电子迷你指数下跌25点，跌幅0.07%。标普500 e-mini上涨0.25点，涨幅0.01%，纳斯达克100 e-mini上涨24.25点，涨幅0.15%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3313a552f1f185ff01396db4679b33e7\" tg-width=\"1080\" tg-height=\"411\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Tesla(TSLA)</b> – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million shares. Tesla rose 1.2% in premarket action.</p><p><blockquote><b>特斯拉(TSLA)</b>——特斯拉CEO Elon Musk又出售了9.73亿美元的特斯拉股票，以支付因行使涵盖210万股股票的期权而产生的税单。特斯拉在盘前上涨1.2%。</blockquote></p><p> <b>Rivian(RIVN)</b> – Rivian turned red from green in the premarket and has yet to experience a losing session since the electric vehicle maker went public last Wednesday. Rivian has been up about 15% in each of the past two trading days and closed Tuesday at $172.01 compared with its IPO price of $78.</p><p><blockquote><b>Rivian(RIVN)</b>-Rivian在盘前由绿转红，自这家电动汽车制造商上周三上市以来尚未经历过亏损。Rivian在过去两个交易日中每个交易日均上涨约15%，周二收盘价为172.01美元，而其IPO价格为78美元。</blockquote></p><p> <b>Lucid Group(LCID)</b> – The electric vehicle maker rose another 5.5% in the premarket following a nearly 24% surge Tuesday. Yesterday’s rally came amid Lucid’s statement that it was seeing “significant demand” for its Lucid Air model.</p><p><blockquote><b>Lucid集团(LCID)</b>–这家电动汽车制造商继周二飙升近24%后，盘前又上涨5.5%。昨天的上涨是在Lucid声明看到对其Lucid Air型号的“巨大需求”之际发生的。</blockquote></p><p> <b>Pfizer(PFE),BioNTech(BNTX)</b> – The FDA has promised a quick review of the application to approve the Pfizer/BioNTech Covid-19 booster dose for all adults. The New York Times reports that a decision could come as soon as Thursday. BioNTech rose 1.6% in the premarket, while Pfizer gained 0.7%.</p><p><blockquote><b>辉瑞(PFE)、BioNTech(BNTX)</b>-FDA承诺快速审查批准辉瑞/BioNTech新冠加强剂量用于所有成年人的申请。《纽约时报》报道称，最早可能于周四做出决定。BioNTech盘前上涨1.6%，辉瑞上涨0.7%。</blockquote></p><p> <b>Roku(ROKU) </b>– The stock was downgraded to “sell” from “neutral” at Moffett Nathanson, which said signs of slowing revenue growth for the video streaming device maker have become more obvious and forced the firm to rethink its long-term assumptions. Roku shares fell 2.8% in premarket trading.</p><p><blockquote><b>Roku(Roku)</b>-Moffett Nathanson将该股评级从“中性”下调至“卖出”，该公司表示，这家视频流媒体设备制造商收入增长放缓的迹象变得更加明显，迫使该公司重新考虑其长期假设。Roku股价在盘前交易中下跌2.8%。</blockquote></p><p> <b>Baidu(BIDU)</b> – Baidu beat estimates on the top and bottom lines for its latest quarter, with the China-based e-commerce company benefiting from stronger ad sales as well as strength in cloud and artificial intelligence products. Baidu added 0.5% in the premarket.</p><p><blockquote><b>百度(BIDU)</b>-百度最近一个季度的营收和利润均超出预期，这家总部位于中国的电子商务公司受益于强劲的广告销售以及云和人工智能产品的实力。百度盘前上涨0.5%。</blockquote></p><p> <b>Visa(V)</b>&nbsp;–&nbsp;Visa&nbsp;fell 3.4% after Amazon.com&nbsp;said it would stop accepting credit cards issued by the world's largest payment processor in the United Kingdom from next year due to the high fees charged for transactions.</p><p><blockquote><b>签证(V)</b>-Visa跌3.4%，此前亚马逊表示，由于交易收取高额费用，将从明年起停止接受全球最大支付处理商英国发行的信用卡。</blockquote></p><p> <b>Boeing(BA)</b>&nbsp;–&nbsp;Wells Fargo&nbsp;upgraded shares of Boeing to overweight from equal weight, saying in a note to clients Wednesday that the company was set up for a stretch of good news following several years of underperformance.Boeing&nbsp;shares&nbsp;rose&nbsp;1.6%&nbsp;in premarket trading.</p><p><blockquote><b>波音(BA)</b>-富国银行周三在给客户的一份报告中表示，该公司在经历了几年的表现不佳后，已经准备好迎接一系列利好消息。波音股价在盘前交易中上涨1.</blockquote></p><p> <b>PayPal(PYPL)</b>&nbsp;–&nbsp;PayPal Holdings&nbsp;shares&nbsp;slip 2.3%&nbsp;in premarket trading after Bernstein analyst Harshita Rawat downgrades the stock to Market Perform from Outperform as change in the payments space accelerates putting PayPal at risk of being disrupted.</p><p><blockquote><b>PayPal(PYPL)</b>-PayPal控股公司股价在盘前交易中下跌2.3%，此前Bernstein分析师Harshita Rawat将该股评级从跑赢大盘下调至大盘表现，因为支付领域的变化加速，PayPal面临被扰乱的风险。</blockquote></p><p> <b>Lowe’s(LOW)</b> – Lowe’s rose 3.4% in the premarket after beating estimates on the top and bottom lines and raising its annual revenue forecast. The home improvement retailer earned an adjusted $2.73 per share for the third quarter, 37 cents above estimates, with comparable store sales up 2.2%. Analysts had expected comp sales to decline by 1.5%.</p><p><blockquote><b>劳氏（低）</b>-劳氏(Lowe's)在营收和利润超出预期并上调年收入预期后，盘前上涨3.4%。这家家居装修零售商第三季度调整后每股收益为2.73美元，比预期高出37美分，同店销售额增长2.2%。分析师此前预计公司销售额将下降1.5%。</blockquote></p><p> <b>Target(TGT)</b> – Target reported an adjusted quarterly profit of $3.03 per share, beating consensus estimates by 20 cents, with revenue also above Street projections. Comparable store sales rose 12.7% compared with forecasts of an 8.2% increase. Despite the beats, the retailer’s shares slid 3.7% in premarket action.</p><p><blockquote><b>目标（TGT）</b>-Target公布调整后季度利润为每股3.03美元，比市场普遍预期高出20美分，收入也高于华尔街预测。同店销售额增长12.7%，预期增长8.2%。尽管表现出色，该零售商的股价在盘前下跌了3.7%。</blockquote></p><p> <b>GlaxoSmithKline(GSK),Vir Biotechnology(VIR)</b> – The drug makers signed contracts to sell about $1 billion worth of their Covid-19 treatment to the U.S. government. The government also has an option to buy additional doses that last through March 2022. Glaxo was down 0.4% in premarket trading, but Vir’s stock soared 13.4%.</p><p><blockquote><b>葛兰素史克(GSK)、维尔生物技术(VIR)</b>-制药商签署了向美国政府出售价值约10亿美元的Covid-19治疗药物的合同。政府还可以选择购买持续到2022年3月的额外剂量。葛兰素史克在盘前交易中下跌0.4%，但Vir股价飙升13.4%。</blockquote></p><p> <b>Arrival(ARVL)</b>&nbsp;–&nbsp;Arrival&nbsp;stock&nbsp;tumbled&nbsp;13.4%&nbsp;in premarket trading.Arrival&nbsp;announced today the commencement of an underwritten public offering of 25,000,000 ordinary shares (the “Follow-on Offering”) pursuant to a registration statement on Form F-1 filed with&nbsp;SEC. In connection with the Follow-on Offering, Arrival intends to grant the underwriters the option to purchase up to 3,750,000 additional ordinary shares. All shares are being offered by Arrival.</p><p><blockquote><b>到达(ARVL)</b>Arrival股票在盘前交易中暴跌13.4%。Arrival今天宣布，根据向美国证券交易委员会提交的F-1表格登记声明，开始承销公开发行25,000,000股普通股（“后续发行”）。就后续发行而言，Arrival打算授予承销商购买最多3,750,000股额外普通股的选择权。所有股票均由Arrival发行。</blockquote></p><p> <b>La-Z-Boy(LZB)</b> – La-Z-Boy jumped 7.6% in premarket trading after the furniture maker beat estimates by 8 cents with a quarterly profit of 85 cents per share. Revenue also beat forecasts, and the company said it continues to see strong consumer demand although it has been impacted by supply chain disruptions.</p><p><blockquote><b>La-Z-Boy(LZB)</b>-La-Z-Boy在盘前交易中上涨7.6%，此前这家家具制造商超出预期8美分，季度利润为每股85美分。收入也超出了预期，该公司表示，尽管受到供应链中断的影响，但消费者需求仍然强劲。</blockquote></p><p></p><p> <b>Deere(DE) </b>– Deere workers will vote on a tentative contract offer today, after rejecting two previous tentative pacts. Those workers have been on strike since October 14.</p><p><blockquote><b>Deere（DE）</b>-在拒绝了之前的两项暂定协议后，Deere工人将于今天就暂定合同进行投票。这些工人自10月14日以来一直在罢工。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LOW":"劳氏","LZB":"La-Z-Boy家具",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","RIVN":"Rivian Automotive, Inc.","V":"Visa","TGT":"塔吉特","VIR":"Vir Biotechnology, Inc.","BIDU":"百度","BNTX":"BioNTech SE","PYPL":"PayPal","ROKU":"Roku Inc","BA":"波音","GSK":"葛兰素史克","PFE":"辉瑞","LCID":"Lucid Group Inc","TSLA":"特斯拉","DE":"迪尔股份有限公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102706296","content_text":"U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.\nAt 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.\n\nStocks making the biggest moves premarket:\nTesla(TSLA) – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million shares. Tesla rose 1.2% in premarket action.\nRivian(RIVN) – Rivian turned red from green in the premarket and has yet to experience a losing session since the electric vehicle maker went public last Wednesday. Rivian has been up about 15% in each of the past two trading days and closed Tuesday at $172.01 compared with its IPO price of $78.\nLucid Group(LCID) – The electric vehicle maker rose another 5.5% in the premarket following a nearly 24% surge Tuesday. Yesterday’s rally came amid Lucid’s statement that it was seeing “significant demand” for its Lucid Air model.\nPfizer(PFE),BioNTech(BNTX) – The FDA has promised a quick review of the application to approve the Pfizer/BioNTech Covid-19 booster dose for all adults. The New York Times reports that a decision could come as soon as Thursday. BioNTech rose 1.6% in the premarket, while Pfizer gained 0.7%.\nRoku(ROKU) – The stock was downgraded to “sell” from “neutral” at Moffett Nathanson, which said signs of slowing revenue growth for the video streaming device maker have become more obvious and forced the firm to rethink its long-term assumptions. Roku shares fell 2.8% in premarket trading.\nBaidu(BIDU) – Baidu beat estimates on the top and bottom lines for its latest quarter, with the China-based e-commerce company benefiting from stronger ad sales as well as strength in cloud and artificial intelligence products. Baidu added 0.5% in the premarket.\nVisa(V) – Visa fell 3.4% after Amazon.com said it would stop accepting credit cards issued by the world's largest payment processor in the United Kingdom from next year due to the high fees charged for transactions.\nBoeing(BA) – Wells Fargo upgraded shares of Boeing to overweight from equal weight, saying in a note to clients Wednesday that the company was set up for a stretch of good news following several years of underperformance.Boeing shares rose 1.6% in premarket trading.\nPayPal(PYPL) – PayPal Holdings shares slip 2.3% in premarket trading after Bernstein analyst Harshita Rawat downgrades the stock to Market Perform from Outperform as change in the payments space accelerates putting PayPal at risk of being disrupted.\nLowe’s(LOW) – Lowe’s rose 3.4% in the premarket after beating estimates on the top and bottom lines and raising its annual revenue forecast. The home improvement retailer earned an adjusted $2.73 per share for the third quarter, 37 cents above estimates, with comparable store sales up 2.2%. Analysts had expected comp sales to decline by 1.5%.\nTarget(TGT) – Target reported an adjusted quarterly profit of $3.03 per share, beating consensus estimates by 20 cents, with revenue also above Street projections. Comparable store sales rose 12.7% compared with forecasts of an 8.2% increase. Despite the beats, the retailer’s shares slid 3.7% in premarket action.\nGlaxoSmithKline(GSK),Vir Biotechnology(VIR) – The drug makers signed contracts to sell about $1 billion worth of their Covid-19 treatment to the U.S. government. The government also has an option to buy additional doses that last through March 2022. Glaxo was down 0.4% in premarket trading, but Vir’s stock soared 13.4%.\nArrival(ARVL) – Arrival stock tumbled 13.4% in premarket trading.Arrival announced today the commencement of an underwritten public offering of 25,000,000 ordinary shares (the “Follow-on Offering”) pursuant to a registration statement on Form F-1 filed with SEC. In connection with the Follow-on Offering, Arrival intends to grant the underwriters the option to purchase up to 3,750,000 additional ordinary shares. All shares are being offered by Arrival.\nLa-Z-Boy(LZB) – La-Z-Boy jumped 7.6% in premarket trading after the furniture maker beat estimates by 8 cents with a quarterly profit of 85 cents per share. Revenue also beat forecasts, and the company said it continues to see strong consumer demand although it has been impacted by supply chain disruptions.\nDeere(DE) – Deere workers will vote on a tentative contract offer today, after rejecting two previous tentative pacts. Those workers have been on strike since October 14.","news_type":1,"symbols_score_info":{"YMmain":0.9,"V":0.9,"PFE":0.9,"TGT":0.9,"ROKU":0.9,".IXIC":0.9,".DJI":0.9,"BA":0.9,"LCID":0.9,"PYPL":0.9,"RIVN":0.9,"TSLA":0.9,"LZB":0.9,"ARVL":0.9,".SPX":0.9,"GSK":0.9,"LOW":0.9,"VIR":0.9,"DE":0.9,"BNTX":0.9,"BIDU":0.9,"ESmain":0.9,"NQmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2051,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873008385,"gmtCreate":1636784519129,"gmtModify":1636784519231,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873008385","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870533937,"gmtCreate":1636631377984,"gmtModify":1636631378308,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870533937","repostId":"1152179749","repostType":4,"repost":{"id":"1152179749","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636630921,"share":"https://www.laohu8.com/m/news/1152179749?lang=zh_CN&edition=full","pubTime":"2021-11-11 19:42","market":"us","language":"en","title":"Lordstown Motors shares rose nearly 12% in premarket trading<blockquote>Lordstown Motors股价在盘前交易中上涨近12%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152179749","media":"Tiger Newspress","summary":"Lordstown Motors shares rose nearly 12% in premarket trading.Lordstown Motors Corp said on Wednesday","content":"<p>Lordstown&nbsp;Motors&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/97e386320197b4b678930cb38e14a8a0\" tg-width=\"870\" tg-height=\"582\" referrerpolicy=\"no-referrer\">Lordstown Motors Corp said on Wednesday that&nbsp;Foxconn has bought stock worth $50 million from the U.S. electric vehicle maker, finalizing an equity investment announced in September.</p><p><blockquote>Lordstown Motors股价在盘前交易中上涨近12%。洛兹敦汽车公司周三表示，富士康已从这家美国电动汽车制造商购买了价值5000万美元的股票，完成了9月份宣布的股权投资。</blockquote></p><p> Foxconn acquired the shares at $6.8983 apiece, Lordstown said.</p><p><blockquote>洛兹敦表示，富士康以每股6.8983美元的价格收购了这些股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown Motors shares rose nearly 12% in premarket trading<blockquote>Lordstown Motors股价在盘前交易中上涨近12%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown Motors shares rose nearly 12% in premarket trading<blockquote>Lordstown Motors股价在盘前交易中上涨近12%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-11 19:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Lordstown&nbsp;Motors&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/97e386320197b4b678930cb38e14a8a0\" tg-width=\"870\" tg-height=\"582\" referrerpolicy=\"no-referrer\">Lordstown Motors Corp said on Wednesday that&nbsp;Foxconn has bought stock worth $50 million from the U.S. electric vehicle maker, finalizing an equity investment announced in September.</p><p><blockquote>Lordstown Motors股价在盘前交易中上涨近12%。洛兹敦汽车公司周三表示，富士康已从这家美国电动汽车制造商购买了价值5000万美元的股票，完成了9月份宣布的股权投资。</blockquote></p><p> Foxconn acquired the shares at $6.8983 apiece, Lordstown said.</p><p><blockquote>洛兹敦表示，富士康以每股6.8983美元的价格收购了这些股票。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152179749","content_text":"Lordstown Motors shares rose nearly 12% in premarket trading.Lordstown Motors Corp said on Wednesday that Foxconn has bought stock worth $50 million from the U.S. electric vehicle maker, finalizing an equity investment announced in September.\nFoxconn acquired the shares at $6.8983 apiece, Lordstown said.","news_type":1,"symbols_score_info":{"RIDE":0.9}},"isVote":1,"tweetType":1,"viewCount":2098,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844253455,"gmtCreate":1636433295709,"gmtModify":1636433296067,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844253455","repostId":"1121670869","repostType":4,"isVote":1,"tweetType":1,"viewCount":3573,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845271827,"gmtCreate":1636345682181,"gmtModify":1636345682593,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/845271827","repostId":"2181284457","repostType":4,"isVote":1,"tweetType":1,"viewCount":2510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845925801,"gmtCreate":1636267978006,"gmtModify":1636267978349,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/845925801","repostId":"2181074782","repostType":4,"isVote":1,"tweetType":1,"viewCount":2653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846532975,"gmtCreate":1636094571515,"gmtModify":1636094571828,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846532975","repostId":"1128227989","repostType":4,"repost":{"id":"1128227989","kind":"news","pubTimestamp":1636067303,"share":"https://www.laohu8.com/m/news/1128227989?lang=zh_CN&edition=full","pubTime":"2021-11-05 07:08","market":"us","language":"en","title":"S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1128227989","media":"Reuters","summary":" - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.Financials dropped 1","content":"<p>(Reuters) - The S&amp;P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p><p><blockquote>（路透社）-标普500和纳斯达克周四上涨，将收盘纪录高位连涨至六个交易日，因高通强劲的财务预测以及投资者消化了美联储开始减少月度债券购买的决定后，芯片制造商股市飙升。</blockquote></p><p> The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase &amp; Co and Goldman Sachs Group weighed on the blue-chip index.</p><p><blockquote>道琼斯工业平均指数小幅下跌，结束了四点收盘的纪录。摩根大通和高盛集团银行股的下跌打压了蓝筹股指数。</blockquote></p><p> Financials dropped 1.3%, most among S&amp;P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p><p><blockquote>金融股下跌1.3%，其中大部分是标普500板块，因美国国债收益率下跌，在美联储表示不急于加息的第二天，市场解除了对美联储更快加息的预期。</blockquote></p><p> “The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p><p><blockquote>John Hancock Investment Management联席首席投资策略师马修·米斯金(Matthew Miskin)表示：“市场的增长方今天看到了更积极的结果，因为它们受益于收益率的下降。”</blockquote></p><p> “The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p><p><blockquote>“鉴于美联储宣布缩减规模，市场总体上一直在为更高的收益率做准备。当我们今天走进来时，这种情况已经发生了逆转。”</blockquote></p><p> The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&amp;P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p><p><blockquote>道琼斯工业平均指数下跌33.35点，跌幅0.09%，至36,124.23点；标普500上涨19.49点，跌幅0.42%，至4,680.06点；纳斯达克综合指数上涨128.72点，跌幅0.81%，至15,940.31点。</blockquote></p><p> The S&amp;P 500 growth index rose 1.2% while the S&amp;P 500 value index fell 0.5%.</p><p><blockquote>标普500增长指数上涨1.2%，标普500价值指数下跌0.5%。</blockquote></p><p> Among S&amp;P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p><p><blockquote>标普500板块中，科技和非必需消费品领涨，均上涨约1.5%。</blockquote></p><p> Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p><p><blockquote>高通股价上涨12.7%，该公司预测本季度利润和收入好于预期，原因是手机、汽车和其他互联网连接设备所用芯片的需求飙升。</blockquote></p><p> The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p><p><blockquote>费城SE半导体指数上涨3.5%，英伟达飙升12%。</blockquote></p><p> Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p><p><blockquote>好于预期的第三季度收益有助于提振股市情绪。根据Refinitiv IBES的数据，约有420家公司发布了财报，预计标普500第三季度盈利将同比增长41.2%。</blockquote></p><p> “The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p><p><blockquote>爱德华·琼斯投资策略师克雷格·费尔表示：“企业盈利情况仍然相当光明。”</blockquote></p><p> “The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p><p><blockquote>“市场正在奖励那些超出预期并上调前景的公司，而市场正在惩罚那些本季度未达到预期的公司，也许更重要的是，这预示着前景更加糟糕。”</blockquote></p><p> Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&amp;P 500 healthcare sector, which fell 0.8%.</p><p><blockquote>Moderna股价暴跌约18%，该公司将其COVID-19疫苗2021年的销售预测削减了多达50亿美元，并努力灌装和分销小瓶，以满足前所未有的全球需求。Moderna股价拖累标普500医疗保健板块，该板块下跌0.8%。</blockquote></p><p> Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p><p><blockquote>数据显示，上周美国新申请失业救济人数降至近20个月来的最低水平，表明经济正在恢复动力。投资者将从周五的月度就业报告中获得对经济的批判性看法。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.12比1；在纳斯达克，1.24比1的比率有利于下跌股。</blockquote></p><p> The S&amp;P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p><p><blockquote>标普500创下75个52周新高和5个新低；纳斯达克综合指数录得224个新高和38个新低。</blockquote></p><p> About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p><p><blockquote>美国交易所约有113亿股易手，高于过去20个交易日104亿股的日均水平。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下，标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-05 07:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - The S&amp;P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p><p><blockquote>（路透社）-标普500和纳斯达克周四上涨，将收盘纪录高位连涨至六个交易日，因高通强劲的财务预测以及投资者消化了美联储开始减少月度债券购买的决定后，芯片制造商股市飙升。</blockquote></p><p> The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase &amp; Co and Goldman Sachs Group weighed on the blue-chip index.</p><p><blockquote>道琼斯工业平均指数小幅下跌，结束了四点收盘的纪录。摩根大通和高盛集团银行股的下跌打压了蓝筹股指数。</blockquote></p><p> Financials dropped 1.3%, most among S&amp;P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p><p><blockquote>金融股下跌1.3%，其中大部分是标普500板块，因美国国债收益率下跌，在美联储表示不急于加息的第二天，市场解除了对美联储更快加息的预期。</blockquote></p><p> “The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p><p><blockquote>John Hancock Investment Management联席首席投资策略师马修·米斯金(Matthew Miskin)表示：“市场的增长方今天看到了更积极的结果，因为它们受益于收益率的下降。”</blockquote></p><p> “The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p><p><blockquote>“鉴于美联储宣布缩减规模，市场总体上一直在为更高的收益率做准备。当我们今天走进来时，这种情况已经发生了逆转。”</blockquote></p><p> The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&amp;P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p><p><blockquote>道琼斯工业平均指数下跌33.35点，跌幅0.09%，至36,124.23点；标普500上涨19.49点，跌幅0.42%，至4,680.06点；纳斯达克综合指数上涨128.72点，跌幅0.81%，至15,940.31点。</blockquote></p><p> The S&amp;P 500 growth index rose 1.2% while the S&amp;P 500 value index fell 0.5%.</p><p><blockquote>标普500增长指数上涨1.2%，标普500价值指数下跌0.5%。</blockquote></p><p> Among S&amp;P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p><p><blockquote>标普500板块中，科技和非必需消费品领涨，均上涨约1.5%。</blockquote></p><p> Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p><p><blockquote>高通股价上涨12.7%，该公司预测本季度利润和收入好于预期，原因是手机、汽车和其他互联网连接设备所用芯片的需求飙升。</blockquote></p><p> The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p><p><blockquote>费城SE半导体指数上涨3.5%，英伟达飙升12%。</blockquote></p><p> Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p><p><blockquote>好于预期的第三季度收益有助于提振股市情绪。根据Refinitiv IBES的数据，约有420家公司发布了财报，预计标普500第三季度盈利将同比增长41.2%。</blockquote></p><p> “The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p><p><blockquote>爱德华·琼斯投资策略师克雷格·费尔表示：“企业盈利情况仍然相当光明。”</blockquote></p><p> “The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p><p><blockquote>“市场正在奖励那些超出预期并上调前景的公司，而市场正在惩罚那些本季度未达到预期的公司，也许更重要的是，这预示着前景更加糟糕。”</blockquote></p><p> Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&amp;P 500 healthcare sector, which fell 0.8%.</p><p><blockquote>Moderna股价暴跌约18%，该公司将其COVID-19疫苗2021年的销售预测削减了多达50亿美元，并努力灌装和分销小瓶，以满足前所未有的全球需求。Moderna股价拖累标普500医疗保健板块，该板块下跌0.8%。</blockquote></p><p> Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p><p><blockquote>数据显示，上周美国新申请失业救济人数降至近20个月来的最低水平，表明经济正在恢复动力。投资者将从周五的月度就业报告中获得对经济的批判性看法。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.12比1；在纳斯达克，1.24比1的比率有利于下跌股。</blockquote></p><p> The S&amp;P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p><p><blockquote>标普500创下75个52周新高和5个新低；纳斯达克综合指数录得224个新高和38个新低。</blockquote></p><p> About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p><p><blockquote>美国交易所约有113亿股易手，高于过去20个交易日104亿股的日均水平。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".DJI":"道琼斯","IVV":"标普500ETF-iShares","SH":"做空标普500-Proshares","OEX":"标普100","SPXU":"三倍做空标普500ETF-ProShares","OEF":"标普100指数ETF-iShares","SSO":"2倍做多标普500ETF-ProShares",".IXIC":"NASDAQ Composite","UPRO":"三倍做多标普500ETF-ProShares",".SPX":"S&P 500 Index","SDS":"两倍做空标普500 ETF-ProShares"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128227989","content_text":"(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.\nThe Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.\nFinancials dropped 1.3%, most among S&P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.\n“The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\n“The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”\nThe Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.\nThe S&P 500 growth index rose 1.2% while the S&P 500 value index fell 0.5%.\nAmong S&P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.\nQualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.\nThe Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.\n“The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.\n“The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”\nModerna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector, which fell 0.8%.\nData showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.\nThe S&P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.\nAbout 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,"ESmain":0.9,".IXIC":0.9,".DJI":0.9,".SPX":0.9,"SH":0.9,"SDS":0.9,"OEF":0.9,"OEX":0.9,"SSO":0.9,"SPXU":0.9,"UPRO":0.9,"IVV":0.9}},"isVote":1,"tweetType":1,"viewCount":3149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841288950,"gmtCreate":1635914936358,"gmtModify":1635914936468,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841288950","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843437826,"gmtCreate":1635849007819,"gmtModify":1635849007922,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843437826","repostId":"1167795347","repostType":4,"isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849163266,"gmtCreate":1635735457005,"gmtModify":1635735457144,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/849163266","repostId":"2179250221","repostType":4,"repost":{"id":"2179250221","kind":"news","pubTimestamp":1635721559,"share":"https://www.laohu8.com/m/news/2179250221?lang=zh_CN&edition=full","pubTime":"2021-11-01 07:05","market":"us","language":"en","title":"Federal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2179250221","media":"Yahoo Finance","summary":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set th","content":"<p><div> The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also ...</p><p><blockquote><div>美联储即将召开的货币政策会议将成为本周的焦点，并可能为期待已久的资产购买缩减公告奠定基础。与此同时，交易者也将...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Federal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFederal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-11-01 07:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also ...</p><p><blockquote><div>美联储即将召开的货币政策会议将成为本周的焦点，并可能为期待已久的资产购买缩减公告奠定基础。与此同时，交易者也将...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RL":"拉夫劳伦","COP":"康菲石油","UBER":"优步","CRSR":"Corsair Gaming, Inc.","EL":"雅诗兰黛","PFE":"辉瑞","BLMN":"Bloomin' Brands","APO":"阿波罗全球管理","CLX":"高乐氏","ATVI":"动视暴雪",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179250221","content_text":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also await more data on the U.S. economic recovery with the Labor Department's monthly jobs report later this week.\nThe Federal Open Market Committee's (FOMC) November meeting will take place from Tuesday to Wednesday, with the policy statement and press conference from the meeting serving as the central bank's penultimate opportunity this year to announce formal plans to begin rolling back its crisis-era quantitative easing program. For the past year-and-a-half, the central bank has been purchasing $120 billion per month in agency mortgage-backed securities and Treasuries, as one major tool to support the economy during the pandemic.\nIn late September, the FOMC's latest monetary policy statement and press conference from Federal Reserve Chair Jerome Powell suggested the central bank was apt to announce the start of tapering before year-end, and continue the tapering process until \"around the middle of next year.\"\n\"The upcoming FOMC meeting will be important for three reasons: 1) the announcement of tapering; 2) guidance around what tapering means for the path of hikes; and 3) nuanced changes in views around inflation risks given recent data,\" wrote Bank of America economist Michelle Meyer in a note.\n\"The statement that announces the new pace of asset purchases will be followed by a note regarding flexibility stating that asset purchases are not on a pre-set course and will depend on the outlook for the labor market and inflation as well as an assessment of the efficacy of asset purchases,\" she predicted.\nShe noted that Powell may also use the press conference to reiterate that the end of tapering would not necessarily indicate the start of rate hikes, and that both policy actions are distinct. In previous public remarks, Powell has already made a similar point in previous public remarks, saying, \"the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.\"\nGiven the market has been anticipating the start to tapering for months now, speculation around when the Fed will make a move on interest rates has become a point of particular interest to investors. Investors and economists have mulled whether the Fed may need to act more quickly than previously telegraphed on adjusting interest rates to stave off inflation, which has proven more long-lasting than some had suggested.\nWASHINGTON, DC - SEPTEMBER 24: Federal Reserve Board Chairman Jerome Powell testifies during a Senate Banking Committee hearing on Capitol Hill on September 24, 2020 in Washington, DC. Powell and U.S. Treasury Secretary Steve Mnuchin are testifying about the CARES Act and the economic effects of the coronavirus pandemic. (Photo by Drew Angerer/Getty Images)Drew Angerer via Getty Images\nIn September, core personal consumption expenditures — the Fed's preferred gauge of underlying inflation — rose 3.6% over last year for a fourth consecutive month, coming in at the fastest clip since 1991. And earlier this month, Powell acknowledged in public remarks that the supply chain constraints and shortages that spurred the latest rise in prices are \"likely to last longer than previously expected, likely well into next year.\"\nWhile the central bank will not release an updated Summary of Economic Projections with their policy statement on Wednesday, the latest projections from the September meeting suggested the committee was split on rate hikes for 2022, with nine members seeing no rate hikes by the end of next year while the other nine members saw at least one hike.\n\"I think the Fed has pretty well determined to start the taper pretty quickly. We expect them to announce it next week and then start it soon thereafter, so that's pretty well carved in stone,\" Kathy Jones, Charles Schwab chief fixed income strategist, told Yahoo Finance Live last week. \"I think the big debate now is how quickly the Fed moves toward actually raising rates. The expectation in the market has really shifted to expecting as many as two rate hikes in 2022 and 2023 ... that’s a pretty aggressive pace of tightening.\"\nOctober jobs report\nOne of this week's most closely watched pieces of economic data will be the October jobs report, which is due for release on Friday from the Labor Department.\nEconomists are looking to see a pick-up in the pace of hiring for October after a disappointing print in September, when just 194,000 non-farm payrolls returned versus the half million expected. Over the past two months, payroll gains averaged at just 280,000. The unemployment rate is expected to take another small step toward pre-pandemic levels in October as well, with the jobless rate anticipated to dip to 4.7% from 4.8% the prior month.\nStill, the labor market has still fallen short its pre-pandemic conditions on a number of fronts. The unemployment rate has yet to return to its 50-year low of 3.5% from February 2020. And as of September, the civilian labor force was still down by about 3.1 million individuals from pre-virus levels.\nOne factor weighing on the labor market in August and September was the Delta variant, which may have deterred some workers from seeking employment in person for risk of infection. And an ongoing element dragging on the labor market's recovery has been a mismatch of supply and demand, with employers struggling to fill a near-record number of job openings while voluntary quits jumped to a historically high level.\n\"Next week’s October payrolls report will shed light on whether supply eased on diminishing constraints or if the labor market continues to face headwinds for now,\" wrote Rubeela Farooqi, chief U.S. economist for High Frequency Economics, in a note last week.\nBut some data from the past couple weeks has reflected favorably on conditions in the labor market in October. Weekly new unemployment claims broke below 300,000 for the first time since the start of the pandemic during the survey week for the October jobs report, or the week that includes the 12th of the month. And in the Conference Board's October Consumer Confidence Index, just 10.6% of consumers said jobs were \"hard to get,\" down from 13.0% in September. That brought the Conference Board's closely watched labor market differential, or percentage of consumers saying jobs are \"hard to get\" subtracted from the percentage saying jobs \"are plentiful,\" to 45, or its highest level since 2000.\nEconomic calendar\n\nMonday: Markit U.S. Manufacturing PMI, Oct. final (59.3 expected, 59.2 in September); Constructing spending, month-over-month, September (0.4% expected, 0.0% in August); ISM Manufacturing Index, Oct. (60.5 expected, 61.1 in September)\nTuesday: No notable reports scheduled for release\nWednesday: MBA Mortgage Applications, week ended Oct. 29 (0.3% during prior week); ADP Employment Change, Oct. (400,000 expected, 568,000 in September); ISM Services Index, October (62.0 expected, 61.9 in September); Factory Orders, September (-0.1% expected, 1.2% in August); Durable goods orders, September final (-0.4% in prior print; Durable goods orders excluding transportation, September final (0.4% in prior print); Non-defense capital goods orders excluding aircraft, September final (0.8% in prior print); Markit U.S. Services PMI, October final (58.2 expected, 58.2 in prior print); Markit U.S. Composite PMI, October final (57.3 in prior print); Federal Open Market Committee monetary policy decision\nThursday: Challenger job cuts, year-over-year, October (-84.9% in September); Initial jobless claims, week ended Oct. 30 (275,000 expected, 281,000 during prior week); Continuing claims, week ended Oct. 23 (2.147 million expected, 2.243 million during prior week); Non-farm productivity, Q3 preliminary (-3.2% expected, 2.1% in Q2); Unit Labor Costs, Q3 preliminary (6.9% expected, 1.3% in Q2); Trade balance, September (-$80.1 billion expected, -$73.3 billion in August)\nFriday: Change in non-farm payrolls, October (450,000 expected, 194,000 in September); Unemployment rate, October (4.7% expected, 4.8% in September); Average hourly earnings, month-over-month, October (4.7% expected, 4.8% in September); Average hourly earnings, year-over-year, October (4.9% expected, 4.6% in September); Labor Force Participation Rate, October (61.8% expected, 61.6% in September); Consumer Credit, September ($16.200 billion expected, $14.379 million in August)\n\nEarnings calendar\n\nMonday: Clorox (CLX), Avis Budget Group (CAR), ZoomInfo Technologies (ZI), Chegg Inc. (CHGG), Diamondback Energy (FANG), The Simon Property Group (SPG) after market close\nTuesday: Under Armour (UAA), Estee Lauder (EL), Ralph Lauren (RL), Apollo Global Management (APO), Corsair Gaming (CRSR), Bloomin' Brands (BLMN), ConocoPhillips (COP), Pfizer (PFE), Groupon (GPN), Marathon Petroleum (MPC) before market open; Mondelez (MDLZ), T-Mobile (TMUS), Akamai (AKAM), Activision Blizzard (ATVI), Lyft (LYFT), Match Group (MTCH), Devon Energy (DVN), Chesapeake Energy (CHK), Coursera (COUR), Zillow Group (ZG), Amgen (AMGN) after market close\nWednesday: Humana (HUM), Discovery Inc. (DISCA), The New York Times (NYT), Norwegian Cruise Line Holdings (NCLH), Marriott International (MAR), CVS Health Corp. (CVS), Sinclair Broadcast Group (SBGI) before market open; Booking Holdings (BKNG), Qorvo (QRVO), The Allstate Corp. (ALL), MGM Resorts International (MGM), $Take-Two Interactive Software(TTWO)$ (TTWO), Electronic Arts (EA), Vimeo (VMEO), Etsy (ETSY), GoDaddy (GDDY), Marathon Oil Corp. (MRO), Roku (ROKU), Qualcomm (QCOM) after market close\nThursday: Cigna (CI), Wayfair (W), ViacomCBS (VIAC), Nikola (NKLA), Duke Energy (DUK), Citrix Systems (CTXS), Regeneron Pharmaceuticals (REGN), Hanesbrands (HBI), Moderna (MRNA), Planet Fitness (PLNT), Vulcan Material (VMC), Kellogg (K), Square (SQ), Cloudflare (NET), Occidental Petroleum (OXY), Uber Technologies (UBER), American International Group (AIG), Shake Shack (SHAK), iHeartMedia (IHRT), Novavax (NVAX), IAC Interactive Corp. (IAC), Peloton (PTON), Dropbox (DBX), DataDog (DDOG), Pinterest (PINS), Skyworks Solutions (SWKS), Expedia (EXPE), Rocket Cos. (RKT), Live Nation Entertainment (LYV), Airbnb (ABNB)\nFriday: Wynn Resorts (WYNN), Dish Networks (DISH), Dominion Energy (D), DraftKings (DKNG), Goodyear Tire and Rubber (GT), Cinemark Holdings (CNK) before market open","news_type":1,"symbols_score_info":{"CRSR":0.9,".DJI":0.9,"PFE":0.9,"EL":0.9,"CLX":0.9,"RL":0.9,"BLMN":0.9,".SPX":0.9,"ATVI":0.9,"COP":0.9,"UBER":0.9,"APO":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857068245,"gmtCreate":1635495718918,"gmtModify":1635495719268,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857068245","repostId":"1197048478","repostType":4,"isVote":1,"tweetType":1,"viewCount":749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855780805,"gmtCreate":1635401410967,"gmtModify":1635401411067,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855780805","repostId":"1127302287","repostType":4,"repost":{"id":"1127302287","kind":"news","pubTimestamp":1635399924,"share":"https://www.laohu8.com/m/news/1127302287?lang=zh_CN&edition=full","pubTime":"2021-10-28 13:45","market":"us","language":"en","title":"Tesla Lands A Massive Deal And Breaks $1 Trillion: Are Shares A Buy?<blockquote>特斯拉达成巨额交易并突破1万亿美元：股票值得买入吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1127302287","media":"Seeking Alpha","summary":"Summary\n\nTesla added nearly $200 billion to its valuation this week following good earnings and an ~","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Tesla added nearly $200 billion to its valuation this week following good earnings and an ~$4.2 billion deal for 100K vehicles from Hertz.</li>  <li>The current growth trajectory and projected long-term growth offer massive potential in deliveries and revenues, but the risk-reward picture is weaker.</li>  <li>Forecasting a mutual outcome of $400 billion in revenues and 20 million units would likely lead to very low ASPs.</li>  <li>Long-term sustenance of the current multiple profile is countered by multiple risks including market share and competition, and industry-wide multiple re-rating.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9f0cfebc83d76c5cc8908a766201917d\" tg-width=\"1536\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>Justin Sullivan/Getty Images News</span></p><p><blockquote><ul><li>继良好的盈利以及以约42亿美元的价格从赫兹购买10万辆汽车后，特斯拉本周的估值增加了近2000亿美元。</li><li>当前的增长轨迹和预计的长期增长在交付和收入方面提供了巨大的潜力，但风险回报情况较弱。</li><li>预测4000亿美元的收入和2000万台的共同结果可能会导致非常低的平均售价。</li><li>当前多重状况的长期维持受到多重风险的阻碍，包括市场份额和竞争，以及全行业的多重重新评级。</li></ul><p class=\"t-img-caption\"><span>贾斯汀·沙利文/盖蒂图片社新闻</span></p></blockquote></p><p> Tesla (TSLA) broke the $1,000 barrier, taking the company to the trillion club on a multi-day rally following the company reporting earnings above consensus and a massive multi-billion dollar deal with Hertz (OTCPK:HTZZ). Tesla continues to grow rapidly even at its size, with&nbsp;deliveries&nbsp;rising ~20% q/q to 241,300 units for Q3. Tesla is offering very attractive growth rates at a scale much larger than EV peers, and as such is one of the hottest names on Wall Street. Trading volumes breached 60 million, more than double Tesla's 10-day average, with dollar volume over $60 billion. Although a substantial portion of these could be quick trades to capitalize on a &gt;12% move on the day, Tesla has been a gift that keeps on giving, and ultimately, it's possible to get stuck buying at a short-term top, much like in January. Even with a multi-quarter string of revenue and delivery boosts from the deal, the risk-reward outlook to buying at the moment is not highly convincing - while it's not necessarily a good idea to bet against Tesla, it does not seem to be the best time to buy.</p><p><blockquote>特斯拉(TSLA)突破1,000美元大关，在该公司公布高于市场预期的盈利以及与赫兹(OTCPK：HTZZ)达成数十亿美元的巨额交易后，该公司连续多日上涨，进入万亿俱乐部。即使以其规模来看，特斯拉仍继续快速增长，第三季度交付量环比增长约20%，达到241,300辆。特斯拉以比电动汽车同行大得多的规模提供了非常有吸引力的增长率，因此是华尔街最热门的公司之一。交易量突破6000万笔，是特斯拉10天平均水平的两倍多，美元交易量超过600亿美元。尽管其中很大一部分可能是快速交易，以利用当天超过12%的涨幅，但特斯拉一直是一份持续赠送的礼物，最终，有可能在短期顶部买入，就像一月份一样。尽管该交易带来了多个季度的收入和交付量增长，但目前购买的风险回报前景并不十分令人信服——虽然做空特斯拉不一定是个好主意，但似乎也不是最佳购买时机。</blockquote></p><p> <b>A Hertz Fleet Deal</b></p><p><blockquote><b>赫兹车队交易</b></blockquote></p><p> The Hertz deal shows that the demand for large-volume fleet EV exists, with the rental car operator putting in an order worth over 20% of its fleet size for Tesla's vehicles. With the order, Hertz will offer the largest EV in the country.</p><p><blockquote>赫兹的交易表明，对大批量车队电动汽车的需求是存在的，这家租赁汽车运营商订购了价值超过其车队规模20%的特斯拉车辆。根据订单，赫兹将提供该国最大的电动汽车。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3e286a4ee0a7807efc3b113fc7120d2a\" tg-width=\"1280\" tg-height=\"853\" width=\"100%\" height=\"auto\"><span>Graphic from Hertz</span></p><p><blockquote><p class=\"t-img-caption\"><span>图表来自赫兹</span></p></blockquote></p><p> Hertz is jumping behind \"rising global demand and interest\" for EV as the vehicles become more \"mainstream,\" choosing to invest $4.2 billion for Tesla vehicles over the next fourteen months, with the first deliveries and availabilities expected to commence in November.</p><p><blockquote>随着电动汽车变得更加“主流”，赫兹支持电动汽车“不断增长的全球需求和兴趣”，选择在未来14个月内投资42亿美元用于特斯拉汽车，首批交付和上市预计将于11月开始。</blockquote></p><p> Because EV rely on public charging infrastructure, which can be limited or harder to find than gas stations, Hertz will be \"installing thousands of chargers throughout its location network,\" adding to the 3,000 supercharging network available via Tesla. In addition, Hertz's app will provide \"digitized guidance to educate customers about the electric vehicle to get them on their way quickly, and coming soon, an expedited EV rental booking process.\" Customers booking vehicles will have to know how to use certain features like Autopilot, FSD or controlling the car through the app.</p><p><blockquote>由于电动汽车依赖于公共充电基础设施，而公共充电基础设施可能有限或比加油站更难找到，赫兹将“在其位置网络中安装数千个充电器”，增加通过特斯拉提供的3,000个超级充电网络。此外，赫兹的应用程序将提供“数字化指导，向客户介绍电动汽车，让他们快速上路，并很快推出快速电动汽车租赁预订流程。”预订车辆的客户必须知道如何使用某些功能，如自动驾驶仪、FSD或通过应用程序控制汽车。</blockquote></p><p> Hertz did recently emerge from Chapter 11 bankruptcy earlier this summer, and while some questions are raised about the exact funding for a deal of this size will come from given $3.0 billion in total liquidity, operating&nbsp;metrics&nbsp;have improved dramatically and rival 2019's pre-pandemic levels. Although revenues were ~11% lower than 2019, vehicle utilization sat at 78%, 3 percentage points behind as RPD and RPU increased significantly as prices rose. Compared to 2019 for Q2, Hertz saw RPD 53% higher to above $65 and RPU per month 48% higher to $1,557 - more expensive pricing of rental cars due to high demand and insufficient supply did aid these metrics, yet utilization rates reflect a strong rebound in the industry.</p><p><blockquote>赫兹最近确实在今年夏天早些时候摆脱了美国破产法第11章的破产，尽管有人质疑这种规模的交易的确切资金将来自30亿美元的总流动性，但运营指标已显着改善，可与2019年大流行前的水平相媲美。尽管收入比2019年下降了约11%，但车辆利用率为78%，落后3个百分点，因为随着价格上涨，RPD和RPU大幅增加。与2019年第二季度相比，赫兹的RPD增长了53%，达到65美元以上，每月RPU增长了48%，达到1,557美元——由于高需求和供应不足，租车价格上涨确实有助于这些指标，但利用率反映了强劲反弹在行业中。</blockquote></p><p> For Tesla, the deal with Hertz not only signifies a large bump to revenues and deliveries through fiscal 2022 but a broader trend towards large-scale fleet acceptance in ride renting/sharing/hailing. 100,000 units represent close to 12% of Tesla's current TTM volume and about 7% of projected deliveries and revenues for FY22. It's a substantial contribution from a single customer, but it provides a bright outlook into the future of EV in ride hailing/renting - the adoption curve could come quicker than anticipated.</p><p><blockquote>对于特斯拉来说，与赫兹的交易不仅标志着2022财年收入和交付量的大幅增长，也标志着乘车租赁/共享/叫车领域大规模车队接受度的更广泛趋势。100,000辆占特斯拉当前TTM销量的近12%，约占2022财年预计交付量和收入的7%。这是单个客户的巨大贡献，但它为电动汽车在叫车/租赁领域的未来提供了光明的前景——采用曲线可能会比预期的更快。</blockquote></p><p></p><p> In the broader industry, Uber (UBER) is working with multiple different players, including Kia (OTCPK:KIMTF), Arrival (ARVL) and TotalEnergies (TTE) to accelerate EV adoption while Waymo (GOOGL) and Cruise (GM) are working towards self-driving robotaxi services, which still could be years away from large-scale operations. EV can fill parts of that void, with Tesla having the necessary capacity to produce hundreds of thousands of units for fleet operators with GF Shanghai, Berlin and Texas all ramping to scale and building new capacity.</p><p><blockquote>在更广泛的行业中，Uber(UBER)正在与多个不同的参与者合作，包括起亚(OTCPK：KIMTF)、Arrival(ARVL)和TotalEnergies(TTE)，以加速电动汽车的采用，而Waymo(GOOGL)和Cruise(GM)正在努力实现自动驾驶机器人出租车服务，距离大规模运营可能还需要数年时间。电动汽车可以填补部分空白，特斯拉拥有为车队运营商生产数十万辆的必要产能，GF Shanghai、Berlin和Texas都在扩大规模并建设新产能。</blockquote></p><p> <b>Continuing Along the Growth Trajectory</b></p><p><blockquote><b>继续沿着增长轨迹</b></blockquote></p><p> Tesla's Q3 results speak for themselves, with the company firing on all cylinders as performance metrics across the board reached new highs.</p><p><blockquote>特斯拉第三季度的业绩不言自明，随着业绩指标全面创下新高，该公司全力以赴。</blockquote></p><p> The company saw its \"best-ever net income, operating profit and gross profit,\" with operating margins higher than expected, operating cash flow reaching a record, its highest production levels at Fremont, and strong growth in multiple metrics. Auto revenues rose 58% y/y and 18% q/q, slightly lagging deliveries' ~20% q/q growth as ASPs slipped 6% y/y. Higher contribution from China likely was a large factor in the ASP decline, as well as in the uptick in deliveries, with the region reportedly accounting for 133,238 vehicles during the quarter, or 55.2%; this came in higher than predicted as ASPs trended lower. That figure is 6.3 percentage points higher than Q2, with September's ~56,000 units delivered and exported a whopping 70% higher than June.</p><p><blockquote>该公司实现了“有史以来最好的净利润、营业利润和毛利润”，营业利润率高于预期，营业现金流达到创纪录水平，弗里蒙特的最高生产水平，多项指标强劲增长。汽车收入同比增长58%，环比增长18%，略落后于交付量约20%的环比增长，平均售价同比下滑6%。来自中国的更大贡献可能是平均售价下降以及交付量上升的一个重要因素，据报道，该地区本季度交付了133,238辆汽车，占55.2%；由于平均售价呈下降趋势，这一数字高于预期。这一数字比第二季度高出6.3个百分点，9月份交付和出口约56,000辆，比6月份高出70%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd4f9c664d1a45c750aac76ffc372b2a\" tg-width=\"640\" tg-height=\"732\" width=\"100%\" height=\"auto\"><span>Graphic from Tesla</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来自特斯拉</span></p></blockquote></p><p> Deliveries have started to hit a hyper-growth trajectory over the trailing four quarters, with growth emerging in Q3 2020. Since then, Tesla has nearly doubled deliveries, a much faster rate than pre-pandemic growth as EV adoption and capacity increases. At the moment, Tesla's annual capacity is close to 1.1 million, or nearly 40% higher than TTM deliveries, giving the company much more room to grow ahead of completion in Berlin and Texas.</p><p><blockquote>交付量在过去四个季度开始实现高速增长，2020年第三季度出现增长。自那以后，随着电动汽车的采用和产能的增加，特斯拉的交付量几乎翻了一番，比大流行前的增长速度快得多。目前，特斯拉的年产能接近110万辆，比TTM的交付量高出近40%，这为该公司在柏林和德克萨斯竣工之前提供了更大的增长空间。</blockquote></p><p> <b>Hard To Buy Here</b></p><p><blockquote><b>这里很难买到</b></blockquote></p><p> Even with growth rates and operating metrics impressing across the board, it's hard to chalk out a positive risk-reward outlook after shares ran higher this week - the earnings and $4.2 billion Hertz deal added at one point nearly $200 billion to Tesla's valuation, or close to $175 billion at the high in just the two days since the deal was announced. Are the new synergies from the deal and/or earnings good enough to support buying a company worth over 15% more following that announcement? Here, that does not look to be the case.</p><p><blockquote>尽管增长率和运营指标全面令人印象深刻，但在本周股价走高后，也很难描绘出积极的风险回报前景——收益和42亿美元的赫兹交易一度使特斯拉的估值增加了近2000亿美元，或接近交易宣布后仅两天内就达到了1750亿美元的高点。该交易和/或收益带来的新协同效应是否足以支持在该公告发布后收购一家价值超过15%的公司？在这里，情况似乎并非如此。</blockquote></p><p> Over the short-term, such frenzied trading and rapid, high percentage rallies are typically very short-lived - Tesla's last pre-split rally to $900 in early 2020 saw the stock shed 20% in under a week, and a strong rally to nearly $900 post-split in early 2021 saw shares hold for a month after a 10% drop before shedding another 35% through March. Short-term trades can pay off, but from a long-term standpoint, the outlook is bright, but the return potential, not as much.</p><p><blockquote>从短期来看，这种疯狂的交易和快速、高百分比的反弹通常是非常短暂的——特斯拉在2020年初最后一次分拆前反弹至900美元，该股在不到一周的时间内下跌了20%，并在2021年初分拆后强劲反弹至近900美元，股价在下跌10%后维持了一个月，然后在3月份又下跌了35%。短期交易可以获得回报，但从长期角度来看，前景是光明的，但回报潜力却没有那么大。</blockquote></p><p> Tesla projects that it can drive long-term average annual growth of 50% in deliveries, which, from 900,000 deliveries possible for FY21, would see Tesla doing about 4.5 million vehicles per year in 2025. Extending that growth rate further to 2030 would see Tesla delivering 34 million vehicles, or half of global automotive volumes from 2020; this seems to be a very unrealistic scenario, even as Tesla stated that the goal is to have 20 million deliveries by then. To reach that figure, Tesla would have to grow at about 35% annual from 2025's projected figure. All in all, 2025's deliveries could be close to 5% of total global automotive sales volumes while 2030's could be near 20%. Given the competition in the industry, it's hard to see Tesla driving that much market share alone and beating out competition by that far of a margin - even Apple (AAPL) only commands near 15% market share in smartphones, where it's widely seen among the top three in the industry.</p><p><blockquote>特斯拉预计，它可以推动交付量的长期年均增长50%，从2021财年的90万辆交付量来看，特斯拉到2025年每年的交付量将达到约450万辆。将这一增长率进一步延长至2030年，特斯拉将交付3400万辆汽车，占2020年全球汽车销量的一半；这似乎是一个非常不现实的场景，即使特斯拉表示目标是届时交付量达到2000万辆。为了达到这一数字，特斯拉必须比2025年的预计数字以每年35%左右的速度增长。总而言之，2025年的交付量可能接近全球汽车总销量的5%，而2030年可能接近20%。考虑到行业内的竞争，很难看到特斯拉独自占据如此大的市场份额并以如此大的优势击败竞争对手——即使是苹果(AAPL)在智能手机领域也仅占据近15%的市场份额，而在智能手机领域，它被广泛视为行业前三名。</blockquote></p><p> With that forecast, Tesla is also seeing a path to $400 billion in revenues - this would assume that revenue growth slows much faster y/y than deliveries - driving deliveries to 20 million requires 5 years of ~33% average annual growth following 4 years of 50% annual growth while revenues would grow for 5 years at ~20% average annual growth for 5 years following 4 years of 34% average annual growth.</p><p><blockquote>根据这一预测，特斯拉还看到了一条通往4000亿美元收入的道路——这将假设收入增长同比放缓的速度比交付量快得多——将交付量提高到2000万辆需要在4年后的5年内平均年增长率约为33%。50%的年增长率，而收入将在5年内以约20%的平均年增长率增长，而在4年的平均年增长率为34%。</blockquote></p><p></p><p> To hit both of those figures, revenues at $400 billion on deliveries of 20 million, Tesla would have to cut its ASPs significantly, down to $25,000 by 2027 and ~$16,500 by 2029, assuming growth rates in energy storage and other aspects of the business continue. Tesla does envision itself in most major spaces - small/mid/large SUV, sedan/trucks, as well as in affordable &lt;$25,000 models and robotaxis; however, those most likely wouldn't amount to a sub $20,000 ASP, meaning that there are some substantial doubts raised about the feasibility of both targets occurring mutually by 2030. The other possibility that is not included here is that Tesla does not sell a robotaxi fleet but rather manages a multi-million unit fleet itself, therefore having a fair proportion of targeted 2030 volumes not reflected in ASPs.</p><p><blockquote>为了达到这两个数字，即交付量为2000万辆，收入达到4000亿美元，特斯拉必须大幅削减平均售价，到2027年降至25,000美元，到2029年降至约16,500美元，假设储能和业务其他方面的增长率继续。特斯拉确实设想在大多数主要领域——小型/中型/大型SUV、轿车/卡车，以及价格低于25,000美元的车型和机器人出租车；然而，这些目标的平均售价很可能不会低于20,000美元，这意味着到2030年这两个目标同时实现的可行性存在一些重大疑问。这里没有包括的另一种可能性是，特斯拉不出售机器人出租车车队，而是自己管理一支数百万辆的车队，因此2030年目标销量中有相当一部分没有反映在ASP中。</blockquote></p><p> Should Tesla be overshooting the delivery figures, revenues are likely very misguided; but should Tesla in fact be correct in targeting 20 million vehicles through multiple market opportunities, revenues could be completely sandbagging that potential. Time will tell in this regard.</p><p><blockquote>如果特斯拉超额完成交付数据，收入可能会受到严重误导；但如果特斯拉通过多个市场机会瞄准2000万辆汽车的目标实际上是正确的，那么收入可能会完全抵消这一潜力。在这方面，时间会证明一切。</blockquote></p><p> Back to market share - Tesla would likely be seeing around the high-teens to 20% of global automotive volumes by 2030 based ontrendswithin the industry. Yet it's hard to see Tesla achieving and maintaining such a stronghold as startups like XPeng (XPEV) and NIO (NIO) challenge it heavily on price and tech (though both are primarily confined to China geographically still) while ICE leaders are aggressively pushing to EV. Therefore, it's possible that the EV industry will remain fragmented and Tesla will not be able to hold a monopolistic grip on the sector, where it dominates volumes and dictates the industry. The company has just north of 4% total market share, and with competition heating up rapidly, the only scenario to see market share gains possibly reach that degree would be if production capacities reach that 15 million and remain over 50% higher than peers' EV manufacturing capabilities.</p><p><blockquote>回到市场份额——根据行业内的趋势，到2030年，特斯拉汽车销量可能会占全球汽车销量的20%左右。然而，很难看到特斯拉取得并保持这样的据点，因为小鹏汽车（XPEV）和蔚来（蔚来）等初创公司在价格和技术上对其发起了猛烈挑战（尽管两者在地理上仍然主要局限于中国），而ICE领导者则在积极推动电动汽车。因此，电动汽车行业可能仍将是分散的，特斯拉将无法对该行业保持垄断地位，因为它在销量上占据主导地位并决定了该行业。该公司的总市场份额略高于4%，随着竞争迅速升温，市场份额增长可能达到这一程度的唯一情况是产能达到1500万辆，并保持比同行高出50%以上电动汽车制造能力。</blockquote></p><p> In the long-term picture, the broader outlook is that EV will become the new norm, with manufacturers agreeing to work towards 40% to 50% volumes in EV. The overall goal still looks to be an EV-dominant or even full-EV future. Hundreds of new EV models are expected to hit the roads by 2030, greatly increasing the selection to consumers and overall supply volume of the vehicle type. With ICE vehicles as the old 'gold standard' and EV expected to become the 'new', ultimately the valuation premiums for industry disruption and tech are likely to fade and reflect similar multiples to the ICE cohort - at that time, in the long run, a majority of manufacturers will likely all be competing in the same vehicle type, with similar specs and technology. Although Tesla has been ahead of the curve, peers are catching up, and losing a disruption multiple from competitive/market share pressures and lower revenue growth rates, and valuations in the industry falling similar to what ICE manufacturers have experienced, the current 'gold standard' could see fair value at 3x sales and 21x earnings (14% net margin on $400 billion revenues), providing just an ample ~20% upside. Tesla does offer very attractive growth rates and sometimes unpredictable potential, but there's likely to be much better buying opportunities in the future as the risk-reward picture looks unfavorable at the moment.</p><p><blockquote>从长远来看，更广泛的前景是电动汽车将成为新常态，制造商同意努力实现电动汽车销量的40%至50%。总体目标看起来仍然是电动汽车主导甚至全电动汽车的未来。预计到2030年，将有数百款新电动汽车上路，大大增加消费者的选择和车型的整体供应量。随着内燃机汽车成为旧的“黄金标准”，电动汽车有望成为“新标准”，最终行业颠覆和技术的估值溢价可能会消退，并反映出与内燃机汽车相似的倍数——从长远来看，大多数制造商可能都会在同一车型中竞争，具有相似的规格和技术。尽管特斯拉一直处于领先地位，但同行正在迎头赶上，并因竞争/市场份额压力和收入增长率下降而失去了颠覆倍数，行业估值下降与ICE制造商所经历的类似，但当前的“黄金标准”的公允价值可能为销售额的3倍和收益的21倍（4000亿美元收入的14%净利润率），仅提供约20%的充足上涨空间。特斯拉确实提供了非常有吸引力的增长率，有时还有不可预测的潜力，但由于目前风险回报状况看起来不利，未来可能会有更好的购买机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Lands A Massive Deal And Breaks $1 Trillion: Are Shares A Buy?<blockquote>特斯拉达成巨额交易并突破1万亿美元：股票值得买入吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Lands A Massive Deal And Breaks $1 Trillion: Are Shares A Buy?<blockquote>特斯拉达成巨额交易并突破1万亿美元：股票值得买入吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-10-28 13:45</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Tesla added nearly $200 billion to its valuation this week following good earnings and an ~$4.2 billion deal for 100K vehicles from Hertz.</li>  <li>The current growth trajectory and projected long-term growth offer massive potential in deliveries and revenues, but the risk-reward picture is weaker.</li>  <li>Forecasting a mutual outcome of $400 billion in revenues and 20 million units would likely lead to very low ASPs.</li>  <li>Long-term sustenance of the current multiple profile is countered by multiple risks including market share and competition, and industry-wide multiple re-rating.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9f0cfebc83d76c5cc8908a766201917d\" tg-width=\"1536\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>Justin Sullivan/Getty Images News</span></p><p><blockquote><ul><li>继良好的盈利以及以约42亿美元的价格从赫兹购买10万辆汽车后，特斯拉本周的估值增加了近2000亿美元。</li><li>当前的增长轨迹和预计的长期增长在交付和收入方面提供了巨大的潜力，但风险回报情况较弱。</li><li>预测4000亿美元的收入和2000万台的共同结果可能会导致非常低的平均售价。</li><li>当前多重状况的长期维持受到多重风险的阻碍，包括市场份额和竞争，以及全行业的多重重新评级。</li></ul><p class=\"t-img-caption\"><span>贾斯汀·沙利文/盖蒂图片社新闻</span></p></blockquote></p><p> Tesla (TSLA) broke the $1,000 barrier, taking the company to the trillion club on a multi-day rally following the company reporting earnings above consensus and a massive multi-billion dollar deal with Hertz (OTCPK:HTZZ). Tesla continues to grow rapidly even at its size, with&nbsp;deliveries&nbsp;rising ~20% q/q to 241,300 units for Q3. Tesla is offering very attractive growth rates at a scale much larger than EV peers, and as such is one of the hottest names on Wall Street. Trading volumes breached 60 million, more than double Tesla's 10-day average, with dollar volume over $60 billion. Although a substantial portion of these could be quick trades to capitalize on a &gt;12% move on the day, Tesla has been a gift that keeps on giving, and ultimately, it's possible to get stuck buying at a short-term top, much like in January. Even with a multi-quarter string of revenue and delivery boosts from the deal, the risk-reward outlook to buying at the moment is not highly convincing - while it's not necessarily a good idea to bet against Tesla, it does not seem to be the best time to buy.</p><p><blockquote>特斯拉(TSLA)突破1,000美元大关，在该公司公布高于市场预期的盈利以及与赫兹(OTCPK：HTZZ)达成数十亿美元的巨额交易后，该公司连续多日上涨，进入万亿俱乐部。即使以其规模来看，特斯拉仍继续快速增长，第三季度交付量环比增长约20%，达到241,300辆。特斯拉以比电动汽车同行大得多的规模提供了非常有吸引力的增长率，因此是华尔街最热门的公司之一。交易量突破6000万笔，是特斯拉10天平均水平的两倍多，美元交易量超过600亿美元。尽管其中很大一部分可能是快速交易，以利用当天超过12%的涨幅，但特斯拉一直是一份持续赠送的礼物，最终，有可能在短期顶部买入，就像一月份一样。尽管该交易带来了多个季度的收入和交付量增长，但目前购买的风险回报前景并不十分令人信服——虽然做空特斯拉不一定是个好主意，但似乎也不是最佳购买时机。</blockquote></p><p> <b>A Hertz Fleet Deal</b></p><p><blockquote><b>赫兹车队交易</b></blockquote></p><p> The Hertz deal shows that the demand for large-volume fleet EV exists, with the rental car operator putting in an order worth over 20% of its fleet size for Tesla's vehicles. With the order, Hertz will offer the largest EV in the country.</p><p><blockquote>赫兹的交易表明，对大批量车队电动汽车的需求是存在的，这家租赁汽车运营商订购了价值超过其车队规模20%的特斯拉车辆。根据订单，赫兹将提供该国最大的电动汽车。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3e286a4ee0a7807efc3b113fc7120d2a\" tg-width=\"1280\" tg-height=\"853\" width=\"100%\" height=\"auto\"><span>Graphic from Hertz</span></p><p><blockquote><p class=\"t-img-caption\"><span>图表来自赫兹</span></p></blockquote></p><p> Hertz is jumping behind \"rising global demand and interest\" for EV as the vehicles become more \"mainstream,\" choosing to invest $4.2 billion for Tesla vehicles over the next fourteen months, with the first deliveries and availabilities expected to commence in November.</p><p><blockquote>随着电动汽车变得更加“主流”，赫兹支持电动汽车“不断增长的全球需求和兴趣”，选择在未来14个月内投资42亿美元用于特斯拉汽车，首批交付和上市预计将于11月开始。</blockquote></p><p> Because EV rely on public charging infrastructure, which can be limited or harder to find than gas stations, Hertz will be \"installing thousands of chargers throughout its location network,\" adding to the 3,000 supercharging network available via Tesla. In addition, Hertz's app will provide \"digitized guidance to educate customers about the electric vehicle to get them on their way quickly, and coming soon, an expedited EV rental booking process.\" Customers booking vehicles will have to know how to use certain features like Autopilot, FSD or controlling the car through the app.</p><p><blockquote>由于电动汽车依赖于公共充电基础设施，而公共充电基础设施可能有限或比加油站更难找到，赫兹将“在其位置网络中安装数千个充电器”，增加通过特斯拉提供的3,000个超级充电网络。此外，赫兹的应用程序将提供“数字化指导，向客户介绍电动汽车，让他们快速上路，并很快推出快速电动汽车租赁预订流程。”预订车辆的客户必须知道如何使用某些功能，如自动驾驶仪、FSD或通过应用程序控制汽车。</blockquote></p><p> Hertz did recently emerge from Chapter 11 bankruptcy earlier this summer, and while some questions are raised about the exact funding for a deal of this size will come from given $3.0 billion in total liquidity, operating&nbsp;metrics&nbsp;have improved dramatically and rival 2019's pre-pandemic levels. Although revenues were ~11% lower than 2019, vehicle utilization sat at 78%, 3 percentage points behind as RPD and RPU increased significantly as prices rose. Compared to 2019 for Q2, Hertz saw RPD 53% higher to above $65 and RPU per month 48% higher to $1,557 - more expensive pricing of rental cars due to high demand and insufficient supply did aid these metrics, yet utilization rates reflect a strong rebound in the industry.</p><p><blockquote>赫兹最近确实在今年夏天早些时候摆脱了美国破产法第11章的破产，尽管有人质疑这种规模的交易的确切资金将来自30亿美元的总流动性，但运营指标已显着改善，可与2019年大流行前的水平相媲美。尽管收入比2019年下降了约11%，但车辆利用率为78%，落后3个百分点，因为随着价格上涨，RPD和RPU大幅增加。与2019年第二季度相比，赫兹的RPD增长了53%，达到65美元以上，每月RPU增长了48%，达到1,557美元——由于高需求和供应不足，租车价格上涨确实有助于这些指标，但利用率反映了强劲反弹在行业中。</blockquote></p><p> For Tesla, the deal with Hertz not only signifies a large bump to revenues and deliveries through fiscal 2022 but a broader trend towards large-scale fleet acceptance in ride renting/sharing/hailing. 100,000 units represent close to 12% of Tesla's current TTM volume and about 7% of projected deliveries and revenues for FY22. It's a substantial contribution from a single customer, but it provides a bright outlook into the future of EV in ride hailing/renting - the adoption curve could come quicker than anticipated.</p><p><blockquote>对于特斯拉来说，与赫兹的交易不仅标志着2022财年收入和交付量的大幅增长，也标志着乘车租赁/共享/叫车领域大规模车队接受度的更广泛趋势。100,000辆占特斯拉当前TTM销量的近12%，约占2022财年预计交付量和收入的7%。这是单个客户的巨大贡献，但它为电动汽车在叫车/租赁领域的未来提供了光明的前景——采用曲线可能会比预期的更快。</blockquote></p><p></p><p> In the broader industry, Uber (UBER) is working with multiple different players, including Kia (OTCPK:KIMTF), Arrival (ARVL) and TotalEnergies (TTE) to accelerate EV adoption while Waymo (GOOGL) and Cruise (GM) are working towards self-driving robotaxi services, which still could be years away from large-scale operations. EV can fill parts of that void, with Tesla having the necessary capacity to produce hundreds of thousands of units for fleet operators with GF Shanghai, Berlin and Texas all ramping to scale and building new capacity.</p><p><blockquote>在更广泛的行业中，Uber(UBER)正在与多个不同的参与者合作，包括起亚(OTCPK：KIMTF)、Arrival(ARVL)和TotalEnergies(TTE)，以加速电动汽车的采用，而Waymo(GOOGL)和Cruise(GM)正在努力实现自动驾驶机器人出租车服务，距离大规模运营可能还需要数年时间。电动汽车可以填补部分空白，特斯拉拥有为车队运营商生产数十万辆的必要产能，GF Shanghai、Berlin和Texas都在扩大规模并建设新产能。</blockquote></p><p> <b>Continuing Along the Growth Trajectory</b></p><p><blockquote><b>继续沿着增长轨迹</b></blockquote></p><p> Tesla's Q3 results speak for themselves, with the company firing on all cylinders as performance metrics across the board reached new highs.</p><p><blockquote>特斯拉第三季度的业绩不言自明，随着业绩指标全面创下新高，该公司全力以赴。</blockquote></p><p> The company saw its \"best-ever net income, operating profit and gross profit,\" with operating margins higher than expected, operating cash flow reaching a record, its highest production levels at Fremont, and strong growth in multiple metrics. Auto revenues rose 58% y/y and 18% q/q, slightly lagging deliveries' ~20% q/q growth as ASPs slipped 6% y/y. Higher contribution from China likely was a large factor in the ASP decline, as well as in the uptick in deliveries, with the region reportedly accounting for 133,238 vehicles during the quarter, or 55.2%; this came in higher than predicted as ASPs trended lower. That figure is 6.3 percentage points higher than Q2, with September's ~56,000 units delivered and exported a whopping 70% higher than June.</p><p><blockquote>该公司实现了“有史以来最好的净利润、营业利润和毛利润”，营业利润率高于预期，营业现金流达到创纪录水平，弗里蒙特的最高生产水平，多项指标强劲增长。汽车收入同比增长58%，环比增长18%，略落后于交付量约20%的环比增长，平均售价同比下滑6%。来自中国的更大贡献可能是平均售价下降以及交付量上升的一个重要因素，据报道，该地区本季度交付了133,238辆汽车，占55.2%；由于平均售价呈下降趋势，这一数字高于预期。这一数字比第二季度高出6.3个百分点，9月份交付和出口约56,000辆，比6月份高出70%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd4f9c664d1a45c750aac76ffc372b2a\" tg-width=\"640\" tg-height=\"732\" width=\"100%\" height=\"auto\"><span>Graphic from Tesla</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来自特斯拉</span></p></blockquote></p><p> Deliveries have started to hit a hyper-growth trajectory over the trailing four quarters, with growth emerging in Q3 2020. Since then, Tesla has nearly doubled deliveries, a much faster rate than pre-pandemic growth as EV adoption and capacity increases. At the moment, Tesla's annual capacity is close to 1.1 million, or nearly 40% higher than TTM deliveries, giving the company much more room to grow ahead of completion in Berlin and Texas.</p><p><blockquote>交付量在过去四个季度开始实现高速增长，2020年第三季度出现增长。自那以后，随着电动汽车的采用和产能的增加，特斯拉的交付量几乎翻了一番，比大流行前的增长速度快得多。目前，特斯拉的年产能接近110万辆，比TTM的交付量高出近40%，这为该公司在柏林和德克萨斯竣工之前提供了更大的增长空间。</blockquote></p><p> <b>Hard To Buy Here</b></p><p><blockquote><b>这里很难买到</b></blockquote></p><p> Even with growth rates and operating metrics impressing across the board, it's hard to chalk out a positive risk-reward outlook after shares ran higher this week - the earnings and $4.2 billion Hertz deal added at one point nearly $200 billion to Tesla's valuation, or close to $175 billion at the high in just the two days since the deal was announced. Are the new synergies from the deal and/or earnings good enough to support buying a company worth over 15% more following that announcement? Here, that does not look to be the case.</p><p><blockquote>尽管增长率和运营指标全面令人印象深刻，但在本周股价走高后，也很难描绘出积极的风险回报前景——收益和42亿美元的赫兹交易一度使特斯拉的估值增加了近2000亿美元，或接近交易宣布后仅两天内就达到了1750亿美元的高点。该交易和/或收益带来的新协同效应是否足以支持在该公告发布后收购一家价值超过15%的公司？在这里，情况似乎并非如此。</blockquote></p><p> Over the short-term, such frenzied trading and rapid, high percentage rallies are typically very short-lived - Tesla's last pre-split rally to $900 in early 2020 saw the stock shed 20% in under a week, and a strong rally to nearly $900 post-split in early 2021 saw shares hold for a month after a 10% drop before shedding another 35% through March. Short-term trades can pay off, but from a long-term standpoint, the outlook is bright, but the return potential, not as much.</p><p><blockquote>从短期来看，这种疯狂的交易和快速、高百分比的反弹通常是非常短暂的——特斯拉在2020年初最后一次分拆前反弹至900美元，该股在不到一周的时间内下跌了20%，并在2021年初分拆后强劲反弹至近900美元，股价在下跌10%后维持了一个月，然后在3月份又下跌了35%。短期交易可以获得回报，但从长期角度来看，前景是光明的，但回报潜力却没有那么大。</blockquote></p><p> Tesla projects that it can drive long-term average annual growth of 50% in deliveries, which, from 900,000 deliveries possible for FY21, would see Tesla doing about 4.5 million vehicles per year in 2025. Extending that growth rate further to 2030 would see Tesla delivering 34 million vehicles, or half of global automotive volumes from 2020; this seems to be a very unrealistic scenario, even as Tesla stated that the goal is to have 20 million deliveries by then. To reach that figure, Tesla would have to grow at about 35% annual from 2025's projected figure. All in all, 2025's deliveries could be close to 5% of total global automotive sales volumes while 2030's could be near 20%. Given the competition in the industry, it's hard to see Tesla driving that much market share alone and beating out competition by that far of a margin - even Apple (AAPL) only commands near 15% market share in smartphones, where it's widely seen among the top three in the industry.</p><p><blockquote>特斯拉预计，它可以推动交付量的长期年均增长50%，从2021财年的90万辆交付量来看，特斯拉到2025年每年的交付量将达到约450万辆。将这一增长率进一步延长至2030年，特斯拉将交付3400万辆汽车，占2020年全球汽车销量的一半；这似乎是一个非常不现实的场景，即使特斯拉表示目标是届时交付量达到2000万辆。为了达到这一数字，特斯拉必须比2025年的预计数字以每年35%左右的速度增长。总而言之，2025年的交付量可能接近全球汽车总销量的5%，而2030年可能接近20%。考虑到行业内的竞争，很难看到特斯拉独自占据如此大的市场份额并以如此大的优势击败竞争对手——即使是苹果(AAPL)在智能手机领域也仅占据近15%的市场份额，而在智能手机领域，它被广泛视为行业前三名。</blockquote></p><p> With that forecast, Tesla is also seeing a path to $400 billion in revenues - this would assume that revenue growth slows much faster y/y than deliveries - driving deliveries to 20 million requires 5 years of ~33% average annual growth following 4 years of 50% annual growth while revenues would grow for 5 years at ~20% average annual growth for 5 years following 4 years of 34% average annual growth.</p><p><blockquote>根据这一预测，特斯拉还看到了一条通往4000亿美元收入的道路——这将假设收入增长同比放缓的速度比交付量快得多——将交付量提高到2000万辆需要在4年后的5年内平均年增长率约为33%。50%的年增长率，而收入将在5年内以约20%的平均年增长率增长，而在4年的平均年增长率为34%。</blockquote></p><p></p><p> To hit both of those figures, revenues at $400 billion on deliveries of 20 million, Tesla would have to cut its ASPs significantly, down to $25,000 by 2027 and ~$16,500 by 2029, assuming growth rates in energy storage and other aspects of the business continue. Tesla does envision itself in most major spaces - small/mid/large SUV, sedan/trucks, as well as in affordable &lt;$25,000 models and robotaxis; however, those most likely wouldn't amount to a sub $20,000 ASP, meaning that there are some substantial doubts raised about the feasibility of both targets occurring mutually by 2030. The other possibility that is not included here is that Tesla does not sell a robotaxi fleet but rather manages a multi-million unit fleet itself, therefore having a fair proportion of targeted 2030 volumes not reflected in ASPs.</p><p><blockquote>为了达到这两个数字，即交付量为2000万辆，收入达到4000亿美元，特斯拉必须大幅削减平均售价，到2027年降至25,000美元，到2029年降至约16,500美元，假设储能和业务其他方面的增长率继续。特斯拉确实设想在大多数主要领域——小型/中型/大型SUV、轿车/卡车，以及价格低于25,000美元的车型和机器人出租车；然而，这些目标的平均售价很可能不会低于20,000美元，这意味着到2030年这两个目标同时实现的可行性存在一些重大疑问。这里没有包括的另一种可能性是，特斯拉不出售机器人出租车车队，而是自己管理一支数百万辆的车队，因此2030年目标销量中有相当一部分没有反映在ASP中。</blockquote></p><p> Should Tesla be overshooting the delivery figures, revenues are likely very misguided; but should Tesla in fact be correct in targeting 20 million vehicles through multiple market opportunities, revenues could be completely sandbagging that potential. Time will tell in this regard.</p><p><blockquote>如果特斯拉超额完成交付数据，收入可能会受到严重误导；但如果特斯拉通过多个市场机会瞄准2000万辆汽车的目标实际上是正确的，那么收入可能会完全抵消这一潜力。在这方面，时间会证明一切。</blockquote></p><p> Back to market share - Tesla would likely be seeing around the high-teens to 20% of global automotive volumes by 2030 based ontrendswithin the industry. Yet it's hard to see Tesla achieving and maintaining such a stronghold as startups like XPeng (XPEV) and NIO (NIO) challenge it heavily on price and tech (though both are primarily confined to China geographically still) while ICE leaders are aggressively pushing to EV. Therefore, it's possible that the EV industry will remain fragmented and Tesla will not be able to hold a monopolistic grip on the sector, where it dominates volumes and dictates the industry. The company has just north of 4% total market share, and with competition heating up rapidly, the only scenario to see market share gains possibly reach that degree would be if production capacities reach that 15 million and remain over 50% higher than peers' EV manufacturing capabilities.</p><p><blockquote>回到市场份额——根据行业内的趋势，到2030年，特斯拉汽车销量可能会占全球汽车销量的20%左右。然而，很难看到特斯拉取得并保持这样的据点，因为小鹏汽车（XPEV）和蔚来（蔚来）等初创公司在价格和技术上对其发起了猛烈挑战（尽管两者在地理上仍然主要局限于中国），而ICE领导者则在积极推动电动汽车。因此，电动汽车行业可能仍将是分散的，特斯拉将无法对该行业保持垄断地位，因为它在销量上占据主导地位并决定了该行业。该公司的总市场份额略高于4%，随着竞争迅速升温，市场份额增长可能达到这一程度的唯一情况是产能达到1500万辆，并保持比同行高出50%以上电动汽车制造能力。</blockquote></p><p> In the long-term picture, the broader outlook is that EV will become the new norm, with manufacturers agreeing to work towards 40% to 50% volumes in EV. The overall goal still looks to be an EV-dominant or even full-EV future. Hundreds of new EV models are expected to hit the roads by 2030, greatly increasing the selection to consumers and overall supply volume of the vehicle type. With ICE vehicles as the old 'gold standard' and EV expected to become the 'new', ultimately the valuation premiums for industry disruption and tech are likely to fade and reflect similar multiples to the ICE cohort - at that time, in the long run, a majority of manufacturers will likely all be competing in the same vehicle type, with similar specs and technology. Although Tesla has been ahead of the curve, peers are catching up, and losing a disruption multiple from competitive/market share pressures and lower revenue growth rates, and valuations in the industry falling similar to what ICE manufacturers have experienced, the current 'gold standard' could see fair value at 3x sales and 21x earnings (14% net margin on $400 billion revenues), providing just an ample ~20% upside. Tesla does offer very attractive growth rates and sometimes unpredictable potential, but there's likely to be much better buying opportunities in the future as the risk-reward picture looks unfavorable at the moment.</p><p><blockquote>从长远来看，更广泛的前景是电动汽车将成为新常态，制造商同意努力实现电动汽车销量的40%至50%。总体目标看起来仍然是电动汽车主导甚至全电动汽车的未来。预计到2030年，将有数百款新电动汽车上路，大大增加消费者的选择和车型的整体供应量。随着内燃机汽车成为旧的“黄金标准”，电动汽车有望成为“新标准”，最终行业颠覆和技术的估值溢价可能会消退，并反映出与内燃机汽车相似的倍数——从长远来看，大多数制造商可能都会在同一车型中竞争，具有相似的规格和技术。尽管特斯拉一直处于领先地位，但同行正在迎头赶上，并因竞争/市场份额压力和收入增长率下降而失去了颠覆倍数，行业估值下降与ICE制造商所经历的类似，但当前的“黄金标准”的公允价值可能为销售额的3倍和收益的21倍（4000亿美元收入的14%净利润率），仅提供约20%的充足上涨空间。特斯拉确实提供了非常有吸引力的增长率，有时还有不可预测的潜力，但由于目前风险回报状况看起来不利，未来可能会有更好的购买机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4462564-tesla-tsla-massive-deal-breaks-1-trillion-shares-buy\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4462564-tesla-tsla-massive-deal-breaks-1-trillion-shares-buy","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127302287","content_text":"Summary\n\nTesla added nearly $200 billion to its valuation this week following good earnings and an ~$4.2 billion deal for 100K vehicles from Hertz.\nThe current growth trajectory and projected long-term growth offer massive potential in deliveries and revenues, but the risk-reward picture is weaker.\nForecasting a mutual outcome of $400 billion in revenues and 20 million units would likely lead to very low ASPs.\nLong-term sustenance of the current multiple profile is countered by multiple risks including market share and competition, and industry-wide multiple re-rating.\n\nJustin Sullivan/Getty Images News\nTesla (TSLA) broke the $1,000 barrier, taking the company to the trillion club on a multi-day rally following the company reporting earnings above consensus and a massive multi-billion dollar deal with Hertz (OTCPK:HTZZ). Tesla continues to grow rapidly even at its size, with deliveries rising ~20% q/q to 241,300 units for Q3. Tesla is offering very attractive growth rates at a scale much larger than EV peers, and as such is one of the hottest names on Wall Street. Trading volumes breached 60 million, more than double Tesla's 10-day average, with dollar volume over $60 billion. Although a substantial portion of these could be quick trades to capitalize on a >12% move on the day, Tesla has been a gift that keeps on giving, and ultimately, it's possible to get stuck buying at a short-term top, much like in January. Even with a multi-quarter string of revenue and delivery boosts from the deal, the risk-reward outlook to buying at the moment is not highly convincing - while it's not necessarily a good idea to bet against Tesla, it does not seem to be the best time to buy.\nA Hertz Fleet Deal\nThe Hertz deal shows that the demand for large-volume fleet EV exists, with the rental car operator putting in an order worth over 20% of its fleet size for Tesla's vehicles. With the order, Hertz will offer the largest EV in the country.\nGraphic from Hertz\nHertz is jumping behind \"rising global demand and interest\" for EV as the vehicles become more \"mainstream,\" choosing to invest $4.2 billion for Tesla vehicles over the next fourteen months, with the first deliveries and availabilities expected to commence in November.\nBecause EV rely on public charging infrastructure, which can be limited or harder to find than gas stations, Hertz will be \"installing thousands of chargers throughout its location network,\" adding to the 3,000 supercharging network available via Tesla. In addition, Hertz's app will provide \"digitized guidance to educate customers about the electric vehicle to get them on their way quickly, and coming soon, an expedited EV rental booking process.\" Customers booking vehicles will have to know how to use certain features like Autopilot, FSD or controlling the car through the app.\nHertz did recently emerge from Chapter 11 bankruptcy earlier this summer, and while some questions are raised about the exact funding for a deal of this size will come from given $3.0 billion in total liquidity, operating metrics have improved dramatically and rival 2019's pre-pandemic levels. Although revenues were ~11% lower than 2019, vehicle utilization sat at 78%, 3 percentage points behind as RPD and RPU increased significantly as prices rose. Compared to 2019 for Q2, Hertz saw RPD 53% higher to above $65 and RPU per month 48% higher to $1,557 - more expensive pricing of rental cars due to high demand and insufficient supply did aid these metrics, yet utilization rates reflect a strong rebound in the industry.\nFor Tesla, the deal with Hertz not only signifies a large bump to revenues and deliveries through fiscal 2022 but a broader trend towards large-scale fleet acceptance in ride renting/sharing/hailing. 100,000 units represent close to 12% of Tesla's current TTM volume and about 7% of projected deliveries and revenues for FY22. It's a substantial contribution from a single customer, but it provides a bright outlook into the future of EV in ride hailing/renting - the adoption curve could come quicker than anticipated.\nIn the broader industry, Uber (UBER) is working with multiple different players, including Kia (OTCPK:KIMTF), Arrival (ARVL) and TotalEnergies (TTE) to accelerate EV adoption while Waymo (GOOGL) and Cruise (GM) are working towards self-driving robotaxi services, which still could be years away from large-scale operations. EV can fill parts of that void, with Tesla having the necessary capacity to produce hundreds of thousands of units for fleet operators with GF Shanghai, Berlin and Texas all ramping to scale and building new capacity.\nContinuing Along the Growth Trajectory\nTesla's Q3 results speak for themselves, with the company firing on all cylinders as performance metrics across the board reached new highs.\nThe company saw its \"best-ever net income, operating profit and gross profit,\" with operating margins higher than expected, operating cash flow reaching a record, its highest production levels at Fremont, and strong growth in multiple metrics. Auto revenues rose 58% y/y and 18% q/q, slightly lagging deliveries' ~20% q/q growth as ASPs slipped 6% y/y. Higher contribution from China likely was a large factor in the ASP decline, as well as in the uptick in deliveries, with the region reportedly accounting for 133,238 vehicles during the quarter, or 55.2%; this came in higher than predicted as ASPs trended lower. That figure is 6.3 percentage points higher than Q2, with September's ~56,000 units delivered and exported a whopping 70% higher than June.\nGraphic from Tesla\nDeliveries have started to hit a hyper-growth trajectory over the trailing four quarters, with growth emerging in Q3 2020. Since then, Tesla has nearly doubled deliveries, a much faster rate than pre-pandemic growth as EV adoption and capacity increases. At the moment, Tesla's annual capacity is close to 1.1 million, or nearly 40% higher than TTM deliveries, giving the company much more room to grow ahead of completion in Berlin and Texas.\nHard To Buy Here\nEven with growth rates and operating metrics impressing across the board, it's hard to chalk out a positive risk-reward outlook after shares ran higher this week - the earnings and $4.2 billion Hertz deal added at one point nearly $200 billion to Tesla's valuation, or close to $175 billion at the high in just the two days since the deal was announced. Are the new synergies from the deal and/or earnings good enough to support buying a company worth over 15% more following that announcement? Here, that does not look to be the case.\nOver the short-term, such frenzied trading and rapid, high percentage rallies are typically very short-lived - Tesla's last pre-split rally to $900 in early 2020 saw the stock shed 20% in under a week, and a strong rally to nearly $900 post-split in early 2021 saw shares hold for a month after a 10% drop before shedding another 35% through March. Short-term trades can pay off, but from a long-term standpoint, the outlook is bright, but the return potential, not as much.\nTesla projects that it can drive long-term average annual growth of 50% in deliveries, which, from 900,000 deliveries possible for FY21, would see Tesla doing about 4.5 million vehicles per year in 2025. Extending that growth rate further to 2030 would see Tesla delivering 34 million vehicles, or half of global automotive volumes from 2020; this seems to be a very unrealistic scenario, even as Tesla stated that the goal is to have 20 million deliveries by then. To reach that figure, Tesla would have to grow at about 35% annual from 2025's projected figure. All in all, 2025's deliveries could be close to 5% of total global automotive sales volumes while 2030's could be near 20%. Given the competition in the industry, it's hard to see Tesla driving that much market share alone and beating out competition by that far of a margin - even Apple (AAPL) only commands near 15% market share in smartphones, where it's widely seen among the top three in the industry.\nWith that forecast, Tesla is also seeing a path to $400 billion in revenues - this would assume that revenue growth slows much faster y/y than deliveries - driving deliveries to 20 million requires 5 years of ~33% average annual growth following 4 years of 50% annual growth while revenues would grow for 5 years at ~20% average annual growth for 5 years following 4 years of 34% average annual growth.\nTo hit both of those figures, revenues at $400 billion on deliveries of 20 million, Tesla would have to cut its ASPs significantly, down to $25,000 by 2027 and ~$16,500 by 2029, assuming growth rates in energy storage and other aspects of the business continue. Tesla does envision itself in most major spaces - small/mid/large SUV, sedan/trucks, as well as in affordable <$25,000 models and robotaxis; however, those most likely wouldn't amount to a sub $20,000 ASP, meaning that there are some substantial doubts raised about the feasibility of both targets occurring mutually by 2030. The other possibility that is not included here is that Tesla does not sell a robotaxi fleet but rather manages a multi-million unit fleet itself, therefore having a fair proportion of targeted 2030 volumes not reflected in ASPs.\nShould Tesla be overshooting the delivery figures, revenues are likely very misguided; but should Tesla in fact be correct in targeting 20 million vehicles through multiple market opportunities, revenues could be completely sandbagging that potential. Time will tell in this regard.\nBack to market share - Tesla would likely be seeing around the high-teens to 20% of global automotive volumes by 2030 based ontrendswithin the industry. Yet it's hard to see Tesla achieving and maintaining such a stronghold as startups like XPeng (XPEV) and NIO (NIO) challenge it heavily on price and tech (though both are primarily confined to China geographically still) while ICE leaders are aggressively pushing to EV. Therefore, it's possible that the EV industry will remain fragmented and Tesla will not be able to hold a monopolistic grip on the sector, where it dominates volumes and dictates the industry. The company has just north of 4% total market share, and with competition heating up rapidly, the only scenario to see market share gains possibly reach that degree would be if production capacities reach that 15 million and remain over 50% higher than peers' EV manufacturing capabilities.\nIn the long-term picture, the broader outlook is that EV will become the new norm, with manufacturers agreeing to work towards 40% to 50% volumes in EV. The overall goal still looks to be an EV-dominant or even full-EV future. Hundreds of new EV models are expected to hit the roads by 2030, greatly increasing the selection to consumers and overall supply volume of the vehicle type. With ICE vehicles as the old 'gold standard' and EV expected to become the 'new', ultimately the valuation premiums for industry disruption and tech are likely to fade and reflect similar multiples to the ICE cohort - at that time, in the long run, a majority of manufacturers will likely all be competing in the same vehicle type, with similar specs and technology. Although Tesla has been ahead of the curve, peers are catching up, and losing a disruption multiple from competitive/market share pressures and lower revenue growth rates, and valuations in the industry falling similar to what ICE manufacturers have experienced, the current 'gold standard' could see fair value at 3x sales and 21x earnings (14% net margin on $400 billion revenues), providing just an ample ~20% upside. Tesla does offer very attractive growth rates and sometimes unpredictable potential, but there's likely to be much better buying opportunities in the future as the risk-reward picture looks unfavorable at the moment.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855908602,"gmtCreate":1635321812670,"gmtModify":1635321812776,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help me like","listText":"help me like","text":"help me like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855908602","repostId":"1140781680","repostType":4,"repost":{"id":"1140781680","kind":"news","pubTimestamp":1635320254,"share":"https://www.laohu8.com/m/news/1140781680?lang=zh_CN&edition=full","pubTime":"2021-10-27 15:37","market":"us","language":"en","title":"GM Earnings Are Coming. Fasten Your Seat Belts.<blockquote>通用汽车财报即将公布。系好安全带。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1140781680","media":"Barrons","summary":"General Motors reports third-quarter results Wednesday morning. Investors, frankly, don’t know what ","content":"<p>General Motors&nbsp;reports third-quarter results Wednesday morning. Investors, frankly, don’t know what to expect. That could lead to more wild trading in GM stock.</p><p><blockquote>通用汽车周三上午公布第三季度业绩。坦率地说，投资者不知道会发生什么。这可能会导致通用汽车股票的更疯狂交易。</blockquote></p><p> Since GM (ticker: GM) last reported earnings in early August, the stock has been essentially flat. The&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;are up about 3% and 2%, respectively, over the same span.</p><p><blockquote>自通用汽车（股票代码：GM）上次于八月初公布财报以来，该股基本持平。同期，标准普尔500指数和道琼斯工业平均指数分别上涨约3%和2%。</blockquote></p><p> Still, the stock has taken shareholders on a volatile ride to get to even. Shares dropped almost 9% the day of the second-quarter earnings report. GM stock has fallen from about $58 a share just before second-quarter earnings to about $47 a share before bounding back and trading north of $59 early in October. Shares were roughly flat, at $57.73, in recent trading. The S&amp;P 500 was up 0.7%.</p><p><blockquote>尽管如此，该股仍带领股东经历了一段波动的旅程，最终实现了收支平衡。第二季度收益报告发布当天，股价下跌近9%。通用汽车股价已从第二季度财报公布前的每股约58美元跌至每股约47美元，随后反弹并于10月初突破59美元。在最近的交易中，股价大致持平，为57.73美元。标普500上涨0.7%。</blockquote></p><p> Second-quarter operating profits beat expectations, but guidance for second-half 2021 earnings sunk the shares, disappointing investors. Two things dragged guidance down. First, the global semiconductor shortage constraining car production wasn’t abating. Next, recall costs for faulty batteries in Chevy Bolt EVs&nbsp;were rising.</p><p><blockquote>第二季度营业利润超出预期，但2021年下半年盈利指引导致股价下跌，令投资者失望。有两件事拖累了指导。首先，限制汽车生产的全球半导体短缺并未减弱。其次，雪佛兰Bolt电动汽车故障电池的召回成本正在上升。</blockquote></p><p> GM stock got a boost in October when battery supplier&nbsp;LG Chem&nbsp;(051910.Korea) agreed to reimburse GM about $2 billion for recall costs.</p><p><blockquote>10月份，当电池供应商LG化学(051910.Korea)同意向通用汽车偿还约20亿美元的召回费用时，通用汽车股价得到提振。</blockquote></p><p> The auto maker’s stock got another boost that same month when management hosted an investor day, focusing on its long-term vehicle electrification and autonomous-driving goals. GM wants to double sales by 2030 off a base of $140 billion. That goal will be discussed on Wednesday, but near-term results won’t impact that goal.</p><p><blockquote>同月，当管理层举办投资者日活动，重点关注其长期汽车电气化和自动驾驶目标时，该汽车制造商的股价再次上涨。通用汽车希望到2030年将销售额在1400亿美元的基础上翻一番。该目标将在周三讨论，但近期结果不会影响该目标。</blockquote></p><p> The semiconductor shortage persists. Investors have to balance the continuing shortage against high vehicle prices. Light-vehicle sales in the U.S. dropped about 13% in the third quarter. But auto dealers such as&nbsp;AutoNation&nbsp;(AN) and&nbsp;Lithia Motors&nbsp;(LAD) are blowing away Street earnings estimates because of high per-car profitability.</p><p><blockquote>半导体短缺持续存在。投资者必须在持续的短缺和高昂的汽车价格之间取得平衡。第三季度美国轻型汽车销量下降约13%。但由于每辆车的盈利能力较高，AutoNation(AN)和Lithia Motors(LAD)等汽车经销商的盈利预期超出了华尔街的预期。</blockquote></p><p> Wall Street is looking for about $1 in per-share earnings from $26.4 billion in sales. GM reported $1.97 in adjusted per-share earnings from $34.2 billion in sales.</p><p><blockquote>华尔街预计264亿美元的销售额中每股收益约为1美元。通用汽车公布的调整后每股收益为1.97美元，销售额为342亿美元。</blockquote></p><p> This time around, options markets are implying about a 5% move, up or down, following GM’s earnings report.</p><p><blockquote>这一次，在通用汽车发布收益报告后，期权市场暗示将上涨或下跌约5%。</blockquote></p><p> “Results—sales, margins, working cap, [free cash flow]—will unlikely be pretty,” wrote RBC analyst Joseph Spak in an industry earnings preview report back in late September. He is still positive on auto-maker stocks, as auto sales should pick up in 2022 after the semiconductor shortage abates. He rates GM shares Buy and has a $74 price target for the stock.</p><p><blockquote>加拿大皇家银行(RBC)分析师约瑟夫·斯帕克(Joseph Spak)在9月底的行业收益预览报告中写道：“结果——销售额、利润率、工作上限、[自由现金流]——不太可能漂亮。”他仍然看好汽车制造商股票，因为在半导体短缺缓解后，汽车销量应该会在2022年回升。他将通用汽车股票评级为买入，并将该股目标价定为74美元。</blockquote></p><p> GM management will host a conference call at 10 a.m. Eastern time after it releases numbers.</p><p><blockquote>通用汽车管理层将于上午10点召开电话会议。东部时间发布数据后。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GM Earnings Are Coming. Fasten Your Seat Belts.<blockquote>通用汽车财报即将公布。系好安全带。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGM Earnings Are Coming. Fasten Your Seat Belts.<blockquote>通用汽车财报即将公布。系好安全带。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-10-27 15:37</span>\n</p>\n</h4>\n</header>\n<article>\n<p>General Motors&nbsp;reports third-quarter results Wednesday morning. Investors, frankly, don’t know what to expect. That could lead to more wild trading in GM stock.</p><p><blockquote>通用汽车周三上午公布第三季度业绩。坦率地说，投资者不知道会发生什么。这可能会导致通用汽车股票的更疯狂交易。</blockquote></p><p> Since GM (ticker: GM) last reported earnings in early August, the stock has been essentially flat. The&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;are up about 3% and 2%, respectively, over the same span.</p><p><blockquote>自通用汽车（股票代码：GM）上次于八月初公布财报以来，该股基本持平。同期，标准普尔500指数和道琼斯工业平均指数分别上涨约3%和2%。</blockquote></p><p> Still, the stock has taken shareholders on a volatile ride to get to even. Shares dropped almost 9% the day of the second-quarter earnings report. GM stock has fallen from about $58 a share just before second-quarter earnings to about $47 a share before bounding back and trading north of $59 early in October. Shares were roughly flat, at $57.73, in recent trading. The S&amp;P 500 was up 0.7%.</p><p><blockquote>尽管如此，该股仍带领股东经历了一段波动的旅程，最终实现了收支平衡。第二季度收益报告发布当天，股价下跌近9%。通用汽车股价已从第二季度财报公布前的每股约58美元跌至每股约47美元，随后反弹并于10月初突破59美元。在最近的交易中，股价大致持平，为57.73美元。标普500上涨0.7%。</blockquote></p><p> Second-quarter operating profits beat expectations, but guidance for second-half 2021 earnings sunk the shares, disappointing investors. Two things dragged guidance down. First, the global semiconductor shortage constraining car production wasn’t abating. Next, recall costs for faulty batteries in Chevy Bolt EVs&nbsp;were rising.</p><p><blockquote>第二季度营业利润超出预期，但2021年下半年盈利指引导致股价下跌，令投资者失望。有两件事拖累了指导。首先，限制汽车生产的全球半导体短缺并未减弱。其次，雪佛兰Bolt电动汽车故障电池的召回成本正在上升。</blockquote></p><p> GM stock got a boost in October when battery supplier&nbsp;LG Chem&nbsp;(051910.Korea) agreed to reimburse GM about $2 billion for recall costs.</p><p><blockquote>10月份，当电池供应商LG化学(051910.Korea)同意向通用汽车偿还约20亿美元的召回费用时，通用汽车股价得到提振。</blockquote></p><p> The auto maker’s stock got another boost that same month when management hosted an investor day, focusing on its long-term vehicle electrification and autonomous-driving goals. GM wants to double sales by 2030 off a base of $140 billion. That goal will be discussed on Wednesday, but near-term results won’t impact that goal.</p><p><blockquote>同月，当管理层举办投资者日活动，重点关注其长期汽车电气化和自动驾驶目标时，该汽车制造商的股价再次上涨。通用汽车希望到2030年将销售额在1400亿美元的基础上翻一番。该目标将在周三讨论，但近期结果不会影响该目标。</blockquote></p><p> The semiconductor shortage persists. Investors have to balance the continuing shortage against high vehicle prices. Light-vehicle sales in the U.S. dropped about 13% in the third quarter. But auto dealers such as&nbsp;AutoNation&nbsp;(AN) and&nbsp;Lithia Motors&nbsp;(LAD) are blowing away Street earnings estimates because of high per-car profitability.</p><p><blockquote>半导体短缺持续存在。投资者必须在持续的短缺和高昂的汽车价格之间取得平衡。第三季度美国轻型汽车销量下降约13%。但由于每辆车的盈利能力较高，AutoNation(AN)和Lithia Motors(LAD)等汽车经销商的盈利预期超出了华尔街的预期。</blockquote></p><p> Wall Street is looking for about $1 in per-share earnings from $26.4 billion in sales. GM reported $1.97 in adjusted per-share earnings from $34.2 billion in sales.</p><p><blockquote>华尔街预计264亿美元的销售额中每股收益约为1美元。通用汽车公布的调整后每股收益为1.97美元，销售额为342亿美元。</blockquote></p><p> This time around, options markets are implying about a 5% move, up or down, following GM’s earnings report.</p><p><blockquote>这一次，在通用汽车发布收益报告后，期权市场暗示将上涨或下跌约5%。</blockquote></p><p> “Results—sales, margins, working cap, [free cash flow]—will unlikely be pretty,” wrote RBC analyst Joseph Spak in an industry earnings preview report back in late September. He is still positive on auto-maker stocks, as auto sales should pick up in 2022 after the semiconductor shortage abates. He rates GM shares Buy and has a $74 price target for the stock.</p><p><blockquote>加拿大皇家银行(RBC)分析师约瑟夫·斯帕克(Joseph Spak)在9月底的行业收益预览报告中写道：“结果——销售额、利润率、工作上限、[自由现金流]——不太可能漂亮。”他仍然看好汽车制造商股票，因为在半导体短缺缓解后，汽车销量应该会在2022年回升。他将通用汽车股票评级为买入，并将该股目标价定为74美元。</blockquote></p><p> GM management will host a conference call at 10 a.m. Eastern time after it releases numbers.</p><p><blockquote>通用汽车管理层将于上午10点召开电话会议。东部时间发布数据后。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/gm-earnings-are-coming-fasten-your-seat-belts-51635260107?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车"},"source_url":"https://www.barrons.com/articles/gm-earnings-are-coming-fasten-your-seat-belts-51635260107?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140781680","content_text":"General Motors reports third-quarter results Wednesday morning. Investors, frankly, don’t know what to expect. That could lead to more wild trading in GM stock.\nSince GM (ticker: GM) last reported earnings in early August, the stock has been essentially flat. The S&P 500 and Dow Jones Industrial Average are up about 3% and 2%, respectively, over the same span.\nStill, the stock has taken shareholders on a volatile ride to get to even. Shares dropped almost 9% the day of the second-quarter earnings report. GM stock has fallen from about $58 a share just before second-quarter earnings to about $47 a share before bounding back and trading north of $59 early in October. Shares were roughly flat, at $57.73, in recent trading. The S&P 500 was up 0.7%.\nSecond-quarter operating profits beat expectations, but guidance for second-half 2021 earnings sunk the shares, disappointing investors. Two things dragged guidance down. First, the global semiconductor shortage constraining car production wasn’t abating. Next, recall costs for faulty batteries in Chevy Bolt EVs were rising.\nGM stock got a boost in October when battery supplier LG Chem (051910.Korea) agreed to reimburse GM about $2 billion for recall costs.\nThe auto maker’s stock got another boost that same month when management hosted an investor day, focusing on its long-term vehicle electrification and autonomous-driving goals. GM wants to double sales by 2030 off a base of $140 billion. That goal will be discussed on Wednesday, but near-term results won’t impact that goal.\nThe semiconductor shortage persists. Investors have to balance the continuing shortage against high vehicle prices. Light-vehicle sales in the U.S. dropped about 13% in the third quarter. But auto dealers such as AutoNation (AN) and Lithia Motors (LAD) are blowing away Street earnings estimates because of high per-car profitability.\nWall Street is looking for about $1 in per-share earnings from $26.4 billion in sales. GM reported $1.97 in adjusted per-share earnings from $34.2 billion in sales.\nThis time around, options markets are implying about a 5% move, up or down, following GM’s earnings report.\n“Results—sales, margins, working cap, [free cash flow]—will unlikely be pretty,” wrote RBC analyst Joseph Spak in an industry earnings preview report back in late September. He is still positive on auto-maker stocks, as auto sales should pick up in 2022 after the semiconductor shortage abates. He rates GM shares Buy and has a $74 price target for the stock.\nGM management will host a conference call at 10 a.m. Eastern time after it releases numbers.","news_type":1,"symbols_score_info":{"GM":0.9}},"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852064658,"gmtCreate":1635224395721,"gmtModify":1635224396082,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852064658","repostId":"2177412181","repostType":4,"repost":{"id":"2177412181","kind":"highlight","pubTimestamp":1635219132,"share":"https://www.laohu8.com/m/news/2177412181?lang=zh_CN&edition=full","pubTime":"2021-10-26 11:32","market":"us","language":"en","title":"AMD earnings look to again succeed where Intel disappointed<blockquote>AMD盈利有望在英特尔失望的地方再次取得成功</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2177412181","media":"MarketWatch","summary":"AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analy","content":"<p>AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analysts now point to AMD's growing margins as Intel's are projected to shrink</p><p><blockquote>AMD盈利预览：在英特尔连续两个季度下滑后，分析师现在指出，由于英特尔的利润率预计将萎缩，AMD的利润率将不断增长</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/30ec3c9220844c561016f0de86f86f52\" tg-width=\"699\" tg-height=\"394\" referrerpolicy=\"no-referrer\"><span>Advanced Micro Devices Inc.’s growing series of Epyc server chips has been the talk of Wall Street in recent quarters, but that may switch to gross margins in this quarter’s earnings report.</span></p><p><blockquote><p class=\"t-img-caption\"><span>Advanced Micro Devices Inc.不断增长的Epyc服务器芯片系列最近几个季度一直是华尔街的热门话题，但在本季度的收益报告中，这可能会转向毛利率。</span></p></blockquote></p><p> Advanced Micro Devices Inc. is set to follow yet another rough earnings report from Intel Corp., and once again could show gains in an area that caused pain for its larger rival.</p><p><blockquote>超微设备公司（Advanced Micro Devices Inc.）将紧随英特尔公司（Intel Corp.）发布另一份粗略的收益报告，并可能再次在给其规模更大的竞争对手带来痛苦的领域显示收益。</blockquote></p><p> AMD&nbsp;is scheduled to report third-quarter earnings on Tuesday after the close of markets, after Intel&nbsp;reported an earnings beat Thursday that hardly mattered as revenue came in light. More important to analysts was Intel's forecast for declining margins over the next few years as its chief executive doubles down on new manufacturing capacity to try to retake its former glory as the undisputed chip leader.</p><p><blockquote>AMD定于周二收盘后公布第三季度收益，此前英特尔周四公布的收益超出预期，但随着收入的公布，这几乎无关紧要。对分析师来说，更重要的是英特尔预测未来几年利润率将下降，因为其首席执行官加倍投资新的制造能力，试图重新夺回其作为无可争议的芯片领导者的昔日荣耀。</blockquote></p><p> That led to downgrades on Friday and Intel's worst one-day performance since the chip leader said it was going to delay its next generation of chips, an announcement that had fired up even more investor support for AMD back then.</p><p><blockquote>这导致了周五的评级下调，以及英特尔自这家芯片领导者表示将推迟下一代芯片以来最糟糕的单日表现，这一声明当时引发了更多投资者对AMD的支持。</blockquote></p><p> Bernstein analyst Stacy Rasgon, who has a market perform rating on AMD and a $110 price target, said AMD will continue to benefit from Intel's transition, and called attention to an AMD metric that was one of enormous concern during Intel's call: Gross margins.</p><p><blockquote>Bernstein分析师Stacy Rasgon对AMD给予市场表现评级，目标价为110美元，她表示AMD将继续受益于英特尔的转型，并呼吁人们关注英特尔看涨期权期间备受关注的AMD指标之一：毛利率。</blockquote></p><p> \"We believe Street gross margin estimates appear unaggressive going forward (which is not something we have typically said for AMD), and the company is now (for the first time ever) starting to return cash,\" Rasgon said.</p><p><blockquote>拉斯贡表示：“我们认为，未来华尔街的毛利率预期似乎并不激进（这不是我们通常对AMD所说的），该公司现在（有史以来第一次）开始返还现金。”</blockquote></p><p> That underscores another show of how Intel and AMD are transitioning with respect to one another: Analysts on the Intel call were very concerned that Intel's margins were falling despite company assurances they would stay just above 50% for the next few years. Meanwhile, AMD gross margins have been rising, and are likely to break above 50%, if not in this earnings report, then sometime soon. Three months ago, AMD reported gross margins of 48%, up from 44% in the previous year.</p><p><blockquote>这再次凸显了英特尔和AMD如何相互转型：英特尔看涨期权上的分析师非常担心英特尔的利润率正在下降，尽管该公司保证未来几年利润率将保持在50%以上。与此同时，AMD的毛利率一直在上升，很可能会突破50%，如果不是在这份收益报告中，那么很快就会突破50%。三个月前，AMD公布的毛利率为48%，高于上一年的44%。</blockquote></p><p> While AMD is referred to as Intel's \"smaller rival,\" that gap has been steadily closing for a while now. At Friday's close, AMD had a market cap of $145.34 billion, or nearly 73% of Intel's $200.66 billion. Just this past summer, AMD's $111.5 billion valuation was a little more than half Intel's $219.5 billion cap.</p><p><blockquote>虽然AMD被称为英特尔的“较小竞争对手”，但这一差距已经稳步缩小了一段时间。截至周五收盘，AMD市值为1453.4亿美元，占英特尔2006.6亿美元市值的近73%。就在去年夏天，AMD 1115亿美元的估值略高于英特尔2195亿美元上限的一半。</blockquote></p><p> One other are to look at will be data-center sales, as finally swung to a gain in that important segment in the quarter. Over the past two quarters, Intel has posted significant year-over-year declines in the increasingly important category, while AMD has more than doubled its sales. That raises the question whether Intel clawed back some market share, or whether data-center sales were just generally better all around, which AMD's report could answer.</p><p><blockquote>另一个值得关注的是数据中心销售，该销售最终在本季度实现了增长。在过去的两个季度中，英特尔在这一日益重要的类别中的销售额同比大幅下降，而AMD的销售额则增长了一倍多。这就提出了一个问题：英特尔是否夺回了一些市场份额，或者数据中心的销售是否总体上更好，AMD的报告可以回答这个问题。</blockquote></p><p> <b>What to expect</b></p><p><blockquote><b>期待什么</b></blockquote></p><p> <b>Earnings: </b>Of the 34 analysts surveyed by FactSet, AMD on average is expected to post adjusted earnings of 66 cents a share, up from 41 cents a share reported in the year-ago period. Estimize, a software platform that crowdsources estimates from hedge-fund executives, brokerages, buy-side analysts and others, calls for earnings of 72 cents a share.</p><p><blockquote><b>收益：</b>在FactSet调查的34名分析师中，AMD平均预计调整后每股收益为66美分，高于去年同期的每股41美分。Estimize是一个软件平台，众包对冲基金高管、券商、买方分析师和其他人对评级每股收益72美分的估计。</blockquote></p><p> <b>Revenue:</b> Of the 32 analysts polled by FactSet, AMD, on average, is expected to post revenue of $4.11 billion, up from the $2.8 billion reported in the year-ago quarter. AMD had forecast $4 billion to $4.2 billion. Estimize expects revenue of $4.22 billion.</p><p><blockquote><b>收入：</b>在FactSet调查的32名分析师中，AMD平均预计营收为41.1亿美元，高于去年同期的28亿美元。AMD此前预测为40亿至42亿美元。Estimize预计营收为42.2亿美元。</blockquote></p><p> <b>Stock movement:</b> While AMD earnings and sales have both topped Wall Street estimates over the past five quarterly reports, but shares only gained the next day twice, about three months ago and when the stock popped nearly 13% five quarters ago.</p><p><blockquote><b>股票变动：</b>尽管AMD在过去五份季度报告中的盈利和销售额均超出了华尔街的预期，但该股仅在第二天上涨了两次，分别是大约三个月前和五个季度前该股上涨了近13%。</blockquote></p><p> AMD shares rose 9.6% in the third quarter. In contrast, the PHLX Semiconductor Index declined 2.6%, the S&amp;P 500 index rose 0.2%, and the tech-heavy Nasdaq Composite Index declined 0.4%. On Friday, the day after Intel's report, AMD shares closed at a record high of $119.82.</p><p><blockquote>AMD股价第三季度上涨9.6%。相比之下，PHLX半导体指数下跌2.6%，标普500指数上涨0.2%，以科技股为主的纳斯达克综合指数下跌0.4%。周五，也就是英特尔发布报告的第二天，AMD股价收于119.82美元的历史新高。</blockquote></p><p> <b>What analysts are saying</b></p><p><blockquote><b>分析师怎么说</b></blockquote></p><p> Cowen analyst Matthew Ramsay, who has an outperform rating and a $120 price target on AMD, said he's \"lookin' for more of the same.\"</p><p><blockquote>Cowen分析师马修·拉姆齐(Matthew Ramsay)对AMD给予跑赢大盘评级，目标价为120美元，他表示“正在寻找更多同样的结果”。</blockquote></p><p> \"We continue to monitor the PC market for signs of demand slowing or supply improving,\" Ramsay said. \"Near-term, we see resilient demand outside Chromebooks, but prefer a prudent/agnostic view on 2022 like AMD took on its last call.\"</p><p><blockquote>Ramsay表示：“我们将继续关注PC市场，寻找需求放缓或供应改善的迹象。”“短期内，我们看到Chromebook以外的需求具有弹性，但更倾向于对2022年采取谨慎/不可知论的观点，就像AMD在上一次看涨期权中采取的那样。”</blockquote></p><p> Earlier in the month, research firms released data showing that pandemic-fueled growth in PC shipments had slowed considerably as the world not only wrestles with a chip shortage but overall supply-chain issues.</p><p><blockquote>本月早些时候，研究公司发布的数据显示，疫情推动的个人电脑出货量增长已大幅放缓，因为世界不仅面临芯片短缺问题，还面临整体供应链问题。</blockquote></p><p></p><p> On data-center sales, Ramsay is even more optimistic estimating that segment will account for more than 25% of sales compared with less than 20% a year ago.</p><p><blockquote>在数据中心销售额方面，Ramsay更加乐观地估计该细分市场将占销售额的25%以上，而一年前这一比例还不到20%。</blockquote></p><p> \"We believe datacenter passing a quarter of AMD's business could draw investor attention,\" Ramsay said. \"We remind investors that the most important business for AMD remains datacenter, which we estimate doubled in 2020, with CEO Lisa Su noting she sees the business momentum accelerating in 2021.\"</p><p><blockquote>拉姆齐表示：“我们相信数据中心超过AMD四分之一的业务可能会引起投资者的关注。”“我们提醒投资者，AMD最重要的业务仍然是数据中心，我们估计该业务在2020年翻了一番，首席执行官Lisa Su指出，她预计2021年业务势头将加速。”</blockquote></p><p> Susquehanna Financial analyst Christopher Rolland, who has a positive rating and a $130 price target on AMD, said he expects another solid quarter driven by enterprise and server sales, but that \"given the slowing PC market, we do not expect mgmt to raise their FY top-line guidance as they have done in numerous updates over the last year.\"</p><p><blockquote>Susquehanna Financial分析师Christopher Rolland对AMD给予正面评级，目标价为130美元，他表示，他预计企业和服务器销售将推动另一个稳健的季度，但“鉴于PC市场放缓，我们预计管理层不会提高他们的财务业绩。”正如他们在去年的多次更新中所做的那样，顶线指导。”</blockquote></p><p> Still, Rolland expects AMD to report share gains from Intel in both desktop and laptop PCs as well as enterprise and gaming PCs.</p><p><blockquote>尽管如此，魅兰预计AMD在台式机和笔记本电脑以及企业级和游戏PC领域的份额将从英特尔增长。</blockquote></p><p> Of the 39 analysts who cover AMD, 23 have buy or overweight ratings, and 16 have hold ratings, with an average price target of $117.55.</p><p><blockquote>在关注AMD的39名分析师中，23名分析师给予买入或跑赢大盘评级，16名分析师给予持有评级，平均目标价为117.55美元。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD earnings look to again succeed where Intel disappointed<blockquote>AMD盈利有望在英特尔失望的地方再次取得成功</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD earnings look to again succeed where Intel disappointed<blockquote>AMD盈利有望在英特尔失望的地方再次取得成功</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-10-26 11:32</span>\n</p>\n</h4>\n</header>\n<article>\n<p>AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analysts now point to AMD's growing margins as Intel's are projected to shrink</p><p><blockquote>AMD盈利预览：在英特尔连续两个季度下滑后，分析师现在指出，由于英特尔的利润率预计将萎缩，AMD的利润率将不断增长</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/30ec3c9220844c561016f0de86f86f52\" tg-width=\"699\" tg-height=\"394\" referrerpolicy=\"no-referrer\"><span>Advanced Micro Devices Inc.’s growing series of Epyc server chips has been the talk of Wall Street in recent quarters, but that may switch to gross margins in this quarter’s earnings report.</span></p><p><blockquote><p class=\"t-img-caption\"><span>Advanced Micro Devices Inc.不断增长的Epyc服务器芯片系列最近几个季度一直是华尔街的热门话题，但在本季度的收益报告中，这可能会转向毛利率。</span></p></blockquote></p><p> Advanced Micro Devices Inc. is set to follow yet another rough earnings report from Intel Corp., and once again could show gains in an area that caused pain for its larger rival.</p><p><blockquote>超微设备公司（Advanced Micro Devices Inc.）将紧随英特尔公司（Intel Corp.）发布另一份粗略的收益报告，并可能再次在给其规模更大的竞争对手带来痛苦的领域显示收益。</blockquote></p><p> AMD&nbsp;is scheduled to report third-quarter earnings on Tuesday after the close of markets, after Intel&nbsp;reported an earnings beat Thursday that hardly mattered as revenue came in light. More important to analysts was Intel's forecast for declining margins over the next few years as its chief executive doubles down on new manufacturing capacity to try to retake its former glory as the undisputed chip leader.</p><p><blockquote>AMD定于周二收盘后公布第三季度收益，此前英特尔周四公布的收益超出预期，但随着收入的公布，这几乎无关紧要。对分析师来说，更重要的是英特尔预测未来几年利润率将下降，因为其首席执行官加倍投资新的制造能力，试图重新夺回其作为无可争议的芯片领导者的昔日荣耀。</blockquote></p><p> That led to downgrades on Friday and Intel's worst one-day performance since the chip leader said it was going to delay its next generation of chips, an announcement that had fired up even more investor support for AMD back then.</p><p><blockquote>这导致了周五的评级下调，以及英特尔自这家芯片领导者表示将推迟下一代芯片以来最糟糕的单日表现，这一声明当时引发了更多投资者对AMD的支持。</blockquote></p><p> Bernstein analyst Stacy Rasgon, who has a market perform rating on AMD and a $110 price target, said AMD will continue to benefit from Intel's transition, and called attention to an AMD metric that was one of enormous concern during Intel's call: Gross margins.</p><p><blockquote>Bernstein分析师Stacy Rasgon对AMD给予市场表现评级，目标价为110美元，她表示AMD将继续受益于英特尔的转型，并呼吁人们关注英特尔看涨期权期间备受关注的AMD指标之一：毛利率。</blockquote></p><p> \"We believe Street gross margin estimates appear unaggressive going forward (which is not something we have typically said for AMD), and the company is now (for the first time ever) starting to return cash,\" Rasgon said.</p><p><blockquote>拉斯贡表示：“我们认为，未来华尔街的毛利率预期似乎并不激进（这不是我们通常对AMD所说的），该公司现在（有史以来第一次）开始返还现金。”</blockquote></p><p> That underscores another show of how Intel and AMD are transitioning with respect to one another: Analysts on the Intel call were very concerned that Intel's margins were falling despite company assurances they would stay just above 50% for the next few years. Meanwhile, AMD gross margins have been rising, and are likely to break above 50%, if not in this earnings report, then sometime soon. Three months ago, AMD reported gross margins of 48%, up from 44% in the previous year.</p><p><blockquote>这再次凸显了英特尔和AMD如何相互转型：英特尔看涨期权上的分析师非常担心英特尔的利润率正在下降，尽管该公司保证未来几年利润率将保持在50%以上。与此同时，AMD的毛利率一直在上升，很可能会突破50%，如果不是在这份收益报告中，那么很快就会突破50%。三个月前，AMD公布的毛利率为48%，高于上一年的44%。</blockquote></p><p> While AMD is referred to as Intel's \"smaller rival,\" that gap has been steadily closing for a while now. At Friday's close, AMD had a market cap of $145.34 billion, or nearly 73% of Intel's $200.66 billion. Just this past summer, AMD's $111.5 billion valuation was a little more than half Intel's $219.5 billion cap.</p><p><blockquote>虽然AMD被称为英特尔的“较小竞争对手”，但这一差距已经稳步缩小了一段时间。截至周五收盘，AMD市值为1453.4亿美元，占英特尔2006.6亿美元市值的近73%。就在去年夏天，AMD 1115亿美元的估值略高于英特尔2195亿美元上限的一半。</blockquote></p><p> One other are to look at will be data-center sales, as finally swung to a gain in that important segment in the quarter. Over the past two quarters, Intel has posted significant year-over-year declines in the increasingly important category, while AMD has more than doubled its sales. That raises the question whether Intel clawed back some market share, or whether data-center sales were just generally better all around, which AMD's report could answer.</p><p><blockquote>另一个值得关注的是数据中心销售，该销售最终在本季度实现了增长。在过去的两个季度中，英特尔在这一日益重要的类别中的销售额同比大幅下降，而AMD的销售额则增长了一倍多。这就提出了一个问题：英特尔是否夺回了一些市场份额，或者数据中心的销售是否总体上更好，AMD的报告可以回答这个问题。</blockquote></p><p> <b>What to expect</b></p><p><blockquote><b>期待什么</b></blockquote></p><p> <b>Earnings: </b>Of the 34 analysts surveyed by FactSet, AMD on average is expected to post adjusted earnings of 66 cents a share, up from 41 cents a share reported in the year-ago period. Estimize, a software platform that crowdsources estimates from hedge-fund executives, brokerages, buy-side analysts and others, calls for earnings of 72 cents a share.</p><p><blockquote><b>收益：</b>在FactSet调查的34名分析师中，AMD平均预计调整后每股收益为66美分，高于去年同期的每股41美分。Estimize是一个软件平台，众包对冲基金高管、券商、买方分析师和其他人对评级每股收益72美分的估计。</blockquote></p><p> <b>Revenue:</b> Of the 32 analysts polled by FactSet, AMD, on average, is expected to post revenue of $4.11 billion, up from the $2.8 billion reported in the year-ago quarter. AMD had forecast $4 billion to $4.2 billion. Estimize expects revenue of $4.22 billion.</p><p><blockquote><b>收入：</b>在FactSet调查的32名分析师中，AMD平均预计营收为41.1亿美元，高于去年同期的28亿美元。AMD此前预测为40亿至42亿美元。Estimize预计营收为42.2亿美元。</blockquote></p><p> <b>Stock movement:</b> While AMD earnings and sales have both topped Wall Street estimates over the past five quarterly reports, but shares only gained the next day twice, about three months ago and when the stock popped nearly 13% five quarters ago.</p><p><blockquote><b>股票变动：</b>尽管AMD在过去五份季度报告中的盈利和销售额均超出了华尔街的预期，但该股仅在第二天上涨了两次，分别是大约三个月前和五个季度前该股上涨了近13%。</blockquote></p><p> AMD shares rose 9.6% in the third quarter. In contrast, the PHLX Semiconductor Index declined 2.6%, the S&amp;P 500 index rose 0.2%, and the tech-heavy Nasdaq Composite Index declined 0.4%. On Friday, the day after Intel's report, AMD shares closed at a record high of $119.82.</p><p><blockquote>AMD股价第三季度上涨9.6%。相比之下，PHLX半导体指数下跌2.6%，标普500指数上涨0.2%，以科技股为主的纳斯达克综合指数下跌0.4%。周五，也就是英特尔发布报告的第二天，AMD股价收于119.82美元的历史新高。</blockquote></p><p> <b>What analysts are saying</b></p><p><blockquote><b>分析师怎么说</b></blockquote></p><p> Cowen analyst Matthew Ramsay, who has an outperform rating and a $120 price target on AMD, said he's \"lookin' for more of the same.\"</p><p><blockquote>Cowen分析师马修·拉姆齐(Matthew Ramsay)对AMD给予跑赢大盘评级，目标价为120美元，他表示“正在寻找更多同样的结果”。</blockquote></p><p> \"We continue to monitor the PC market for signs of demand slowing or supply improving,\" Ramsay said. \"Near-term, we see resilient demand outside Chromebooks, but prefer a prudent/agnostic view on 2022 like AMD took on its last call.\"</p><p><blockquote>Ramsay表示：“我们将继续关注PC市场，寻找需求放缓或供应改善的迹象。”“短期内，我们看到Chromebook以外的需求具有弹性，但更倾向于对2022年采取谨慎/不可知论的观点，就像AMD在上一次看涨期权中采取的那样。”</blockquote></p><p> Earlier in the month, research firms released data showing that pandemic-fueled growth in PC shipments had slowed considerably as the world not only wrestles with a chip shortage but overall supply-chain issues.</p><p><blockquote>本月早些时候，研究公司发布的数据显示，疫情推动的个人电脑出货量增长已大幅放缓，因为世界不仅面临芯片短缺问题，还面临整体供应链问题。</blockquote></p><p></p><p> On data-center sales, Ramsay is even more optimistic estimating that segment will account for more than 25% of sales compared with less than 20% a year ago.</p><p><blockquote>在数据中心销售额方面，Ramsay更加乐观地估计该细分市场将占销售额的25%以上，而一年前这一比例还不到20%。</blockquote></p><p> \"We believe datacenter passing a quarter of AMD's business could draw investor attention,\" Ramsay said. \"We remind investors that the most important business for AMD remains datacenter, which we estimate doubled in 2020, with CEO Lisa Su noting she sees the business momentum accelerating in 2021.\"</p><p><blockquote>拉姆齐表示：“我们相信数据中心超过AMD四分之一的业务可能会引起投资者的关注。”“我们提醒投资者，AMD最重要的业务仍然是数据中心，我们估计该业务在2020年翻了一番，首席执行官Lisa Su指出，她预计2021年业务势头将加速。”</blockquote></p><p> Susquehanna Financial analyst Christopher Rolland, who has a positive rating and a $130 price target on AMD, said he expects another solid quarter driven by enterprise and server sales, but that \"given the slowing PC market, we do not expect mgmt to raise their FY top-line guidance as they have done in numerous updates over the last year.\"</p><p><blockquote>Susquehanna Financial分析师Christopher Rolland对AMD给予正面评级，目标价为130美元，他表示，他预计企业和服务器销售将推动另一个稳健的季度，但“鉴于PC市场放缓，我们预计管理层不会提高他们的财务业绩。”正如他们在去年的多次更新中所做的那样，顶线指导。”</blockquote></p><p> Still, Rolland expects AMD to report share gains from Intel in both desktop and laptop PCs as well as enterprise and gaming PCs.</p><p><blockquote>尽管如此，魅兰预计AMD在台式机和笔记本电脑以及企业级和游戏PC领域的份额将从英特尔增长。</blockquote></p><p> Of the 39 analysts who cover AMD, 23 have buy or overweight ratings, and 16 have hold ratings, with an average price target of $117.55.</p><p><blockquote>在关注AMD的39名分析师中，23名分析师给予买入或跑赢大盘评级，16名分析师给予持有评级，平均目标价为117.55美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/amd-earnings-look-to-again-succeed-where-intel-disappointed-11634942264?mod=mw_quote_news\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"source_url":"https://www.marketwatch.com/story/amd-earnings-look-to-again-succeed-where-intel-disappointed-11634942264?mod=mw_quote_news","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177412181","content_text":"AMD earnings preview: After showing data-center gains as Intel declined two quarters in a row, analysts now point to AMD's growing margins as Intel's are projected to shrink\nAdvanced Micro Devices Inc.’s growing series of Epyc server chips has been the talk of Wall Street in recent quarters, but that may switch to gross margins in this quarter’s earnings report.\nAdvanced Micro Devices Inc. is set to follow yet another rough earnings report from Intel Corp., and once again could show gains in an area that caused pain for its larger rival.\nAMD is scheduled to report third-quarter earnings on Tuesday after the close of markets, after Intel reported an earnings beat Thursday that hardly mattered as revenue came in light. More important to analysts was Intel's forecast for declining margins over the next few years as its chief executive doubles down on new manufacturing capacity to try to retake its former glory as the undisputed chip leader.\nThat led to downgrades on Friday and Intel's worst one-day performance since the chip leader said it was going to delay its next generation of chips, an announcement that had fired up even more investor support for AMD back then.\nBernstein analyst Stacy Rasgon, who has a market perform rating on AMD and a $110 price target, said AMD will continue to benefit from Intel's transition, and called attention to an AMD metric that was one of enormous concern during Intel's call: Gross margins.\n\"We believe Street gross margin estimates appear unaggressive going forward (which is not something we have typically said for AMD), and the company is now (for the first time ever) starting to return cash,\" Rasgon said.\nThat underscores another show of how Intel and AMD are transitioning with respect to one another: Analysts on the Intel call were very concerned that Intel's margins were falling despite company assurances they would stay just above 50% for the next few years. Meanwhile, AMD gross margins have been rising, and are likely to break above 50%, if not in this earnings report, then sometime soon. Three months ago, AMD reported gross margins of 48%, up from 44% in the previous year.\nWhile AMD is referred to as Intel's \"smaller rival,\" that gap has been steadily closing for a while now. At Friday's close, AMD had a market cap of $145.34 billion, or nearly 73% of Intel's $200.66 billion. Just this past summer, AMD's $111.5 billion valuation was a little more than half Intel's $219.5 billion cap.\nOne other are to look at will be data-center sales, as finally swung to a gain in that important segment in the quarter. Over the past two quarters, Intel has posted significant year-over-year declines in the increasingly important category, while AMD has more than doubled its sales. That raises the question whether Intel clawed back some market share, or whether data-center sales were just generally better all around, which AMD's report could answer.\nWhat to expect\nEarnings: Of the 34 analysts surveyed by FactSet, AMD on average is expected to post adjusted earnings of 66 cents a share, up from 41 cents a share reported in the year-ago period. Estimize, a software platform that crowdsources estimates from hedge-fund executives, brokerages, buy-side analysts and others, calls for earnings of 72 cents a share.\nRevenue: Of the 32 analysts polled by FactSet, AMD, on average, is expected to post revenue of $4.11 billion, up from the $2.8 billion reported in the year-ago quarter. AMD had forecast $4 billion to $4.2 billion. Estimize expects revenue of $4.22 billion.\nStock movement: While AMD earnings and sales have both topped Wall Street estimates over the past five quarterly reports, but shares only gained the next day twice, about three months ago and when the stock popped nearly 13% five quarters ago.\nAMD shares rose 9.6% in the third quarter. In contrast, the PHLX Semiconductor Index declined 2.6%, the S&P 500 index rose 0.2%, and the tech-heavy Nasdaq Composite Index declined 0.4%. On Friday, the day after Intel's report, AMD shares closed at a record high of $119.82.\nWhat analysts are saying\nCowen analyst Matthew Ramsay, who has an outperform rating and a $120 price target on AMD, said he's \"lookin' for more of the same.\"\n\"We continue to monitor the PC market for signs of demand slowing or supply improving,\" Ramsay said. \"Near-term, we see resilient demand outside Chromebooks, but prefer a prudent/agnostic view on 2022 like AMD took on its last call.\"\nEarlier in the month, research firms released data showing that pandemic-fueled growth in PC shipments had slowed considerably as the world not only wrestles with a chip shortage but overall supply-chain issues.\nOn data-center sales, Ramsay is even more optimistic estimating that segment will account for more than 25% of sales compared with less than 20% a year ago.\n\"We believe datacenter passing a quarter of AMD's business could draw investor attention,\" Ramsay said. \"We remind investors that the most important business for AMD remains datacenter, which we estimate doubled in 2020, with CEO Lisa Su noting she sees the business momentum accelerating in 2021.\"\nSusquehanna Financial analyst Christopher Rolland, who has a positive rating and a $130 price target on AMD, said he expects another solid quarter driven by enterprise and server sales, but that \"given the slowing PC market, we do not expect mgmt to raise their FY top-line guidance as they have done in numerous updates over the last year.\"\nStill, Rolland expects AMD to report share gains from Intel in both desktop and laptop PCs as well as enterprise and gaming PCs.\nOf the 39 analysts who cover AMD, 23 have buy or overweight ratings, and 16 have hold ratings, with an average price target of $117.55.","news_type":1,"symbols_score_info":{"AMD":0.9}},"isVote":1,"tweetType":1,"viewCount":716,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858905093,"gmtCreate":1634958623253,"gmtModify":1634958623593,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/858905093","repostId":"1172683205","repostType":4,"isVote":1,"tweetType":1,"viewCount":771,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851884528,"gmtCreate":1634892593718,"gmtModify":1634895404349,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/851884528","repostId":"1145809326","repostType":4,"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850477593,"gmtCreate":1634622451079,"gmtModify":1634622451408,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578460931764306","idStr":"3578460931764306"},"themes":[],"htmlText":"&nbsp;help like pls","listText":"&nbsp;help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850477593","repostId":"1147398025","repostType":4,"repost":{"id":"1147398025","kind":"news","pubTimestamp":1634608414,"share":"https://www.laohu8.com/m/news/1147398025?lang=zh_CN&edition=full","pubTime":"2021-10-19 09:53","market":"us","language":"en","title":"Tesla and 15 Other EV Stocks Are Worth Almost as Much as 50 Traditional Car Makers. How That Makes Sense.<blockquote>特斯拉和其他15只电动汽车股票的价值几乎相当于50家传统汽车制造商的价值。这怎么说得通。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147398025","media":"Barrons","summary":"Tesla and other electric-vehicle makers account for almost half of the value wrapped up in car-manuf","content":"<p>Tesla&nbsp;and other electric-vehicle makers account for almost half of the value wrapped up in car-manufacturer stocks. Does that make sense?</p><p><blockquote>特斯拉和其他电动汽车制造商几乎占汽车制造商股票价值的一半。这有意义吗？</blockquote></p><p> Monday, Bernstein analyst Toni Sacconaghi asked that question. He’s a&nbsp;Tesla&nbsp;(ticker: TSLA) bear—rating shares Sell with a $300 price target—mainly because he believes the stock is pricey. Still, EVs can be worth half of the industry if investors buy into three ideas.</p><p><blockquote>周一，伯恩斯坦分析师托尼·萨科纳吉提出了这个问题。他对特斯拉（股票代码：TSLA）股票给予看跌评级，目标价为300美元，主要是因为他认为该股价格昂贵。尽管如此，如果投资者接受三个想法，电动汽车的价值可能会达到整个行业的一半。</blockquote></p><p> Today, 16 EV makers—including Tesla and yet-to-be public Rivian—are worth a combined $1.14 trillion. Tesla accounts for 74% of total EV value. Four of the top 10 most valuable auto makers are EV companies including: Tesla, Rivian,BYD&nbsp;(1211.Hong Kong), and&nbsp;NIO&nbsp;(NIO).</p><p><blockquote>如今，包括特斯拉和尚未上市的Rivian在内的16家电动汽车制造商的总价值为1.14万亿美元。特斯拉占电动汽车总价值的74%。十大最有价值汽车制造商中有四家是电动汽车公司，包括：特斯拉、Rivian、比亚迪（1211.Hong Kong）和蔚来（蔚来）。</blockquote></p><p> As for the makers of conventional vehicles, more than 50 auto makers are worth a combined $1.42 trillion. The most valuable traditional car companies are:Toyota Motor&nbsp;(TM),Volkswagen&nbsp;(VOW3.Germany),Daimler&nbsp;(DAI.Germany), and&nbsp;General Motors&nbsp;(GM).</p><p><blockquote>至于传统汽车制造商，50多家汽车制造商的总价值为1.42万亿美元。最有价值的传统车企是：丰田汽车(TM)、大众汽车(VOW3.Germany)、戴姆勒(DAI.Germany)、通用汽车(GM)。</blockquote></p><p> Sales by the traditional companies still dominates unit volume, selling about 99% of the cars globally—97% of those are gasoline-powered, and 2% are EV. The EV pure-plays sell the remaining 1% worldwide.</p><p><blockquote>传统公司的销量仍然主导着销量，在全球销售了约99%的汽车，其中97%是汽油动力汽车，2%是电动汽车。纯电动汽车在全球范围内销售剩余的1%。</blockquote></p><p> “The thinking, of course, is that pure-play EV vendors will ultimately come to dominate the automotive world,” wrote Sacconaghi in a Monday report.</p><p><blockquote>萨科纳吉在周一的一份报告中写道：“当然，我们的想法是纯电动汽车供应商最终将主导汽车世界。”</blockquote></p><p> That’s the first thing investors need to believe to justify EV valuations. Sacconaghi points out that 2014 pure-play EV companies accounted for 14% of electric-car sales. That’s 28% today. Pure-play EV companies’ market share is growing.</p><p><blockquote>这是投资者需要相信的第一件事，以证明电动汽车估值的合理性。萨科纳吉指出，2014年纯电动汽车公司占电动汽车销量的14%。今天是28%。纯电动汽车公司的市场份额正在增长。</blockquote></p><p> That’s the second belief required to stay bullish on EV makers’ stocks—that market share will continue to improve. “We suspect the market believes …that traditional OEMs will not be able to deliver competitive EV offerings in the future,” adds the analyst in his report. OEM is short for original equipment manufacturer, industry jargon for auto maker.</p><p><blockquote>这是保持看好电动汽车制造商股票所需的第二个信念——市场份额将继续提高。这位分析师在报告中补充道：“我们怀疑市场认为……传统原始设备制造商未来将无法提供有竞争力的电动汽车产品。”OEM是原始设备制造商的缩写，是汽车制造商的行业术语。</blockquote></p><p> The final thing investors need to believe is that EVs will be more profitable, per car, than conventional vehicles. EV companies tend to sell direct—which can help profitability. EV makers are also the leaders in selling add-on subscription based services. Tesla’s Full Self-Driving Capability, or FSD, is probably the best example. Tesla sells the higher levels of its autonomous-driving software as a monthly subscription or for $10,000.</p><p><blockquote>投资者需要相信的最后一件事是，电动汽车的每辆车利润将比传统汽车更高。电动汽车公司倾向于直接销售，这有助于提高盈利能力。电动汽车制造商也是销售附加订阅服务的领导者。特斯拉的全自动驾驶能力（FSD）可能是最好的例子。特斯拉以每月订阅或10,000美元的价格出售更高级别的自动驾驶软件。</blockquote></p><p> The mix of volume and profit growth driven by superior products could justify valuations, but Sacconaghi isn’t a believer. “Our contention is that the automotive industry is an increasingly global and hypercompetitive industry and we believe that surplus profits and technology innovation will likely be competed away over time.”</p><p><blockquote>优质产品推动的销量和利润增长的组合可能证明估值是合理的，但萨科纳吉并不相信这一点。“我们的论点是，汽车行业是一个日益全球化和竞争激烈的行业，我们相信，随着时间的推移，剩余利润和技术创新可能会被竞争夺走。”</blockquote></p><p> His views of the industry is one of the reasons he calls Tesla valuation “too rich.”</p><p><blockquote>他对该行业的看法是他对评级·特斯拉估值“过高”的原因之一。</blockquote></p><p> Time will tell who is right. Sacconaghi’s target price still implies Tesla should be the world’s most valuable car company, just not two to three times the value of Toyota.</p><p><blockquote>时间会证明谁是对的。萨科纳吉的目标价仍然意味着特斯拉应该是世界上最有价值的汽车公司，只是不是丰田价值的两到三倍。</blockquote></p><p> Tesla stock has been on a tear of late, adding 34% over the past three months as investors have become more bullish about third quarter earnings due out on Wednesday evening. Shares have gained another 3.2% Monday.</p><p><blockquote>由于投资者对周三晚间公布的第三季度财报更加看好，特斯拉股价最近一直在上涨，过去三个月上涨了34%。周一股价又上涨3.2%。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla and 15 Other EV Stocks Are Worth Almost as Much as 50 Traditional Car Makers. How That Makes Sense.<blockquote>特斯拉和其他15只电动汽车股票的价值几乎相当于50家传统汽车制造商的价值。这怎么说得通。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla and 15 Other EV Stocks Are Worth Almost as Much as 50 Traditional Car Makers. How That Makes Sense.<blockquote>特斯拉和其他15只电动汽车股票的价值几乎相当于50家传统汽车制造商的价值。这怎么说得通。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-10-19 09:53</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla&nbsp;and other electric-vehicle makers account for almost half of the value wrapped up in car-manufacturer stocks. Does that make sense?</p><p><blockquote>特斯拉和其他电动汽车制造商几乎占汽车制造商股票价值的一半。这有意义吗？</blockquote></p><p> Monday, Bernstein analyst Toni Sacconaghi asked that question. He’s a&nbsp;Tesla&nbsp;(ticker: TSLA) bear—rating shares Sell with a $300 price target—mainly because he believes the stock is pricey. Still, EVs can be worth half of the industry if investors buy into three ideas.</p><p><blockquote>周一，伯恩斯坦分析师托尼·萨科纳吉提出了这个问题。他对特斯拉（股票代码：TSLA）股票给予看跌评级，目标价为300美元，主要是因为他认为该股价格昂贵。尽管如此，如果投资者接受三个想法，电动汽车的价值可能会达到整个行业的一半。</blockquote></p><p> Today, 16 EV makers—including Tesla and yet-to-be public Rivian—are worth a combined $1.14 trillion. Tesla accounts for 74% of total EV value. Four of the top 10 most valuable auto makers are EV companies including: Tesla, Rivian,BYD&nbsp;(1211.Hong Kong), and&nbsp;NIO&nbsp;(NIO).</p><p><blockquote>如今，包括特斯拉和尚未上市的Rivian在内的16家电动汽车制造商的总价值为1.14万亿美元。特斯拉占电动汽车总价值的74%。十大最有价值汽车制造商中有四家是电动汽车公司，包括：特斯拉、Rivian、比亚迪（1211.Hong Kong）和蔚来（蔚来）。</blockquote></p><p> As for the makers of conventional vehicles, more than 50 auto makers are worth a combined $1.42 trillion. The most valuable traditional car companies are:Toyota Motor&nbsp;(TM),Volkswagen&nbsp;(VOW3.Germany),Daimler&nbsp;(DAI.Germany), and&nbsp;General Motors&nbsp;(GM).</p><p><blockquote>至于传统汽车制造商，50多家汽车制造商的总价值为1.42万亿美元。最有价值的传统车企是：丰田汽车(TM)、大众汽车(VOW3.Germany)、戴姆勒(DAI.Germany)、通用汽车(GM)。</blockquote></p><p> Sales by the traditional companies still dominates unit volume, selling about 99% of the cars globally—97% of those are gasoline-powered, and 2% are EV. The EV pure-plays sell the remaining 1% worldwide.</p><p><blockquote>传统公司的销量仍然主导着销量，在全球销售了约99%的汽车，其中97%是汽油动力汽车，2%是电动汽车。纯电动汽车在全球范围内销售剩余的1%。</blockquote></p><p> “The thinking, of course, is that pure-play EV vendors will ultimately come to dominate the automotive world,” wrote Sacconaghi in a Monday report.</p><p><blockquote>萨科纳吉在周一的一份报告中写道：“当然，我们的想法是纯电动汽车供应商最终将主导汽车世界。”</blockquote></p><p> That’s the first thing investors need to believe to justify EV valuations. Sacconaghi points out that 2014 pure-play EV companies accounted for 14% of electric-car sales. That’s 28% today. Pure-play EV companies’ market share is growing.</p><p><blockquote>这是投资者需要相信的第一件事，以证明电动汽车估值的合理性。萨科纳吉指出，2014年纯电动汽车公司占电动汽车销量的14%。今天是28%。纯电动汽车公司的市场份额正在增长。</blockquote></p><p> That’s the second belief required to stay bullish on EV makers’ stocks—that market share will continue to improve. “We suspect the market believes …that traditional OEMs will not be able to deliver competitive EV offerings in the future,” adds the analyst in his report. OEM is short for original equipment manufacturer, industry jargon for auto maker.</p><p><blockquote>这是保持看好电动汽车制造商股票所需的第二个信念——市场份额将继续提高。这位分析师在报告中补充道：“我们怀疑市场认为……传统原始设备制造商未来将无法提供有竞争力的电动汽车产品。”OEM是原始设备制造商的缩写，是汽车制造商的行业术语。</blockquote></p><p> The final thing investors need to believe is that EVs will be more profitable, per car, than conventional vehicles. EV companies tend to sell direct—which can help profitability. EV makers are also the leaders in selling add-on subscription based services. Tesla’s Full Self-Driving Capability, or FSD, is probably the best example. Tesla sells the higher levels of its autonomous-driving software as a monthly subscription or for $10,000.</p><p><blockquote>投资者需要相信的最后一件事是，电动汽车的每辆车利润将比传统汽车更高。电动汽车公司倾向于直接销售，这有助于提高盈利能力。电动汽车制造商也是销售附加订阅服务的领导者。特斯拉的全自动驾驶能力（FSD）可能是最好的例子。特斯拉以每月订阅或10,000美元的价格出售更高级别的自动驾驶软件。</blockquote></p><p> The mix of volume and profit growth driven by superior products could justify valuations, but Sacconaghi isn’t a believer. “Our contention is that the automotive industry is an increasingly global and hypercompetitive industry and we believe that surplus profits and technology innovation will likely be competed away over time.”</p><p><blockquote>优质产品推动的销量和利润增长的组合可能证明估值是合理的，但萨科纳吉并不相信这一点。“我们的论点是，汽车行业是一个日益全球化和竞争激烈的行业，我们相信，随着时间的推移，剩余利润和技术创新可能会被竞争夺走。”</blockquote></p><p> His views of the industry is one of the reasons he calls Tesla valuation “too rich.”</p><p><blockquote>他对该行业的看法是他对评级·特斯拉估值“过高”的原因之一。</blockquote></p><p> Time will tell who is right. Sacconaghi’s target price still implies Tesla should be the world’s most valuable car company, just not two to three times the value of Toyota.</p><p><blockquote>时间会证明谁是对的。萨科纳吉的目标价仍然意味着特斯拉应该是世界上最有价值的汽车公司，只是不是丰田价值的两到三倍。</blockquote></p><p> Tesla stock has been on a tear of late, adding 34% over the past three months as investors have become more bullish about third quarter earnings due out on Wednesday evening. Shares have gained another 3.2% Monday.</p><p><blockquote>由于投资者对周三晚间公布的第三季度财报更加看好，特斯拉股价最近一直在上涨，过去三个月上涨了34%。周一股价又上涨3.2%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/tesla-stock-nio-51634569822?mod=hp_DAY_6\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VLKAF":"Volkswagen AG","01211":"比亚迪股份","XPEV":"小鹏汽车","TSLA":"特斯拉","NIO":"蔚来","GM":"通用汽车","LI":"理想汽车","DDAIF":"戴姆勒汽车","TM":"丰田汽车"},"source_url":"https://www.barrons.com/articles/tesla-stock-nio-51634569822?mod=hp_DAY_6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147398025","content_text":"Tesla and other electric-vehicle makers account for almost half of the value wrapped up in car-manufacturer stocks. Does that make sense?\nMonday, Bernstein analyst Toni Sacconaghi asked that question. He’s a Tesla (ticker: TSLA) bear—rating shares Sell with a $300 price target—mainly because he believes the stock is pricey. Still, EVs can be worth half of the industry if investors buy into three ideas.\nToday, 16 EV makers—including Tesla and yet-to-be public Rivian—are worth a combined $1.14 trillion. Tesla accounts for 74% of total EV value. Four of the top 10 most valuable auto makers are EV companies including: Tesla, Rivian,BYD (1211.Hong Kong), and NIO (NIO).\nAs for the makers of conventional vehicles, more than 50 auto makers are worth a combined $1.42 trillion. The most valuable traditional car companies are:Toyota Motor (TM),Volkswagen (VOW3.Germany),Daimler (DAI.Germany), and General Motors (GM).\nSales by the traditional companies still dominates unit volume, selling about 99% of the cars globally—97% of those are gasoline-powered, and 2% are EV. The EV pure-plays sell the remaining 1% worldwide.\n“The thinking, of course, is that pure-play EV vendors will ultimately come to dominate the automotive world,” wrote Sacconaghi in a Monday report.\nThat’s the first thing investors need to believe to justify EV valuations. Sacconaghi points out that 2014 pure-play EV companies accounted for 14% of electric-car sales. That’s 28% today. Pure-play EV companies’ market share is growing.\nThat’s the second belief required to stay bullish on EV makers’ stocks—that market share will continue to improve. “We suspect the market believes …that traditional OEMs will not be able to deliver competitive EV offerings in the future,” adds the analyst in his report. OEM is short for original equipment manufacturer, industry jargon for auto maker.\nThe final thing investors need to believe is that EVs will be more profitable, per car, than conventional vehicles. EV companies tend to sell direct—which can help profitability. EV makers are also the leaders in selling add-on subscription based services. Tesla’s Full Self-Driving Capability, or FSD, is probably the best example. Tesla sells the higher levels of its autonomous-driving software as a monthly subscription or for $10,000.\nThe mix of volume and profit growth driven by superior products could justify valuations, but Sacconaghi isn’t a believer. “Our contention is that the automotive industry is an increasingly global and hypercompetitive industry and we believe that surplus profits and technology innovation will likely be competed away over time.”\nHis views of the industry is one of the reasons he calls Tesla valuation “too rich.”\nTime will tell who is right. Sacconaghi’s target price still implies Tesla should be the world’s most valuable car company, just not two to three times the value of Toyota.\nTesla stock has been on a tear of late, adding 34% over the past three months as investors have become more bullish about third quarter earnings due out on Wednesday evening. Shares have gained another 3.2% Monday.","news_type":1,"symbols_score_info":{"NIO":0.9,"DDAIF":0.9,"XPEV":0.9,"GM":0.9,"TM":0.9,"VLKAF":0.9,"LI":0.9,"TSLA":0.9,"01211":0.9}},"isVote":1,"tweetType":1,"viewCount":604,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":845925801,"gmtCreate":1636267978006,"gmtModify":1636267978349,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/845925801","repostId":"2181074782","repostType":4,"isVote":1,"tweetType":1,"viewCount":2653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851884528,"gmtCreate":1634892593718,"gmtModify":1634895404349,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/851884528","repostId":"1145809326","repostType":4,"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878134865,"gmtCreate":1637158688164,"gmtModify":1637158688263,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help liek","listText":"help liek","text":"help liek","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/878134865","repostId":"1102706296","repostType":4,"repost":{"id":"1102706296","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637154279,"share":"https://www.laohu8.com/m/news/1102706296?lang=zh_CN&edition=full","pubTime":"2021-11-17 21:04","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102706296","media":"Tiger Newspress","summary":"U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.At 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.Tesla – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million","content":"<p>U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.</p><p><blockquote>美国股指期货周三持平，因强劲的零售盈利和数据显示经济复苏步入正轨后，投资者对美联储提前加息感到担忧。</blockquote></p><p> At 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&amp;P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.</p><p><blockquote>美国东部时间上午08:00，道琼斯电子迷你指数下跌25点，跌幅0.07%。标普500 e-mini上涨0.25点，涨幅0.01%，纳斯达克100 e-mini上涨24.25点，涨幅0.15%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3313a552f1f185ff01396db4679b33e7\" tg-width=\"1080\" tg-height=\"411\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Tesla(TSLA)</b> – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million shares. Tesla rose 1.2% in premarket action.</p><p><blockquote><b>特斯拉(TSLA)</b>——特斯拉CEO Elon Musk又出售了9.73亿美元的特斯拉股票，以支付因行使涵盖210万股股票的期权而产生的税单。特斯拉在盘前上涨1.2%。</blockquote></p><p> <b>Rivian(RIVN)</b> – Rivian turned red from green in the premarket and has yet to experience a losing session since the electric vehicle maker went public last Wednesday. Rivian has been up about 15% in each of the past two trading days and closed Tuesday at $172.01 compared with its IPO price of $78.</p><p><blockquote><b>Rivian(RIVN)</b>-Rivian在盘前由绿转红，自这家电动汽车制造商上周三上市以来尚未经历过亏损。Rivian在过去两个交易日中每个交易日均上涨约15%，周二收盘价为172.01美元，而其IPO价格为78美元。</blockquote></p><p> <b>Lucid Group(LCID)</b> – The electric vehicle maker rose another 5.5% in the premarket following a nearly 24% surge Tuesday. Yesterday’s rally came amid Lucid’s statement that it was seeing “significant demand” for its Lucid Air model.</p><p><blockquote><b>Lucid集团(LCID)</b>–这家电动汽车制造商继周二飙升近24%后，盘前又上涨5.5%。昨天的上涨是在Lucid声明看到对其Lucid Air型号的“巨大需求”之际发生的。</blockquote></p><p> <b>Pfizer(PFE),BioNTech(BNTX)</b> – The FDA has promised a quick review of the application to approve the Pfizer/BioNTech Covid-19 booster dose for all adults. The New York Times reports that a decision could come as soon as Thursday. BioNTech rose 1.6% in the premarket, while Pfizer gained 0.7%.</p><p><blockquote><b>辉瑞(PFE)、BioNTech(BNTX)</b>-FDA承诺快速审查批准辉瑞/BioNTech新冠加强剂量用于所有成年人的申请。《纽约时报》报道称，最早可能于周四做出决定。BioNTech盘前上涨1.6%，辉瑞上涨0.7%。</blockquote></p><p> <b>Roku(ROKU) </b>– The stock was downgraded to “sell” from “neutral” at Moffett Nathanson, which said signs of slowing revenue growth for the video streaming device maker have become more obvious and forced the firm to rethink its long-term assumptions. Roku shares fell 2.8% in premarket trading.</p><p><blockquote><b>Roku(Roku)</b>-Moffett Nathanson将该股评级从“中性”下调至“卖出”，该公司表示，这家视频流媒体设备制造商收入增长放缓的迹象变得更加明显，迫使该公司重新考虑其长期假设。Roku股价在盘前交易中下跌2.8%。</blockquote></p><p> <b>Baidu(BIDU)</b> – Baidu beat estimates on the top and bottom lines for its latest quarter, with the China-based e-commerce company benefiting from stronger ad sales as well as strength in cloud and artificial intelligence products. Baidu added 0.5% in the premarket.</p><p><blockquote><b>百度(BIDU)</b>-百度最近一个季度的营收和利润均超出预期，这家总部位于中国的电子商务公司受益于强劲的广告销售以及云和人工智能产品的实力。百度盘前上涨0.5%。</blockquote></p><p> <b>Visa(V)</b>&nbsp;–&nbsp;Visa&nbsp;fell 3.4% after Amazon.com&nbsp;said it would stop accepting credit cards issued by the world's largest payment processor in the United Kingdom from next year due to the high fees charged for transactions.</p><p><blockquote><b>签证(V)</b>-Visa跌3.4%，此前亚马逊表示，由于交易收取高额费用，将从明年起停止接受全球最大支付处理商英国发行的信用卡。</blockquote></p><p> <b>Boeing(BA)</b>&nbsp;–&nbsp;Wells Fargo&nbsp;upgraded shares of Boeing to overweight from equal weight, saying in a note to clients Wednesday that the company was set up for a stretch of good news following several years of underperformance.Boeing&nbsp;shares&nbsp;rose&nbsp;1.6%&nbsp;in premarket trading.</p><p><blockquote><b>波音(BA)</b>-富国银行周三在给客户的一份报告中表示，该公司在经历了几年的表现不佳后，已经准备好迎接一系列利好消息。波音股价在盘前交易中上涨1.</blockquote></p><p> <b>PayPal(PYPL)</b>&nbsp;–&nbsp;PayPal Holdings&nbsp;shares&nbsp;slip 2.3%&nbsp;in premarket trading after Bernstein analyst Harshita Rawat downgrades the stock to Market Perform from Outperform as change in the payments space accelerates putting PayPal at risk of being disrupted.</p><p><blockquote><b>PayPal(PYPL)</b>-PayPal控股公司股价在盘前交易中下跌2.3%，此前Bernstein分析师Harshita Rawat将该股评级从跑赢大盘下调至大盘表现，因为支付领域的变化加速，PayPal面临被扰乱的风险。</blockquote></p><p> <b>Lowe’s(LOW)</b> – Lowe’s rose 3.4% in the premarket after beating estimates on the top and bottom lines and raising its annual revenue forecast. The home improvement retailer earned an adjusted $2.73 per share for the third quarter, 37 cents above estimates, with comparable store sales up 2.2%. Analysts had expected comp sales to decline by 1.5%.</p><p><blockquote><b>劳氏（低）</b>-劳氏(Lowe's)在营收和利润超出预期并上调年收入预期后，盘前上涨3.4%。这家家居装修零售商第三季度调整后每股收益为2.73美元，比预期高出37美分，同店销售额增长2.2%。分析师此前预计公司销售额将下降1.5%。</blockquote></p><p> <b>Target(TGT)</b> – Target reported an adjusted quarterly profit of $3.03 per share, beating consensus estimates by 20 cents, with revenue also above Street projections. Comparable store sales rose 12.7% compared with forecasts of an 8.2% increase. Despite the beats, the retailer’s shares slid 3.7% in premarket action.</p><p><blockquote><b>目标（TGT）</b>-Target公布调整后季度利润为每股3.03美元，比市场普遍预期高出20美分，收入也高于华尔街预测。同店销售额增长12.7%，预期增长8.2%。尽管表现出色，该零售商的股价在盘前下跌了3.7%。</blockquote></p><p> <b>GlaxoSmithKline(GSK),Vir Biotechnology(VIR)</b> – The drug makers signed contracts to sell about $1 billion worth of their Covid-19 treatment to the U.S. government. The government also has an option to buy additional doses that last through March 2022. Glaxo was down 0.4% in premarket trading, but Vir’s stock soared 13.4%.</p><p><blockquote><b>葛兰素史克(GSK)、维尔生物技术(VIR)</b>-制药商签署了向美国政府出售价值约10亿美元的Covid-19治疗药物的合同。政府还可以选择购买持续到2022年3月的额外剂量。葛兰素史克在盘前交易中下跌0.4%，但Vir股价飙升13.4%。</blockquote></p><p> <b>Arrival(ARVL)</b>&nbsp;–&nbsp;Arrival&nbsp;stock&nbsp;tumbled&nbsp;13.4%&nbsp;in premarket trading.Arrival&nbsp;announced today the commencement of an underwritten public offering of 25,000,000 ordinary shares (the “Follow-on Offering”) pursuant to a registration statement on Form F-1 filed with&nbsp;SEC. In connection with the Follow-on Offering, Arrival intends to grant the underwriters the option to purchase up to 3,750,000 additional ordinary shares. All shares are being offered by Arrival.</p><p><blockquote><b>到达(ARVL)</b>Arrival股票在盘前交易中暴跌13.4%。Arrival今天宣布，根据向美国证券交易委员会提交的F-1表格登记声明，开始承销公开发行25,000,000股普通股（“后续发行”）。就后续发行而言，Arrival打算授予承销商购买最多3,750,000股额外普通股的选择权。所有股票均由Arrival发行。</blockquote></p><p> <b>La-Z-Boy(LZB)</b> – La-Z-Boy jumped 7.6% in premarket trading after the furniture maker beat estimates by 8 cents with a quarterly profit of 85 cents per share. Revenue also beat forecasts, and the company said it continues to see strong consumer demand although it has been impacted by supply chain disruptions.</p><p><blockquote><b>La-Z-Boy(LZB)</b>-La-Z-Boy在盘前交易中上涨7.6%，此前这家家具制造商超出预期8美分，季度利润为每股85美分。收入也超出了预期，该公司表示，尽管受到供应链中断的影响，但消费者需求仍然强劲。</blockquote></p><p></p><p> <b>Deere(DE) </b>– Deere workers will vote on a tentative contract offer today, after rejecting two previous tentative pacts. Those workers have been on strike since October 14.</p><p><blockquote><b>Deere（DE）</b>-在拒绝了之前的两项暂定协议后，Deere工人将于今天就暂定合同进行投票。这些工人自10月14日以来一直在罢工。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-17 21:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.</p><p><blockquote>美国股指期货周三持平，因强劲的零售盈利和数据显示经济复苏步入正轨后，投资者对美联储提前加息感到担忧。</blockquote></p><p> At 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&amp;P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.</p><p><blockquote>美国东部时间上午08:00，道琼斯电子迷你指数下跌25点，跌幅0.07%。标普500 e-mini上涨0.25点，涨幅0.01%，纳斯达克100 e-mini上涨24.25点，涨幅0.15%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3313a552f1f185ff01396db4679b33e7\" tg-width=\"1080\" tg-height=\"411\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Stocks making the biggest moves premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Tesla(TSLA)</b> – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million shares. Tesla rose 1.2% in premarket action.</p><p><blockquote><b>特斯拉(TSLA)</b>——特斯拉CEO Elon Musk又出售了9.73亿美元的特斯拉股票，以支付因行使涵盖210万股股票的期权而产生的税单。特斯拉在盘前上涨1.2%。</blockquote></p><p> <b>Rivian(RIVN)</b> – Rivian turned red from green in the premarket and has yet to experience a losing session since the electric vehicle maker went public last Wednesday. Rivian has been up about 15% in each of the past two trading days and closed Tuesday at $172.01 compared with its IPO price of $78.</p><p><blockquote><b>Rivian(RIVN)</b>-Rivian在盘前由绿转红，自这家电动汽车制造商上周三上市以来尚未经历过亏损。Rivian在过去两个交易日中每个交易日均上涨约15%，周二收盘价为172.01美元，而其IPO价格为78美元。</blockquote></p><p> <b>Lucid Group(LCID)</b> – The electric vehicle maker rose another 5.5% in the premarket following a nearly 24% surge Tuesday. Yesterday’s rally came amid Lucid’s statement that it was seeing “significant demand” for its Lucid Air model.</p><p><blockquote><b>Lucid集团(LCID)</b>–这家电动汽车制造商继周二飙升近24%后，盘前又上涨5.5%。昨天的上涨是在Lucid声明看到对其Lucid Air型号的“巨大需求”之际发生的。</blockquote></p><p> <b>Pfizer(PFE),BioNTech(BNTX)</b> – The FDA has promised a quick review of the application to approve the Pfizer/BioNTech Covid-19 booster dose for all adults. The New York Times reports that a decision could come as soon as Thursday. BioNTech rose 1.6% in the premarket, while Pfizer gained 0.7%.</p><p><blockquote><b>辉瑞(PFE)、BioNTech(BNTX)</b>-FDA承诺快速审查批准辉瑞/BioNTech新冠加强剂量用于所有成年人的申请。《纽约时报》报道称，最早可能于周四做出决定。BioNTech盘前上涨1.6%，辉瑞上涨0.7%。</blockquote></p><p> <b>Roku(ROKU) </b>– The stock was downgraded to “sell” from “neutral” at Moffett Nathanson, which said signs of slowing revenue growth for the video streaming device maker have become more obvious and forced the firm to rethink its long-term assumptions. Roku shares fell 2.8% in premarket trading.</p><p><blockquote><b>Roku(Roku)</b>-Moffett Nathanson将该股评级从“中性”下调至“卖出”，该公司表示，这家视频流媒体设备制造商收入增长放缓的迹象变得更加明显，迫使该公司重新考虑其长期假设。Roku股价在盘前交易中下跌2.8%。</blockquote></p><p> <b>Baidu(BIDU)</b> – Baidu beat estimates on the top and bottom lines for its latest quarter, with the China-based e-commerce company benefiting from stronger ad sales as well as strength in cloud and artificial intelligence products. Baidu added 0.5% in the premarket.</p><p><blockquote><b>百度(BIDU)</b>-百度最近一个季度的营收和利润均超出预期，这家总部位于中国的电子商务公司受益于强劲的广告销售以及云和人工智能产品的实力。百度盘前上涨0.5%。</blockquote></p><p> <b>Visa(V)</b>&nbsp;–&nbsp;Visa&nbsp;fell 3.4% after Amazon.com&nbsp;said it would stop accepting credit cards issued by the world's largest payment processor in the United Kingdom from next year due to the high fees charged for transactions.</p><p><blockquote><b>签证(V)</b>-Visa跌3.4%，此前亚马逊表示，由于交易收取高额费用，将从明年起停止接受全球最大支付处理商英国发行的信用卡。</blockquote></p><p> <b>Boeing(BA)</b>&nbsp;–&nbsp;Wells Fargo&nbsp;upgraded shares of Boeing to overweight from equal weight, saying in a note to clients Wednesday that the company was set up for a stretch of good news following several years of underperformance.Boeing&nbsp;shares&nbsp;rose&nbsp;1.6%&nbsp;in premarket trading.</p><p><blockquote><b>波音(BA)</b>-富国银行周三在给客户的一份报告中表示，该公司在经历了几年的表现不佳后，已经准备好迎接一系列利好消息。波音股价在盘前交易中上涨1.</blockquote></p><p> <b>PayPal(PYPL)</b>&nbsp;–&nbsp;PayPal Holdings&nbsp;shares&nbsp;slip 2.3%&nbsp;in premarket trading after Bernstein analyst Harshita Rawat downgrades the stock to Market Perform from Outperform as change in the payments space accelerates putting PayPal at risk of being disrupted.</p><p><blockquote><b>PayPal(PYPL)</b>-PayPal控股公司股价在盘前交易中下跌2.3%，此前Bernstein分析师Harshita Rawat将该股评级从跑赢大盘下调至大盘表现，因为支付领域的变化加速，PayPal面临被扰乱的风险。</blockquote></p><p> <b>Lowe’s(LOW)</b> – Lowe’s rose 3.4% in the premarket after beating estimates on the top and bottom lines and raising its annual revenue forecast. The home improvement retailer earned an adjusted $2.73 per share for the third quarter, 37 cents above estimates, with comparable store sales up 2.2%. Analysts had expected comp sales to decline by 1.5%.</p><p><blockquote><b>劳氏（低）</b>-劳氏(Lowe's)在营收和利润超出预期并上调年收入预期后，盘前上涨3.4%。这家家居装修零售商第三季度调整后每股收益为2.73美元，比预期高出37美分，同店销售额增长2.2%。分析师此前预计公司销售额将下降1.5%。</blockquote></p><p> <b>Target(TGT)</b> – Target reported an adjusted quarterly profit of $3.03 per share, beating consensus estimates by 20 cents, with revenue also above Street projections. Comparable store sales rose 12.7% compared with forecasts of an 8.2% increase. Despite the beats, the retailer’s shares slid 3.7% in premarket action.</p><p><blockquote><b>目标（TGT）</b>-Target公布调整后季度利润为每股3.03美元，比市场普遍预期高出20美分，收入也高于华尔街预测。同店销售额增长12.7%，预期增长8.2%。尽管表现出色，该零售商的股价在盘前下跌了3.7%。</blockquote></p><p> <b>GlaxoSmithKline(GSK),Vir Biotechnology(VIR)</b> – The drug makers signed contracts to sell about $1 billion worth of their Covid-19 treatment to the U.S. government. The government also has an option to buy additional doses that last through March 2022. Glaxo was down 0.4% in premarket trading, but Vir’s stock soared 13.4%.</p><p><blockquote><b>葛兰素史克(GSK)、维尔生物技术(VIR)</b>-制药商签署了向美国政府出售价值约10亿美元的Covid-19治疗药物的合同。政府还可以选择购买持续到2022年3月的额外剂量。葛兰素史克在盘前交易中下跌0.4%，但Vir股价飙升13.4%。</blockquote></p><p> <b>Arrival(ARVL)</b>&nbsp;–&nbsp;Arrival&nbsp;stock&nbsp;tumbled&nbsp;13.4%&nbsp;in premarket trading.Arrival&nbsp;announced today the commencement of an underwritten public offering of 25,000,000 ordinary shares (the “Follow-on Offering”) pursuant to a registration statement on Form F-1 filed with&nbsp;SEC. In connection with the Follow-on Offering, Arrival intends to grant the underwriters the option to purchase up to 3,750,000 additional ordinary shares. All shares are being offered by Arrival.</p><p><blockquote><b>到达(ARVL)</b>Arrival股票在盘前交易中暴跌13.4%。Arrival今天宣布，根据向美国证券交易委员会提交的F-1表格登记声明，开始承销公开发行25,000,000股普通股（“后续发行”）。就后续发行而言，Arrival打算授予承销商购买最多3,750,000股额外普通股的选择权。所有股票均由Arrival发行。</blockquote></p><p> <b>La-Z-Boy(LZB)</b> – La-Z-Boy jumped 7.6% in premarket trading after the furniture maker beat estimates by 8 cents with a quarterly profit of 85 cents per share. Revenue also beat forecasts, and the company said it continues to see strong consumer demand although it has been impacted by supply chain disruptions.</p><p><blockquote><b>La-Z-Boy(LZB)</b>-La-Z-Boy在盘前交易中上涨7.6%，此前这家家具制造商超出预期8美分，季度利润为每股85美分。收入也超出了预期，该公司表示，尽管受到供应链中断的影响，但消费者需求仍然强劲。</blockquote></p><p></p><p> <b>Deere(DE) </b>– Deere workers will vote on a tentative contract offer today, after rejecting two previous tentative pacts. Those workers have been on strike since October 14.</p><p><blockquote><b>Deere（DE）</b>-在拒绝了之前的两项暂定协议后，Deere工人将于今天就暂定合同进行投票。这些工人自10月14日以来一直在罢工。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LOW":"劳氏","LZB":"La-Z-Boy家具",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","RIVN":"Rivian Automotive, Inc.","V":"Visa","TGT":"塔吉特","VIR":"Vir Biotechnology, Inc.","BIDU":"百度","BNTX":"BioNTech SE","PYPL":"PayPal","ROKU":"Roku Inc","BA":"波音","GSK":"葛兰素史克","PFE":"辉瑞","LCID":"Lucid Group Inc","TSLA":"特斯拉","DE":"迪尔股份有限公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102706296","content_text":"U.S. stock index futures were flat on Wednesday as investors fretted over early rate hikes by the Federal Reserve after strong retail earnings and data showed an economic recovery was on track.\nAt 08:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%. S&P 500 e-minis were up 0.25 points, or 0.01% and Nasdaq 100 e-minis were up 24.25 points, or 0.15%.\n\nStocks making the biggest moves premarket:\nTesla(TSLA) – Tesla CEO Elon Musk sold another $973 million in Tesla stock to cover a tax bill generated by the exercise of options covering 2.1 million shares. Tesla rose 1.2% in premarket action.\nRivian(RIVN) – Rivian turned red from green in the premarket and has yet to experience a losing session since the electric vehicle maker went public last Wednesday. Rivian has been up about 15% in each of the past two trading days and closed Tuesday at $172.01 compared with its IPO price of $78.\nLucid Group(LCID) – The electric vehicle maker rose another 5.5% in the premarket following a nearly 24% surge Tuesday. Yesterday’s rally came amid Lucid’s statement that it was seeing “significant demand” for its Lucid Air model.\nPfizer(PFE),BioNTech(BNTX) – The FDA has promised a quick review of the application to approve the Pfizer/BioNTech Covid-19 booster dose for all adults. The New York Times reports that a decision could come as soon as Thursday. BioNTech rose 1.6% in the premarket, while Pfizer gained 0.7%.\nRoku(ROKU) – The stock was downgraded to “sell” from “neutral” at Moffett Nathanson, which said signs of slowing revenue growth for the video streaming device maker have become more obvious and forced the firm to rethink its long-term assumptions. Roku shares fell 2.8% in premarket trading.\nBaidu(BIDU) – Baidu beat estimates on the top and bottom lines for its latest quarter, with the China-based e-commerce company benefiting from stronger ad sales as well as strength in cloud and artificial intelligence products. Baidu added 0.5% in the premarket.\nVisa(V) – Visa fell 3.4% after Amazon.com said it would stop accepting credit cards issued by the world's largest payment processor in the United Kingdom from next year due to the high fees charged for transactions.\nBoeing(BA) – Wells Fargo upgraded shares of Boeing to overweight from equal weight, saying in a note to clients Wednesday that the company was set up for a stretch of good news following several years of underperformance.Boeing shares rose 1.6% in premarket trading.\nPayPal(PYPL) – PayPal Holdings shares slip 2.3% in premarket trading after Bernstein analyst Harshita Rawat downgrades the stock to Market Perform from Outperform as change in the payments space accelerates putting PayPal at risk of being disrupted.\nLowe’s(LOW) – Lowe’s rose 3.4% in the premarket after beating estimates on the top and bottom lines and raising its annual revenue forecast. The home improvement retailer earned an adjusted $2.73 per share for the third quarter, 37 cents above estimates, with comparable store sales up 2.2%. Analysts had expected comp sales to decline by 1.5%.\nTarget(TGT) – Target reported an adjusted quarterly profit of $3.03 per share, beating consensus estimates by 20 cents, with revenue also above Street projections. Comparable store sales rose 12.7% compared with forecasts of an 8.2% increase. Despite the beats, the retailer’s shares slid 3.7% in premarket action.\nGlaxoSmithKline(GSK),Vir Biotechnology(VIR) – The drug makers signed contracts to sell about $1 billion worth of their Covid-19 treatment to the U.S. government. The government also has an option to buy additional doses that last through March 2022. Glaxo was down 0.4% in premarket trading, but Vir’s stock soared 13.4%.\nArrival(ARVL) – Arrival stock tumbled 13.4% in premarket trading.Arrival announced today the commencement of an underwritten public offering of 25,000,000 ordinary shares (the “Follow-on Offering”) pursuant to a registration statement on Form F-1 filed with SEC. In connection with the Follow-on Offering, Arrival intends to grant the underwriters the option to purchase up to 3,750,000 additional ordinary shares. All shares are being offered by Arrival.\nLa-Z-Boy(LZB) – La-Z-Boy jumped 7.6% in premarket trading after the furniture maker beat estimates by 8 cents with a quarterly profit of 85 cents per share. Revenue also beat forecasts, and the company said it continues to see strong consumer demand although it has been impacted by supply chain disruptions.\nDeere(DE) – Deere workers will vote on a tentative contract offer today, after rejecting two previous tentative pacts. Those workers have been on strike since October 14.","news_type":1,"symbols_score_info":{"YMmain":0.9,"V":0.9,"PFE":0.9,"TGT":0.9,"ROKU":0.9,".IXIC":0.9,".DJI":0.9,"BA":0.9,"LCID":0.9,"PYPL":0.9,"RIVN":0.9,"TSLA":0.9,"LZB":0.9,"ARVL":0.9,".SPX":0.9,"GSK":0.9,"LOW":0.9,"VIR":0.9,"DE":0.9,"BNTX":0.9,"BIDU":0.9,"ESmain":0.9,"NQmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2051,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":181179108,"gmtCreate":1623381268604,"gmtModify":1634033953418,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like and comment pls","listText":"help like and comment pls","text":"help like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/181179108","repostId":"1182261359","repostType":4,"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137260685,"gmtCreate":1622351104347,"gmtModify":1634102106760,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like and comment pls","listText":"help like and comment pls","text":"help like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/137260685","repostId":"2138948877","repostType":4,"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":823714334,"gmtCreate":1633661484783,"gmtModify":1633661485174,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/823714334","repostId":"1163018074","repostType":4,"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":886583897,"gmtCreate":1631605326019,"gmtModify":1631889296019,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/886583897","repostId":"1133790240","repostType":4,"repost":{"id":"1133790240","kind":"news","pubTimestamp":1631605138,"share":"https://www.laohu8.com/m/news/1133790240?lang=zh_CN&edition=full","pubTime":"2021-09-14 15:38","market":"us","language":"en","title":"Here's Why Ocugen Is Skyrocketing On Monday<blockquote>这就是Ocugen周一飙升的原因</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133790240","media":"Motley Fool","summary":"There's both good and bad news for this troubled coronavirus vaccine biotech.\nWhat happened\nOcugen(N","content":"<p>There's both good and bad news for this troubled coronavirus vaccine biotech.</p><p><blockquote>对于这种陷入困境的冠状病毒疫苗生物技术公司来说，既有好消息也有坏消息。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> <b>Ocugen</b>(NASDAQ:OCGN)&nbsp;shares surged 15.8% on heavy volume to $8.28 apiece on Monday, sources told Indian news agency Asian News International that the World Health Organization will likely grant emergency use listing for Indian coronavirus vaccine Covaxin this week.</p><p><blockquote><b>奥库根</b>（纳斯达克：OCGN）周一股价放量飙升15.8%，至每股8.28美元，消息人士告诉印度通讯社亚洲新闻国际，世界卫生组织可能会在本周批准印度冠状病毒疫苗Covaxin的紧急使用上市。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> An EUL from the WHO would give credibility for more regulatory agencies around the world to approve Covaxin. In clinical trials, the vaccine demonstrated 77.8% effectiveness against symptomatic COVID-19, including those cases caused by variant strains. India-based Bharat Biotech owns the worldwide commercialization rights to Covaxin except in the U.S. and Canada, where it licensed them to Ocugen.</p><p><blockquote>世卫组织的EUL将为世界各地更多监管机构批准科瓦克辛提供可信度。在临床试验中，该疫苗对有症状的新冠肺炎（包括由变异毒株引起的病例）表现出77.8%的有效性。总部位于印度的Bharat Biotech拥有科瓦克辛的全球商业化权利，但在美国和加拿大除外，该公司将其授权给了Ocugen。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/303e002c71ec48a633f9aeed23a7c925\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> While the WHO development is good news, keep in mind that Ocugen is a research-stagebiotechwith no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.</p><p><blockquote>虽然世卫组织的进展是个好消息，但请记住，Ocugen是一家处于研究阶段的生物技术公司，没有后期候选产品，甚至不拥有科瓦克辛。更糟糕的是，该公司一直在向美国寻求生物制剂许可申请。美国食品药品监督管理局自6月起批准，这将需要很长时间，还需要额外的临床试验来支持该申请。如果这还不够，这家合资企业一半的利润将归巴拉特生物技术公司所有。</blockquote></p><p> The company's market cap has soared to $1.5 billion -- even though it only plans to sell 100 million doses of Covaxin in the states. At a time when there is an abundance of&nbsp;approved alternatives&nbsp;available, it's best to be careful around Ocugen's stock.</p><p><blockquote>该公司的市值已飙升至15亿美元——尽管它只计划在美国销售1亿剂科瓦克辛。在有大量经批准的替代品可用的时候，最好小心Ocugen的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Ocugen Is Skyrocketing On Monday<blockquote>这就是Ocugen周一飙升的原因</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Ocugen Is Skyrocketing On Monday<blockquote>这就是Ocugen周一飙升的原因</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-14 15:38</span>\n</p>\n</h4>\n</header>\n<article>\n<p>There's both good and bad news for this troubled coronavirus vaccine biotech.</p><p><blockquote>对于这种陷入困境的冠状病毒疫苗生物技术公司来说，既有好消息也有坏消息。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> <b>Ocugen</b>(NASDAQ:OCGN)&nbsp;shares surged 15.8% on heavy volume to $8.28 apiece on Monday, sources told Indian news agency Asian News International that the World Health Organization will likely grant emergency use listing for Indian coronavirus vaccine Covaxin this week.</p><p><blockquote><b>奥库根</b>（纳斯达克：OCGN）周一股价放量飙升15.8%，至每股8.28美元，消息人士告诉印度通讯社亚洲新闻国际，世界卫生组织可能会在本周批准印度冠状病毒疫苗Covaxin的紧急使用上市。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> An EUL from the WHO would give credibility for more regulatory agencies around the world to approve Covaxin. In clinical trials, the vaccine demonstrated 77.8% effectiveness against symptomatic COVID-19, including those cases caused by variant strains. India-based Bharat Biotech owns the worldwide commercialization rights to Covaxin except in the U.S. and Canada, where it licensed them to Ocugen.</p><p><blockquote>世卫组织的EUL将为世界各地更多监管机构批准科瓦克辛提供可信度。在临床试验中，该疫苗对有症状的新冠肺炎（包括由变异毒株引起的病例）表现出77.8%的有效性。总部位于印度的Bharat Biotech拥有科瓦克辛的全球商业化权利，但在美国和加拿大除外，该公司将其授权给了Ocugen。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/303e002c71ec48a633f9aeed23a7c925\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> While the WHO development is good news, keep in mind that Ocugen is a research-stagebiotechwith no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.</p><p><blockquote>虽然世卫组织的进展是个好消息，但请记住，Ocugen是一家处于研究阶段的生物技术公司，没有后期候选产品，甚至不拥有科瓦克辛。更糟糕的是，该公司一直在向美国寻求生物制剂许可申请。美国食品药品监督管理局自6月起批准，这将需要很长时间，还需要额外的临床试验来支持该申请。如果这还不够，这家合资企业一半的利润将归巴拉特生物技术公司所有。</blockquote></p><p> The company's market cap has soared to $1.5 billion -- even though it only plans to sell 100 million doses of Covaxin in the states. At a time when there is an abundance of&nbsp;approved alternatives&nbsp;available, it's best to be careful around Ocugen's stock.</p><p><blockquote>该公司的市值已飙升至15亿美元——尽管它只计划在美国销售1亿剂科瓦克辛。在有大量经批准的替代品可用的时候，最好小心Ocugen的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/13/heres-why-ocugen-is-skyrocketing-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2021/09/13/heres-why-ocugen-is-skyrocketing-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133790240","content_text":"There's both good and bad news for this troubled coronavirus vaccine biotech.\nWhat happened\nOcugen(NASDAQ:OCGN) shares surged 15.8% on heavy volume to $8.28 apiece on Monday, sources told Indian news agency Asian News International that the World Health Organization will likely grant emergency use listing for Indian coronavirus vaccine Covaxin this week.\nSo what\nAn EUL from the WHO would give credibility for more regulatory agencies around the world to approve Covaxin. In clinical trials, the vaccine demonstrated 77.8% effectiveness against symptomatic COVID-19, including those cases caused by variant strains. India-based Bharat Biotech owns the worldwide commercialization rights to Covaxin except in the U.S. and Canada, where it licensed them to Ocugen.\nIMAGE SOURCE: GETTY IMAGES.\nNow what\nWhile the WHO development is good news, keep in mind that Ocugen is a research-stagebiotechwith no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.\nThe company's market cap has soared to $1.5 billion -- even though it only plans to sell 100 million doses of Covaxin in the states. At a time when there is an abundance of approved alternatives available, it's best to be careful around Ocugen's stock.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863651385,"gmtCreate":1632388986547,"gmtModify":1632800740641,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls&nbsp;","listText":"help like pls&nbsp;","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/863651385","repostId":"1142732764","repostType":4,"isVote":1,"tweetType":1,"viewCount":611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815173443,"gmtCreate":1630661040782,"gmtModify":1631891408405,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/815173443","repostId":"1115885693","repostType":4,"repost":{"id":"1115885693","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630657884,"share":"https://www.laohu8.com/m/news/1115885693?lang=zh_CN&edition=full","pubTime":"2021-09-03 16:31","market":"us","language":"en","title":"Meta Materials shares jumped 9.5% in premarket trading<blockquote>Meta Materials股价盘前交易上涨9.5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115885693","media":"Tiger Newspress","summary":"Meta Materials shares jumped 9.5% in premarket trading.\nAs growth investors focus on companies with ","content":"<p>Meta&nbsp;Materials&nbsp;shares&nbsp;jumped&nbsp;9.5%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>Meta Materials股价在盘前交易中上涨9.</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6735d98c58dd37f7b480d596413f56f0\" tg-width=\"872\" tg-height=\"621\" referrerpolicy=\"no-referrer\">As growth investors focus on companies with high-end, innovative technologies, Meta Materials has come into focus. This is a company designed to be the next-generation growth stock investors are looking for. The company produces a range of high-performance nano composites and other functional materials powering the explosive technological growth our economy is seeing.</p><p><blockquote>随着成长型投资者关注拥有高端创新技术的公司，Meta Materials成为人们关注的焦点。这家公司旨在成为投资者正在寻找的下一代成长型股票。该公司生产一系列高性能纳米复合材料和其他功能材料，为我们经济的爆炸性技术增长提供动力。</blockquote></p><p> Accordingly, Meta Materials is growing in interest among investors as a “picks and shovels” play on various strong secular catalysts. A speculative pick, Meta Materials provides investors with tremendous growth potential.</p><p><blockquote>因此，投资者对Meta Materials越来越感兴趣，因为它是各种强大的长期催化剂的“镐和铲子”游戏。Meta Materials是一种投机性选择，为投资者提供了巨大的增长潜力。</blockquote></p><p> However, another key catalyst appears to be driving MMAT stock. Let’s dive into what investors are focusing on right now.</p><p><blockquote>然而，另一个关键催化剂似乎正在推动MMAT股票。让我们深入了解投资者目前关注的内容。</blockquote></p><p> Potential short-squeeze stocks have been taking off once again this past week. For investors in Meta Materials, this is a good thing.</p><p><blockquote>过去一周，潜在的轧空股票再次起飞。对于元材料的投资者来说，这是一件好事。</blockquote></p><p> It appears Meta Materials has made the short-squeeze list among many retail traders. However, yesteday, an&nbsp;<b>S3 Partners</b>&nbsp;executive outlined his short-squeeze thesis for MMAT stock. This call, via a&nbsp;<i>CNBC</i>&nbsp;interview, has unsurprisingly emboldened retail traders to jump into MMAT stock.</p><p><blockquote>Meta Materials似乎已被许多散户交易者列入轧空名单。然而昨天，一个<b>S3合作伙伴</b>高管概述了他对MMAT股票的轧空论点。这个看涨期权，通过一个<i>CNBC</i>采访，不出所料，鼓励散户交易者买入MMAT股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meta Materials shares jumped 9.5% in premarket trading<blockquote>Meta Materials股价盘前交易上涨9.5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeta Materials shares jumped 9.5% in premarket trading<blockquote>Meta Materials股价盘前交易上涨9.5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-03 16:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Meta&nbsp;Materials&nbsp;shares&nbsp;jumped&nbsp;9.5%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>Meta Materials股价在盘前交易中上涨9.</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6735d98c58dd37f7b480d596413f56f0\" tg-width=\"872\" tg-height=\"621\" referrerpolicy=\"no-referrer\">As growth investors focus on companies with high-end, innovative technologies, Meta Materials has come into focus. This is a company designed to be the next-generation growth stock investors are looking for. The company produces a range of high-performance nano composites and other functional materials powering the explosive technological growth our economy is seeing.</p><p><blockquote>随着成长型投资者关注拥有高端创新技术的公司，Meta Materials成为人们关注的焦点。这家公司旨在成为投资者正在寻找的下一代成长型股票。该公司生产一系列高性能纳米复合材料和其他功能材料，为我们经济的爆炸性技术增长提供动力。</blockquote></p><p> Accordingly, Meta Materials is growing in interest among investors as a “picks and shovels” play on various strong secular catalysts. A speculative pick, Meta Materials provides investors with tremendous growth potential.</p><p><blockquote>因此，投资者对Meta Materials越来越感兴趣，因为它是各种强大的长期催化剂的“镐和铲子”游戏。Meta Materials是一种投机性选择，为投资者提供了巨大的增长潜力。</blockquote></p><p> However, another key catalyst appears to be driving MMAT stock. Let’s dive into what investors are focusing on right now.</p><p><blockquote>然而，另一个关键催化剂似乎正在推动MMAT股票。让我们深入了解投资者目前关注的内容。</blockquote></p><p> Potential short-squeeze stocks have been taking off once again this past week. For investors in Meta Materials, this is a good thing.</p><p><blockquote>过去一周，潜在的轧空股票再次起飞。对于元材料的投资者来说，这是一件好事。</blockquote></p><p> It appears Meta Materials has made the short-squeeze list among many retail traders. However, yesteday, an&nbsp;<b>S3 Partners</b>&nbsp;executive outlined his short-squeeze thesis for MMAT stock. This call, via a&nbsp;<i>CNBC</i>&nbsp;interview, has unsurprisingly emboldened retail traders to jump into MMAT stock.</p><p><blockquote>Meta Materials似乎已被许多散户交易者列入轧空名单。然而昨天，一个<b>S3合作伙伴</b>高管概述了他对MMAT股票的轧空论点。这个看涨期权，通过一个<i>CNBC</i>采访，不出所料，鼓励散户交易者买入MMAT股票。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MMAT":"Meta Materials Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115885693","content_text":"Meta Materials shares jumped 9.5% in premarket trading.\nAs growth investors focus on companies with high-end, innovative technologies, Meta Materials has come into focus. This is a company designed to be the next-generation growth stock investors are looking for. The company produces a range of high-performance nano composites and other functional materials powering the explosive technological growth our economy is seeing.\nAccordingly, Meta Materials is growing in interest among investors as a “picks and shovels” play on various strong secular catalysts. A speculative pick, Meta Materials provides investors with tremendous growth potential.\nHowever, another key catalyst appears to be driving MMAT stock. Let’s dive into what investors are focusing on right now.\nPotential short-squeeze stocks have been taking off once again this past week. For investors in Meta Materials, this is a good thing.\nIt appears Meta Materials has made the short-squeeze list among many retail traders. However, yesteday, an S3 Partners executive outlined his short-squeeze thesis for MMAT stock. This call, via a CNBC interview, has unsurprisingly emboldened retail traders to jump into MMAT stock.","news_type":1,"symbols_score_info":{"MMAT":0.9}},"isVote":1,"tweetType":1,"viewCount":438,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802100268,"gmtCreate":1627726180854,"gmtModify":1633756779422,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/802100268","repostId":"2155001152","repostType":4,"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173169601,"gmtCreate":1626647274203,"gmtModify":1633925386534,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"pls help like and comment&nbsp;","listText":"pls help like and comment&nbsp;","text":"pls help like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/173169601","repostId":"1183956332","repostType":4,"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129043652,"gmtCreate":1624347523776,"gmtModify":1634007448108,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"pls help like and comment pls&nbsp;","listText":"pls help like and comment pls&nbsp;","text":"pls help like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/129043652","repostId":"1100733883","repostType":4,"isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":828380466,"gmtCreate":1633844106193,"gmtModify":1633844106292,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/828380466","repostId":"2174920514","repostType":4,"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820541294,"gmtCreate":1633407469043,"gmtModify":1633407469376,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/820541294","repostId":"2172968917","repostType":4,"isVote":1,"tweetType":1,"viewCount":420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862463890,"gmtCreate":1632902989426,"gmtModify":1632903019543,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/862463890","repostId":"1198528044","repostType":4,"repost":{"id":"1198528044","kind":"news","pubTimestamp":1632882697,"share":"https://www.laohu8.com/m/news/1198528044?lang=zh_CN&edition=full","pubTime":"2021-09-29 10:31","market":"us","language":"en","title":"Technically Speaking: Is The Market \"Melting-Up?\"<blockquote>从技术上讲：市场正在“融化”吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1198528044","media":"seekingalpha","summary":"Summary\n\nGiven the Fed’s ongoing balance sheet operations, investors fully believe they have protect","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.</li>  <li>As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.</li>  <li>While it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent “this time is different”.</li> </ul> Is the<i>“market melting-up?”</i>Such was the question I received from my colleague at<i>Cut The Crap Investing.</i>It is an excellent question given the relentless increase in what investors believe is a<i>“no risk”</i>market.</p><p><blockquote><ul><li>鉴于美联储正在进行的资产负债表操作，投资者完全相信他们有能力免受经济衰退的影响。</li><li>与往常一样，投资大众相信未来的收益将证明在融化期间价格上涨是合理的。从来都不是那样的。</li><li>虽然在融化持续期间利用它是至关重要的，但不要过于自满“这次不同了”。</li></ul>是<i>“市场融化？”</i>这是我从我的同事那里收到的问题<i>少废话投资。</i>考虑到投资者认为的持续增长，这是一个很好的问题<i>“没有风险”</i>市场。</blockquote></p><p> Of course, we need a definition of precisely what constitutes a melt-up.</p><p><blockquote>当然，我们需要一个准确定义什么是融化。</blockquote></p><p>   <i>“A melt-up is a sustained and often unexpected improvement in the investment performance of an asset or asset class, driven partly</i>  <i><b>by a stampede of investors who don’t want to miss out on its rise,</b></i>  <i>rather than by fundamental improvements in the economy.“</i>–  <i>Investopedia</i>  Currently, there is sufficient evidence to support the idea of an exuberant market.<b><i>As noted previously:</i></b></p><p><blockquote><i>他说：“熔断是指一项资产或资产类别的投资表现持续且往往出乎意料的改善，部分原因是</i><i><b>不想错过其上涨机会的投资者蜂拥而至，</b></i><i>而不是经济的根本改善。”</i>–<i>投资百科</i>目前，有足够的证据支持市场繁荣的观点。<b><i>如前所述：</i></b></blockquote></p><p>   <i>“Near peaks of market cycles, investors become swept up by the underlying exuberance. That exuberance breeds the “rationalization” that “this time is different.” So how do you know the market is exuberant currently? Via Sentiment Trader:”</i>    <i>‘This type of market activity is an indication that markets have returned their ‘enthusiasm’ stage. Such is characterized by:’</i>  <ul>  <li><b><i>High optimism</i></b></li>  <li><b><i>Easy credit (too easy, with loose terms)</i></b></li>  <li><b><i>A rush of initial and secondary offerings</i></b></li>  <li><b><i>Risky stocks outperforming</i></b></li>  <li><b><i>Stretched valuations</i></b></li> </ul> <img src=\"https://static.tigerbbs.com/ff8de3a84084162ca86b415584bbf793\" tg-width=\"731\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote><i>“在市场周期接近顶峰时，投资者会被潜在的繁荣所席卷。这种繁荣滋生了“合理化”，即“这次不同了”。那么，你如何知道市场目前是繁荣的呢？通过情绪交易者：”</i><i>这种类型的市场活动表明市场已经回到了“热情”阶段。其特征在于：</i><ul><li><b><i>高度乐观</i></b></li><li><b><i>宽松信贷（太宽松，条款宽松）</i></b></li><li><b><i>首次和二次发行热潮</i></b></li><li><b><i>风险股跑赢大盘</i></b></li><li><b><i>估值过高</i></b></li></ul></blockquote></p><p> However, while one would expect individuals to exhibit caution in such an environment, the opposite is true. Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.</p><p><blockquote>然而，虽然人们会期望个人在这样的环境中表现出谨慎，但事实恰恰相反。鉴于美联储正在进行的资产负债表操作，投资者完全相信他们有能力免受经济衰退的影响。</blockquote></p><p> <b>A Visualization Of A Market Melting-Up</b></p><p><blockquote><b>市场融化的可视化</b></blockquote></p><p> It is often easier to visualize something rather than explain it.<b>Since 1900, only two previous market periods qualify as a melt-up: 1920-1929 and 1995-2000.</b>The chart below shows both periods in terms of price.</p><p><blockquote>想象某事通常比解释它更容易。<b>自1900年以来，只有两个市场时期符合熔化的条件：1920-1929年和1995-2000年。</b>下图显示了这两个时期的价格。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a218c7efe2ebd874d05c9ff7dd564436\" tg-width=\"797\" tg-height=\"437\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/9f193c9c32d55747bf7ff511c2f9fd53\" tg-width=\"793\" tg-height=\"439\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> However, the melt-up is also visually represented by the incredibly sharp rise in valuations. Such is essential because earnings are not rising at a fast enough clip to support higher prices.<b>As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.</b></p><p><blockquote>然而，估值的大幅上涨也直观地体现了这种融化。这一点至关重要，因为盈利增长速度不足以支撑价格上涨。<b>与往常一样，投资大众相信未来的收益将证明在融化期间价格上涨是合理的。从来都不是那样的。</b></blockquote></p><p> <img src=\"https://static.tigerbbs.com/c69e418d5a19d6fd03b305ab111e3be3\" tg-width=\"794\" tg-height=\"440\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/af03d3bbd071b8edfdf3a19e2c7b0bcd\" tg-width=\"796\" tg-height=\"437\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> We can compare those two previous periods with the current advance from the March 2020 lows. Again, we see a very similar sharp advance in price combined with a surge in valuations. As expected, investors are currently hoping that future earnings will rise sharply enough to justify current prices. However, the justification for paying high prices is the Federal Reserve’s ongoing balance sheet expansion.</p><p><blockquote>我们可以将前两个时期与当前从2020年3月低点的上涨进行比较。我们再次看到非常相似的价格大幅上涨和估值飙升。正如预期的那样，投资者目前希望未来收益将大幅上涨，足以证明当前价格的合理性。然而，支付高价的理由是美联储持续的资产负债表扩张。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f3562aea27b24ad4921d0f5cd497e072\" tg-width=\"804\" tg-height=\"444\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The following chart looks that the price advance and valuation measures a little differently. It shows the current deviation from the long-term exponential growth trend. Not surprisingly, during a market<i>“melt-up,”</i>there is a rapid deviation from the growth trend matching the acceleration in valuations.</p><p><blockquote>下图显示，价格上涨和估值指标略有不同。它显示了当前与长期指数增长趋势的背离。毫不奇怪，在市场期间<i>“融化。”</i>与估值加速相匹配的增长趋势出现了快速背离。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1419cf4b2afdcdc0f61e0cad862f498d\" tg-width=\"836\" tg-height=\"460\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The problem with market<i>“melt-ups”</i>is not the melt-up itself but what always follows.</p><p><blockquote>市场的问题<i>“融化”</i>不是融化本身，而是随之而来的一切。</blockquote></p><p> <b>Melting-Up Leads To Melting-Down</b></p><p><blockquote><b>熔化导致熔化</b></blockquote></p><p> A market melting-up is exciting while it lasts. During melt-ups, investors begin to rationalize why<i>“this time is different.”</i>They start taking on excess leverage to try and capitalize on the rapid advance in prices, and fundamentals take a back seat to price momentum.</p><p><blockquote>市场融化持续下去是令人兴奋的。在熔断期间，投资者开始合理化原因<i>“这次不一样。”</i>他们开始过度杠杆，试图利用价格的快速上涨，基本面让位于价格动能。</blockquote></p><p></p><p> Market melt-ups are all about<i>“psychology.”</i><b>Historically, whatever has been the catalyst to spark the disregard of risk is readily witnessed in the corresponding surge in price and valuations.</b>The chart below shows the long-term deviations in relative strength, deviations, and valuations. The previous<i>‘melt-up”</i>periods should be easy to spot when compared with the advance currently.</p><p><blockquote>市场融化都是关于<i>“心理学。”</i><b>从历史上看，无论引发忽视风险的催化剂是什么，都很容易在价格和估值的相应飙升中看到。</b>下图显示了相对强度、偏差和估值的长期偏差。上一篇<i>“融化”</i>与目前的进展相比，时期应该很容易发现。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bc04cb25c0199dd17475a551a5dd7ec1\" tg-width=\"869\" tg-height=\"1024\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Given that current extensions match only a few rare periods in history, a couple of points should be readily apparent.</p><p><blockquote>鉴于目前的延期仅与历史上少数罕见的时期相匹配，有几点应该是显而易见的。</blockquote></p><p> <ol>  <li><b><i>Melt-ups can longer than logic would predict.</i></b></li>  <li><b><i>The prevailing psychology is always “this time is different.”</i></b></li>  <li><b><i>Valuations are dismissed in exchange for measures of momentum and forward expectations.</i></b></li>  <li><b><i>Investors take on excess leverage and risk in order to participate in a seemingly “can’t lose” market.</i></b></li>  <li><b><i>Lastly, and inevitably, “melt-ups” end and always in the worst possible outcomes.</i></b></li> </ol> It is essential to recognize the markets are in a<i>“melt-up,</i>” and the duration of that event is unknowable. Therefore, investors need a strategy to participate in the advance and mitigate the damage from the eventual<i>“melting-down.”</i></p><p><blockquote><ol><li><b><i>融化的时间可能比逻辑预测的要长。</i></b></li><li><b><i>普遍的心理总是“这次不一样了”。</i></b></li><li><b><i>估值被驳回，以换取动量和前瞻性预期的衡量标准。</i></b></li><li><b><i>投资者为了参与一个看似“输不起”的市场，承担了过多的杠杆和风险。</i></b></li><li><b><i>最后，不可避免的是，“融化”以最糟糕的结果告终。</i></b></li></ol>必须认识到市场正处于<i>“融化，</i>“而且该事件的持续时间是未知的。因此，投资者需要一种策略来参与提前并减轻最终的损失<i>“熔化。”</i></blockquote></p><p> <b>Surviving The Melt-Up</b></p><p><blockquote><b>在融化中幸存下来</b></blockquote></p><p> <b>As noted, none of this means the next</b><b><i>“bear market”</i></b><b>is lurking.</b>Given that a market melting-up is a function of psychology, they can last longer and go further than logic would predict. What is required to “<i>end”</i>a melt-up is an unanticipated exogenous event that changes psychology from bullish to bearish. Such is when the stampede for the exits occurs, and prices decline very quickly.</p><p><blockquote><b>如上所述，这些都不意味着下一个</b><b><i>“熊市”</i></b><b>正在潜伏。</b>鉴于市场融化是心理作用，它们可以持续更长时间，走得比逻辑预测的更远。需要什么“<i>结束“</i>融化是一种意想不到的外生事件，它将心理从看涨转变为看跌。这就是人们蜂拥退出的时候，价格会迅速下跌。</blockquote></p><p> As such, investors need a set of guidelines to participate in the market advance. But, of course, the hard part is keeping those gains when corrections inevitably occur.</p><p><blockquote>因此，投资者需要一套指导方针来参与市场上涨。但是，当然，困难的部分是在不可避免地发生调整时保持这些收益。</blockquote></p><p> As portfolio managers for our clients, such is precisely the approach we must take. Accordingly, I have provided a general overview of the process that we employ.</p><p><blockquote>作为客户的投资组合经理，这正是我们必须采取的方法。因此，我提供了我们采用的流程的总体概述。</blockquote></p><p> <ol>  <li><i><b>Tighten up stop-loss levels</b></i><i>to current support levels for each position.(Provides identifiable exit points when the market reverses.)</i></li>  <li><i><b>Hedge portfolios</b></i><i>against major market declines.(Non-correlated assets, short-market positions, index put options)</i></li>  <li><i><b>Take profits</b></i><i>in positions that have been big winners(Rebalancing overbought or extended positions to capture gains but continue to participate in the advance.)</i></li>  <li><i><b>Sell laggards</b></i><i>and losers</i>.<i>(If something isn’t working in a market melt-up, it most likely won’t work during a broad decline. Better to eliminate the risk early.)</i></li>  <li><i><b>Raise cash</b></i><i>and rebalance portfolios to target weightings.(Rebalancing risk on a regular basis keeps hidden risks somewhat mitigated.)</i></li> </ol> <b>Notice, nothing in there says,</b><b><i>“sell everything and go to cash.”</i></b></p><p><blockquote><ol><li><i><b>收紧止损水平</b></i><i>每个头寸的当前支撑位。（当市场反转时提供可识别的退出点。）</i></li><li><i><b>对冲投资组合</b></i><i>（非相关资产、空头市场头寸、指数看跌期权）</i></li><li><i><b>获利了结</b></i><i>在已经成为大赢家的头寸中（重新平衡超买或扩展头寸以获取收益，但继续参与上涨。）</i></li><li><i><b>出售落后者</b></i><i>和失败者</i>.<i>（如果某些东西在市场融化时不起作用，那么在广泛下跌时很可能也不会起作用。最好尽早消除风险。）</i></li><li><i><b>筹集现金</b></i><i>并重新平衡投资组合以达到目标权重。（定期重新平衡风险可以在一定程度上减轻隐藏的风险。）</i></li></ol><b>注意，里面没有任何东西说，</b><b><i>“卖掉所有东西，去兑现。”</i></b></blockquote></p><p> There will be a time to raise significant levels of cash. A good portfolio management strategy will automatically ensure that<i>“stop-loss”</i>levels get triggered, exposure decreases, and cash levels rise when the selling begins.</p><p><blockquote>将会有一段时间来筹集大量现金。一个好的投资组合管理策略会自动确保<i>“止损”</i>当出售开始时，水平被触发，风险减少，现金水平上升。</blockquote></p><p> While it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent<i>“this time is different.”</i></p><p><blockquote>虽然有必要在融化持续期间利用它，但不要过于自满<i>“这次不一样。”</i></blockquote></p><p> It likely isn’t.</p><p><blockquote>很可能不是。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Technically Speaking: Is The Market \"Melting-Up?\"<blockquote>从技术上讲：市场正在“融化”吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTechnically Speaking: Is The Market \"Melting-Up?\"<blockquote>从技术上讲：市场正在“融化”吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2021-09-29 10:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.</li>  <li>As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.</li>  <li>While it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent “this time is different”.</li> </ul> Is the<i>“market melting-up?”</i>Such was the question I received from my colleague at<i>Cut The Crap Investing.</i>It is an excellent question given the relentless increase in what investors believe is a<i>“no risk”</i>market.</p><p><blockquote><ul><li>鉴于美联储正在进行的资产负债表操作，投资者完全相信他们有能力免受经济衰退的影响。</li><li>与往常一样，投资大众相信未来的收益将证明在融化期间价格上涨是合理的。从来都不是那样的。</li><li>虽然在融化持续期间利用它是至关重要的，但不要过于自满“这次不同了”。</li></ul>是<i>“市场融化？”</i>这是我从我的同事那里收到的问题<i>少废话投资。</i>考虑到投资者认为的持续增长，这是一个很好的问题<i>“没有风险”</i>市场。</blockquote></p><p> Of course, we need a definition of precisely what constitutes a melt-up.</p><p><blockquote>当然，我们需要一个准确定义什么是融化。</blockquote></p><p>   <i>“A melt-up is a sustained and often unexpected improvement in the investment performance of an asset or asset class, driven partly</i>  <i><b>by a stampede of investors who don’t want to miss out on its rise,</b></i>  <i>rather than by fundamental improvements in the economy.“</i>–  <i>Investopedia</i>  Currently, there is sufficient evidence to support the idea of an exuberant market.<b><i>As noted previously:</i></b></p><p><blockquote><i>他说：“熔断是指一项资产或资产类别的投资表现持续且往往出乎意料的改善，部分原因是</i><i><b>不想错过其上涨机会的投资者蜂拥而至，</b></i><i>而不是经济的根本改善。”</i>–<i>投资百科</i>目前，有足够的证据支持市场繁荣的观点。<b><i>如前所述：</i></b></blockquote></p><p>   <i>“Near peaks of market cycles, investors become swept up by the underlying exuberance. That exuberance breeds the “rationalization” that “this time is different.” So how do you know the market is exuberant currently? Via Sentiment Trader:”</i>    <i>‘This type of market activity is an indication that markets have returned their ‘enthusiasm’ stage. Such is characterized by:’</i>  <ul>  <li><b><i>High optimism</i></b></li>  <li><b><i>Easy credit (too easy, with loose terms)</i></b></li>  <li><b><i>A rush of initial and secondary offerings</i></b></li>  <li><b><i>Risky stocks outperforming</i></b></li>  <li><b><i>Stretched valuations</i></b></li> </ul> <img src=\"https://static.tigerbbs.com/ff8de3a84084162ca86b415584bbf793\" tg-width=\"731\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote><i>“在市场周期接近顶峰时，投资者会被潜在的繁荣所席卷。这种繁荣滋生了“合理化”，即“这次不同了”。那么，你如何知道市场目前是繁荣的呢？通过情绪交易者：”</i><i>这种类型的市场活动表明市场已经回到了“热情”阶段。其特征在于：</i><ul><li><b><i>高度乐观</i></b></li><li><b><i>宽松信贷（太宽松，条款宽松）</i></b></li><li><b><i>首次和二次发行热潮</i></b></li><li><b><i>风险股跑赢大盘</i></b></li><li><b><i>估值过高</i></b></li></ul></blockquote></p><p> However, while one would expect individuals to exhibit caution in such an environment, the opposite is true. Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.</p><p><blockquote>然而，虽然人们会期望个人在这样的环境中表现出谨慎，但事实恰恰相反。鉴于美联储正在进行的资产负债表操作，投资者完全相信他们有能力免受经济衰退的影响。</blockquote></p><p> <b>A Visualization Of A Market Melting-Up</b></p><p><blockquote><b>市场融化的可视化</b></blockquote></p><p> It is often easier to visualize something rather than explain it.<b>Since 1900, only two previous market periods qualify as a melt-up: 1920-1929 and 1995-2000.</b>The chart below shows both periods in terms of price.</p><p><blockquote>想象某事通常比解释它更容易。<b>自1900年以来，只有两个市场时期符合熔化的条件：1920-1929年和1995-2000年。</b>下图显示了这两个时期的价格。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a218c7efe2ebd874d05c9ff7dd564436\" tg-width=\"797\" tg-height=\"437\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/9f193c9c32d55747bf7ff511c2f9fd53\" tg-width=\"793\" tg-height=\"439\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> However, the melt-up is also visually represented by the incredibly sharp rise in valuations. Such is essential because earnings are not rising at a fast enough clip to support higher prices.<b>As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.</b></p><p><blockquote>然而，估值的大幅上涨也直观地体现了这种融化。这一点至关重要，因为盈利增长速度不足以支撑价格上涨。<b>与往常一样，投资大众相信未来的收益将证明在融化期间价格上涨是合理的。从来都不是那样的。</b></blockquote></p><p> <img src=\"https://static.tigerbbs.com/c69e418d5a19d6fd03b305ab111e3be3\" tg-width=\"794\" tg-height=\"440\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/af03d3bbd071b8edfdf3a19e2c7b0bcd\" tg-width=\"796\" tg-height=\"437\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> We can compare those two previous periods with the current advance from the March 2020 lows. Again, we see a very similar sharp advance in price combined with a surge in valuations. As expected, investors are currently hoping that future earnings will rise sharply enough to justify current prices. However, the justification for paying high prices is the Federal Reserve’s ongoing balance sheet expansion.</p><p><blockquote>我们可以将前两个时期与当前从2020年3月低点的上涨进行比较。我们再次看到非常相似的价格大幅上涨和估值飙升。正如预期的那样，投资者目前希望未来收益将大幅上涨，足以证明当前价格的合理性。然而，支付高价的理由是美联储持续的资产负债表扩张。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f3562aea27b24ad4921d0f5cd497e072\" tg-width=\"804\" tg-height=\"444\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The following chart looks that the price advance and valuation measures a little differently. It shows the current deviation from the long-term exponential growth trend. Not surprisingly, during a market<i>“melt-up,”</i>there is a rapid deviation from the growth trend matching the acceleration in valuations.</p><p><blockquote>下图显示，价格上涨和估值指标略有不同。它显示了当前与长期指数增长趋势的背离。毫不奇怪，在市场期间<i>“融化。”</i>与估值加速相匹配的增长趋势出现了快速背离。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1419cf4b2afdcdc0f61e0cad862f498d\" tg-width=\"836\" tg-height=\"460\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The problem with market<i>“melt-ups”</i>is not the melt-up itself but what always follows.</p><p><blockquote>市场的问题<i>“融化”</i>不是融化本身，而是随之而来的一切。</blockquote></p><p> <b>Melting-Up Leads To Melting-Down</b></p><p><blockquote><b>熔化导致熔化</b></blockquote></p><p> A market melting-up is exciting while it lasts. During melt-ups, investors begin to rationalize why<i>“this time is different.”</i>They start taking on excess leverage to try and capitalize on the rapid advance in prices, and fundamentals take a back seat to price momentum.</p><p><blockquote>市场融化持续下去是令人兴奋的。在熔断期间，投资者开始合理化原因<i>“这次不一样。”</i>他们开始过度杠杆，试图利用价格的快速上涨，基本面让位于价格动能。</blockquote></p><p></p><p> Market melt-ups are all about<i>“psychology.”</i><b>Historically, whatever has been the catalyst to spark the disregard of risk is readily witnessed in the corresponding surge in price and valuations.</b>The chart below shows the long-term deviations in relative strength, deviations, and valuations. The previous<i>‘melt-up”</i>periods should be easy to spot when compared with the advance currently.</p><p><blockquote>市场融化都是关于<i>“心理学。”</i><b>从历史上看，无论引发忽视风险的催化剂是什么，都很容易在价格和估值的相应飙升中看到。</b>下图显示了相对强度、偏差和估值的长期偏差。上一篇<i>“融化”</i>与目前的进展相比，时期应该很容易发现。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bc04cb25c0199dd17475a551a5dd7ec1\" tg-width=\"869\" tg-height=\"1024\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Given that current extensions match only a few rare periods in history, a couple of points should be readily apparent.</p><p><blockquote>鉴于目前的延期仅与历史上少数罕见的时期相匹配，有几点应该是显而易见的。</blockquote></p><p> <ol>  <li><b><i>Melt-ups can longer than logic would predict.</i></b></li>  <li><b><i>The prevailing psychology is always “this time is different.”</i></b></li>  <li><b><i>Valuations are dismissed in exchange for measures of momentum and forward expectations.</i></b></li>  <li><b><i>Investors take on excess leverage and risk in order to participate in a seemingly “can’t lose” market.</i></b></li>  <li><b><i>Lastly, and inevitably, “melt-ups” end and always in the worst possible outcomes.</i></b></li> </ol> It is essential to recognize the markets are in a<i>“melt-up,</i>” and the duration of that event is unknowable. Therefore, investors need a strategy to participate in the advance and mitigate the damage from the eventual<i>“melting-down.”</i></p><p><blockquote><ol><li><b><i>融化的时间可能比逻辑预测的要长。</i></b></li><li><b><i>普遍的心理总是“这次不一样了”。</i></b></li><li><b><i>估值被驳回，以换取动量和前瞻性预期的衡量标准。</i></b></li><li><b><i>投资者为了参与一个看似“输不起”的市场，承担了过多的杠杆和风险。</i></b></li><li><b><i>最后，不可避免的是，“融化”以最糟糕的结果告终。</i></b></li></ol>必须认识到市场正处于<i>“融化，</i>“而且该事件的持续时间是未知的。因此，投资者需要一种策略来参与提前并减轻最终的损失<i>“熔化。”</i></blockquote></p><p> <b>Surviving The Melt-Up</b></p><p><blockquote><b>在融化中幸存下来</b></blockquote></p><p> <b>As noted, none of this means the next</b><b><i>“bear market”</i></b><b>is lurking.</b>Given that a market melting-up is a function of psychology, they can last longer and go further than logic would predict. What is required to “<i>end”</i>a melt-up is an unanticipated exogenous event that changes psychology from bullish to bearish. Such is when the stampede for the exits occurs, and prices decline very quickly.</p><p><blockquote><b>如上所述，这些都不意味着下一个</b><b><i>“熊市”</i></b><b>正在潜伏。</b>鉴于市场融化是心理作用，它们可以持续更长时间，走得比逻辑预测的更远。需要什么“<i>结束“</i>融化是一种意想不到的外生事件，它将心理从看涨转变为看跌。这就是人们蜂拥退出的时候，价格会迅速下跌。</blockquote></p><p> As such, investors need a set of guidelines to participate in the market advance. But, of course, the hard part is keeping those gains when corrections inevitably occur.</p><p><blockquote>因此，投资者需要一套指导方针来参与市场上涨。但是，当然，困难的部分是在不可避免地发生调整时保持这些收益。</blockquote></p><p> As portfolio managers for our clients, such is precisely the approach we must take. Accordingly, I have provided a general overview of the process that we employ.</p><p><blockquote>作为客户的投资组合经理，这正是我们必须采取的方法。因此，我提供了我们采用的流程的总体概述。</blockquote></p><p> <ol>  <li><i><b>Tighten up stop-loss levels</b></i><i>to current support levels for each position.(Provides identifiable exit points when the market reverses.)</i></li>  <li><i><b>Hedge portfolios</b></i><i>against major market declines.(Non-correlated assets, short-market positions, index put options)</i></li>  <li><i><b>Take profits</b></i><i>in positions that have been big winners(Rebalancing overbought or extended positions to capture gains but continue to participate in the advance.)</i></li>  <li><i><b>Sell laggards</b></i><i>and losers</i>.<i>(If something isn’t working in a market melt-up, it most likely won’t work during a broad decline. Better to eliminate the risk early.)</i></li>  <li><i><b>Raise cash</b></i><i>and rebalance portfolios to target weightings.(Rebalancing risk on a regular basis keeps hidden risks somewhat mitigated.)</i></li> </ol> <b>Notice, nothing in there says,</b><b><i>“sell everything and go to cash.”</i></b></p><p><blockquote><ol><li><i><b>收紧止损水平</b></i><i>每个头寸的当前支撑位。（当市场反转时提供可识别的退出点。）</i></li><li><i><b>对冲投资组合</b></i><i>（非相关资产、空头市场头寸、指数看跌期权）</i></li><li><i><b>获利了结</b></i><i>在已经成为大赢家的头寸中（重新平衡超买或扩展头寸以获取收益，但继续参与上涨。）</i></li><li><i><b>出售落后者</b></i><i>和失败者</i>.<i>（如果某些东西在市场融化时不起作用，那么在广泛下跌时很可能也不会起作用。最好尽早消除风险。）</i></li><li><i><b>筹集现金</b></i><i>并重新平衡投资组合以达到目标权重。（定期重新平衡风险可以在一定程度上减轻隐藏的风险。）</i></li></ol><b>注意，里面没有任何东西说，</b><b><i>“卖掉所有东西，去兑现。”</i></b></blockquote></p><p> There will be a time to raise significant levels of cash. A good portfolio management strategy will automatically ensure that<i>“stop-loss”</i>levels get triggered, exposure decreases, and cash levels rise when the selling begins.</p><p><blockquote>将会有一段时间来筹集大量现金。一个好的投资组合管理策略会自动确保<i>“止损”</i>当出售开始时，水平被触发，风险减少，现金水平上升。</blockquote></p><p> While it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent<i>“this time is different.”</i></p><p><blockquote>虽然有必要在融化持续期间利用它，但不要过于自满<i>“这次不一样。”</i></blockquote></p><p> It likely isn’t.</p><p><blockquote>很可能不是。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4457469-technically-speaking-is-the-market-melting-up\">seekingalpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://seekingalpha.com/article/4457469-technically-speaking-is-the-market-melting-up","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198528044","content_text":"Summary\n\nGiven the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.\nAs is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.\nWhile it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent “this time is different”.\n\nIs the“market melting-up?”Such was the question I received from my colleague atCut The Crap Investing.It is an excellent question given the relentless increase in what investors believe is a“no risk”market.\nOf course, we need a definition of precisely what constitutes a melt-up.\n\n“A melt-up is a sustained and often unexpected improvement in the investment performance of an asset or asset class, driven partly\nby a stampede of investors who don’t want to miss out on its rise,\nrather than by fundamental improvements in the economy.“–\n Investopedia\n\nCurrently, there is sufficient evidence to support the idea of an exuberant market.As noted previously:\n\n“Near peaks of market cycles, investors become swept up by the underlying exuberance. That exuberance breeds the “rationalization” that “this time is different.” So how do you know the market is exuberant currently? Via Sentiment Trader:”\n\n\n‘This type of market activity is an indication that markets have returned their ‘enthusiasm’ stage. Such is characterized by:’\n\n\nHigh optimism\nEasy credit (too easy, with loose terms)\nA rush of initial and secondary offerings\nRisky stocks outperforming\nStretched valuations\n\n\nHowever, while one would expect individuals to exhibit caution in such an environment, the opposite is true. Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.\nA Visualization Of A Market Melting-Up\nIt is often easier to visualize something rather than explain it.Since 1900, only two previous market periods qualify as a melt-up: 1920-1929 and 1995-2000.The chart below shows both periods in terms of price.\n\nHowever, the melt-up is also visually represented by the incredibly sharp rise in valuations. Such is essential because earnings are not rising at a fast enough clip to support higher prices.As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.\n\nWe can compare those two previous periods with the current advance from the March 2020 lows. Again, we see a very similar sharp advance in price combined with a surge in valuations. As expected, investors are currently hoping that future earnings will rise sharply enough to justify current prices. However, the justification for paying high prices is the Federal Reserve’s ongoing balance sheet expansion.\n\nThe following chart looks that the price advance and valuation measures a little differently. It shows the current deviation from the long-term exponential growth trend. Not surprisingly, during a market“melt-up,”there is a rapid deviation from the growth trend matching the acceleration in valuations.\n\nThe problem with market“melt-ups”is not the melt-up itself but what always follows.\nMelting-Up Leads To Melting-Down\nA market melting-up is exciting while it lasts. During melt-ups, investors begin to rationalize why“this time is different.”They start taking on excess leverage to try and capitalize on the rapid advance in prices, and fundamentals take a back seat to price momentum.\nMarket melt-ups are all about“psychology.”Historically, whatever has been the catalyst to spark the disregard of risk is readily witnessed in the corresponding surge in price and valuations.The chart below shows the long-term deviations in relative strength, deviations, and valuations. The previous‘melt-up”periods should be easy to spot when compared with the advance currently.\n\nGiven that current extensions match only a few rare periods in history, a couple of points should be readily apparent.\n\nMelt-ups can longer than logic would predict.\nThe prevailing psychology is always “this time is different.”\nValuations are dismissed in exchange for measures of momentum and forward expectations.\nInvestors take on excess leverage and risk in order to participate in a seemingly “can’t lose” market.\nLastly, and inevitably, “melt-ups” end and always in the worst possible outcomes.\n\nIt is essential to recognize the markets are in a“melt-up,” and the duration of that event is unknowable. Therefore, investors need a strategy to participate in the advance and mitigate the damage from the eventual“melting-down.”\nSurviving The Melt-Up\nAs noted, none of this means the next“bear market”is lurking.Given that a market melting-up is a function of psychology, they can last longer and go further than logic would predict. What is required to “end”a melt-up is an unanticipated exogenous event that changes psychology from bullish to bearish. Such is when the stampede for the exits occurs, and prices decline very quickly.\nAs such, investors need a set of guidelines to participate in the market advance. But, of course, the hard part is keeping those gains when corrections inevitably occur.\nAs portfolio managers for our clients, such is precisely the approach we must take. Accordingly, I have provided a general overview of the process that we employ.\n\nTighten up stop-loss levelsto current support levels for each position.(Provides identifiable exit points when the market reverses.)\nHedge portfoliosagainst major market declines.(Non-correlated assets, short-market positions, index put options)\nTake profitsin positions that have been big winners(Rebalancing overbought or extended positions to capture gains but continue to participate in the advance.)\nSell laggardsand losers.(If something isn’t working in a market melt-up, it most likely won’t work during a broad decline. Better to eliminate the risk early.)\nRaise cashand rebalance portfolios to target weightings.(Rebalancing risk on a regular basis keeps hidden risks somewhat mitigated.)\n\nNotice, nothing in there says,“sell everything and go to cash.”\nThere will be a time to raise significant levels of cash. A good portfolio management strategy will automatically ensure that“stop-loss”levels get triggered, exposure decreases, and cash levels rise when the selling begins.\nWhile it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent“this time is different.”\nIt likely isn’t.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":436,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837880141,"gmtCreate":1629873670983,"gmtModify":1631891408421,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837880141","repostId":"2162087564","repostType":4,"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832638955,"gmtCreate":1629617025977,"gmtModify":1631891408424,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like plsss","listText":"help like plsss","text":"help like plsss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/832638955","repostId":"1133515985","repostType":4,"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148878016,"gmtCreate":1625969235335,"gmtModify":1633931283736,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like and comment pls&nbsp;","listText":"help like and comment pls&nbsp;","text":"help like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/148878016","repostId":"1166379040","repostType":4,"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873008385,"gmtCreate":1636784519129,"gmtModify":1636784519231,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like","listText":"help like","text":"help like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873008385","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849163266,"gmtCreate":1635735457005,"gmtModify":1635735457144,"author":{"id":"3578460931764306","authorId":"3578460931764306","name":"HENGJR","avatar":"https://static.tigerbbs.com/0596e746d9a22ec6462910c02c3129ce","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578460931764306","authorIdStr":"3578460931764306"},"themes":[],"htmlText":"help like pls","listText":"help like pls","text":"help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/849163266","repostId":"2179250221","repostType":4,"repost":{"id":"2179250221","kind":"news","pubTimestamp":1635721559,"share":"https://www.laohu8.com/m/news/2179250221?lang=zh_CN&edition=full","pubTime":"2021-11-01 07:05","market":"us","language":"en","title":"Federal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2179250221","media":"Yahoo Finance","summary":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set th","content":"<p><div> The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also ...</p><p><blockquote><div>美联储即将召开的货币政策会议将成为本周的焦点，并可能为期待已久的资产购买缩减公告奠定基础。与此同时，交易者也将...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Federal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFederal Reserve decision, October jobs report: What to know this week<blockquote>美联储决定、十月就业报告：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-11-01 07:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also ...</p><p><blockquote><div>美联储即将召开的货币政策会议将成为本周的焦点，并可能为期待已久的资产购买缩减公告奠定基础。与此同时，交易者也将...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RL":"拉夫劳伦","COP":"康菲石油","UBER":"优步","CRSR":"Corsair Gaming, Inc.","EL":"雅诗兰黛","PFE":"辉瑞","BLMN":"Bloomin' Brands","APO":"阿波罗全球管理","CLX":"高乐氏","ATVI":"动视暴雪",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179250221","content_text":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also await more data on the U.S. economic recovery with the Labor Department's monthly jobs report later this week.\nThe Federal Open Market Committee's (FOMC) November meeting will take place from Tuesday to Wednesday, with the policy statement and press conference from the meeting serving as the central bank's penultimate opportunity this year to announce formal plans to begin rolling back its crisis-era quantitative easing program. For the past year-and-a-half, the central bank has been purchasing $120 billion per month in agency mortgage-backed securities and Treasuries, as one major tool to support the economy during the pandemic.\nIn late September, the FOMC's latest monetary policy statement and press conference from Federal Reserve Chair Jerome Powell suggested the central bank was apt to announce the start of tapering before year-end, and continue the tapering process until \"around the middle of next year.\"\n\"The upcoming FOMC meeting will be important for three reasons: 1) the announcement of tapering; 2) guidance around what tapering means for the path of hikes; and 3) nuanced changes in views around inflation risks given recent data,\" wrote Bank of America economist Michelle Meyer in a note.\n\"The statement that announces the new pace of asset purchases will be followed by a note regarding flexibility stating that asset purchases are not on a pre-set course and will depend on the outlook for the labor market and inflation as well as an assessment of the efficacy of asset purchases,\" she predicted.\nShe noted that Powell may also use the press conference to reiterate that the end of tapering would not necessarily indicate the start of rate hikes, and that both policy actions are distinct. In previous public remarks, Powell has already made a similar point in previous public remarks, saying, \"the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.\"\nGiven the market has been anticipating the start to tapering for months now, speculation around when the Fed will make a move on interest rates has become a point of particular interest to investors. Investors and economists have mulled whether the Fed may need to act more quickly than previously telegraphed on adjusting interest rates to stave off inflation, which has proven more long-lasting than some had suggested.\nWASHINGTON, DC - SEPTEMBER 24: Federal Reserve Board Chairman Jerome Powell testifies during a Senate Banking Committee hearing on Capitol Hill on September 24, 2020 in Washington, DC. Powell and U.S. Treasury Secretary Steve Mnuchin are testifying about the CARES Act and the economic effects of the coronavirus pandemic. (Photo by Drew Angerer/Getty Images)Drew Angerer via Getty Images\nIn September, core personal consumption expenditures — the Fed's preferred gauge of underlying inflation — rose 3.6% over last year for a fourth consecutive month, coming in at the fastest clip since 1991. And earlier this month, Powell acknowledged in public remarks that the supply chain constraints and shortages that spurred the latest rise in prices are \"likely to last longer than previously expected, likely well into next year.\"\nWhile the central bank will not release an updated Summary of Economic Projections with their policy statement on Wednesday, the latest projections from the September meeting suggested the committee was split on rate hikes for 2022, with nine members seeing no rate hikes by the end of next year while the other nine members saw at least one hike.\n\"I think the Fed has pretty well determined to start the taper pretty quickly. We expect them to announce it next week and then start it soon thereafter, so that's pretty well carved in stone,\" Kathy Jones, Charles Schwab chief fixed income strategist, told Yahoo Finance Live last week. \"I think the big debate now is how quickly the Fed moves toward actually raising rates. The expectation in the market has really shifted to expecting as many as two rate hikes in 2022 and 2023 ... that’s a pretty aggressive pace of tightening.\"\nOctober jobs report\nOne of this week's most closely watched pieces of economic data will be the October jobs report, which is due for release on Friday from the Labor Department.\nEconomists are looking to see a pick-up in the pace of hiring for October after a disappointing print in September, when just 194,000 non-farm payrolls returned versus the half million expected. Over the past two months, payroll gains averaged at just 280,000. The unemployment rate is expected to take another small step toward pre-pandemic levels in October as well, with the jobless rate anticipated to dip to 4.7% from 4.8% the prior month.\nStill, the labor market has still fallen short its pre-pandemic conditions on a number of fronts. The unemployment rate has yet to return to its 50-year low of 3.5% from February 2020. And as of September, the civilian labor force was still down by about 3.1 million individuals from pre-virus levels.\nOne factor weighing on the labor market in August and September was the Delta variant, which may have deterred some workers from seeking employment in person for risk of infection. And an ongoing element dragging on the labor market's recovery has been a mismatch of supply and demand, with employers struggling to fill a near-record number of job openings while voluntary quits jumped to a historically high level.\n\"Next week’s October payrolls report will shed light on whether supply eased on diminishing constraints or if the labor market continues to face headwinds for now,\" wrote Rubeela Farooqi, chief U.S. economist for High Frequency Economics, in a note last week.\nBut some data from the past couple weeks has reflected favorably on conditions in the labor market in October. Weekly new unemployment claims broke below 300,000 for the first time since the start of the pandemic during the survey week for the October jobs report, or the week that includes the 12th of the month. And in the Conference Board's October Consumer Confidence Index, just 10.6% of consumers said jobs were \"hard to get,\" down from 13.0% in September. That brought the Conference Board's closely watched labor market differential, or percentage of consumers saying jobs are \"hard to get\" subtracted from the percentage saying jobs \"are plentiful,\" to 45, or its highest level since 2000.\nEconomic calendar\n\nMonday: Markit U.S. Manufacturing PMI, Oct. final (59.3 expected, 59.2 in September); Constructing spending, month-over-month, September (0.4% expected, 0.0% in August); ISM Manufacturing Index, Oct. (60.5 expected, 61.1 in September)\nTuesday: No notable reports scheduled for release\nWednesday: MBA Mortgage Applications, week ended Oct. 29 (0.3% during prior week); ADP Employment Change, Oct. (400,000 expected, 568,000 in September); ISM Services Index, October (62.0 expected, 61.9 in September); Factory Orders, September (-0.1% expected, 1.2% in August); Durable goods orders, September final (-0.4% in prior print; Durable goods orders excluding transportation, September final (0.4% in prior print); Non-defense capital goods orders excluding aircraft, September final (0.8% in prior print); Markit U.S. Services PMI, October final (58.2 expected, 58.2 in prior print); Markit U.S. Composite PMI, October final (57.3 in prior print); Federal Open Market Committee monetary policy decision\nThursday: Challenger job cuts, year-over-year, October (-84.9% in September); Initial jobless claims, week ended Oct. 30 (275,000 expected, 281,000 during prior week); Continuing claims, week ended Oct. 23 (2.147 million expected, 2.243 million during prior week); Non-farm productivity, Q3 preliminary (-3.2% expected, 2.1% in Q2); Unit Labor Costs, Q3 preliminary (6.9% expected, 1.3% in Q2); Trade balance, September (-$80.1 billion expected, -$73.3 billion in August)\nFriday: Change in non-farm payrolls, October (450,000 expected, 194,000 in September); Unemployment rate, October (4.7% expected, 4.8% in September); Average hourly earnings, month-over-month, October (4.7% expected, 4.8% in September); Average hourly earnings, year-over-year, October (4.9% expected, 4.6% in September); Labor Force Participation Rate, October (61.8% expected, 61.6% in September); Consumer Credit, September ($16.200 billion expected, $14.379 million in August)\n\nEarnings calendar\n\nMonday: Clorox (CLX), Avis Budget Group (CAR), ZoomInfo Technologies (ZI), Chegg Inc. (CHGG), Diamondback Energy (FANG), The Simon Property Group (SPG) after market close\nTuesday: Under Armour (UAA), Estee Lauder (EL), Ralph Lauren (RL), Apollo Global Management (APO), Corsair Gaming (CRSR), Bloomin' Brands (BLMN), ConocoPhillips (COP), Pfizer (PFE), Groupon (GPN), Marathon Petroleum (MPC) before market open; Mondelez (MDLZ), T-Mobile (TMUS), Akamai (AKAM), Activision Blizzard (ATVI), Lyft (LYFT), Match Group (MTCH), Devon Energy (DVN), Chesapeake Energy (CHK), Coursera (COUR), Zillow Group (ZG), Amgen (AMGN) after market close\nWednesday: Humana (HUM), Discovery Inc. (DISCA), The New York Times (NYT), Norwegian Cruise Line Holdings (NCLH), Marriott International (MAR), CVS Health Corp. (CVS), Sinclair Broadcast Group (SBGI) before market open; Booking Holdings (BKNG), Qorvo (QRVO), The Allstate Corp. (ALL), MGM Resorts International (MGM), $Take-Two Interactive Software(TTWO)$ (TTWO), Electronic Arts (EA), Vimeo (VMEO), Etsy (ETSY), GoDaddy (GDDY), Marathon Oil Corp. (MRO), Roku (ROKU), Qualcomm (QCOM) after market close\nThursday: Cigna (CI), Wayfair (W), ViacomCBS (VIAC), Nikola (NKLA), Duke Energy (DUK), Citrix Systems (CTXS), Regeneron Pharmaceuticals (REGN), Hanesbrands (HBI), Moderna (MRNA), Planet Fitness (PLNT), Vulcan Material (VMC), Kellogg (K), Square (SQ), Cloudflare (NET), Occidental Petroleum (OXY), Uber Technologies (UBER), American International Group (AIG), Shake Shack (SHAK), iHeartMedia (IHRT), Novavax (NVAX), IAC Interactive Corp. (IAC), Peloton (PTON), Dropbox (DBX), DataDog (DDOG), Pinterest (PINS), Skyworks Solutions (SWKS), Expedia (EXPE), Rocket Cos. (RKT), Live Nation Entertainment (LYV), Airbnb (ABNB)\nFriday: Wynn Resorts (WYNN), Dish Networks (DISH), Dominion Energy (D), DraftKings (DKNG), Goodyear Tire and Rubber (GT), Cinemark Holdings (CNK) before market open","news_type":1,"symbols_score_info":{"CRSR":0.9,".DJI":0.9,"PFE":0.9,"EL":0.9,"CLX":0.9,"RL":0.9,"BLMN":0.9,".SPX":0.9,"ATVI":0.9,"COP":0.9,"UBER":0.9,"APO":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}